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Detecting the start of an outbreak, quantifying its burden, disentangling the contribution of
different pathogens and evaluating the effectiveness of an intervention are research questions
common to several infectious diseases. The answers to these questions provide the epidemio-
logical understanding to prevent future outbreaks, by informing public health policies such
as drug stockpiling, vaccination regimes or non-medical interventions. We investigate the
use of statistical models to quantify burden of respiratory disease and evaluate effectiveness
of public health interventions, while accounting for the challenges posed by surveillance
data. The observational nature of the available information, affected by confounding, makes
causal statements difficult. Improvements to routinely employed methodologies are proposed,
employing phenomenological models to estimate a counterfactual, i.e. what what would have
happened in the absence of a contributing factor or intervention.
We apply these methods to different types of studies, to address specific gaps in the
literature. S. pneumoniae is the leading cause of respiratory morbidity and mortality globally,
especially in young children and in the elderly. To improve the understanding of factors
triggering disease progression, we firstly analyse individual-level information about pneu-
mococcal carriage and lower respiratory tract infection with a multi-state model, using data
from a cohort study in Thailand. Secondly, we clarify the role of viral coinfection and
meteorological conditions in invasive pneumococcal disease (IPD) incidence using English
surveillance data. A novel multivariate linear regression model is proposed to estimate the
influenza-specific contribution additional to the seasonal IPD burden across age groups. We
then quantify the impact of the currently implemented vaccination policy, by estimating
the counterfactual of IPD incidence in absence of vaccination. This allows disentangling
serotype replacement from the vaccine effect, making use of a synthetic control approach.
Finally, an empirical dynamical modelling strategy is employed to quantify the interaction
between influenza and pneumococcus. Counterfactual analysis can also be employed to
quantify the burden of novel respiratory pathogens. The last application of this approach is
to estimate the excess mortality during the the COVID-19 pandemic in England.
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Chapter 1
Introduction
1.1 History of epidemics
"Epidemic", "pandemic", "contagion", "quarantine" are terms that we have come to know
well in recent months due to the COVID-19 emergency. These concepts, however, are by no
means unknown to mankind: outbreaks of infectious disease have importantly conditioned
the history of human civilizations, as evidenced by numerous historical writings describing
plagues and decimated populations over the millennia [81].
The history of epidemics is not recent: epidemics have existed since the first large urban
gatherings existed. This is demonstrated, for example, by an Egyptian stele from the 18th
dynasty (1403-1365 BC) where a scribe is represented with a leg offended by polio, or the
mummy of the pharaoh Ramses (1157 BC), on whose face the pustules of smallpox that
probably killed him are still preserved [94]. Smallpox, a virus capable of mowing down
over 30% of the population, was successfully eradicated only in the late 1970s thanks to a
worldwide vaccination campaign. Before then, it hit the globe for millennia: in Rome, a
city that in ancient times comprised a million inhabitants, both the Antonine plague (165-80
AD), which caused 30000 deaths, and the Cyprian plague (in 250-270 AD), which at its peak
resulted in 5000 deaths a day, were most likely smallpox epidemics [56].
After that, the bacterium Yersinia pestis, causing bubonic plague, has been responsible
for the most devastating epidemics recorded in human history: the first one, known as the
"Justinian plague", raged from Constantinople to Rome between 541 and 750, killing 50%
of the population, with an estimate that historians have calculated of about 30-50 million
victims. A second wave of the same scourge 8 centuries later, the "black plague" of which
Boccaccio narrates, originated in Asia and eliminated 30-50% of the population (30 million
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deaths) [176]. Finally, the third deadliest epidemic occurred just over a century ago: the 1918
Spanish Influenza is considered to have caused 70 to 100 million deaths worldwide [128].
A series of key elements contribute to the outbreak of an epidemic. Zoonosis, or the jump
of species from animals to humans, can occur in situations of close proximity to animals and
poor sanitation. The domestication of plants and animals developed when, after the last ice
age (12-10,000 years ago), man went from small groups of hunter-gatherers to permanent
farmers. This change in habits favored the passage of viruses and bacteria to humans, whose
immune system was faced with these pathogenic parasites for the first time; animals, on
the other hand, had learned to live with them for millennia thanks to a slow mechanism of
co-evolution and selection, that had mitigated its virulence and pathogenicity [38].
Low population density is also one of the reasons that explains why the hunter-gatherer
bands with groups of 30-50 individuals scattered throughout the Pleistocene period were
free of epidemics: with higher contacts between groups of individuals, epidemics became
frequent in the era of urban settlements. Similarly, trade and travel contributed to the spread:
the silk road was the vehicle of the medieval "black plague" [3], as demonstrated by the
origin of the "quarantine" in the ports controlled by Venice in the late 1300s. Ports and
ships have been a point of multiplication of the infections on multiple occasions: it was on a
ship that in the early 1500s the Spanish conquistadors brought to South America not only
weapons, but also infectious agents such as smallpox, measles, salmonella enterica and viral
hemorrhagic fever. This explains how the 500 men of Cortés were able to annihilate the large
Aztec army of Montezuma. It didn’t stop there: in the next 100 years, 22 million deaths
followed, reducing the population of Mexico from 25 million people to only 700,000 in 1623
[135].
In this sense, wars can trigger the start of epidemics, with at least two notorious examples:
the "Spanish" flu epidemic killed over 70 million individuals in the two years following
the First World War, while the Plague of Athens in 430 BC [121] broke out when the city
was under siege during the Peloponnesian war. Poor sanitation, food shortages and stress
typical of conflicts are likely to have aggravated the spread. At the same time, epidemics can
shape the progress of the war and the course of history: Thucydides narrates how Sparta won
in such a context of weakness for the Athenian army, imposing oligarchy over democracy
for the centuries to come [173]. He also left us a gist of medical knowledge: he noted that
those who survive infection are protected from future encounters with the same disease (i.e.
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develop immunity), becoming useful members of society for the care of the sick and the
various subsistence activities [18].
1.2 Epidemiology and public health of outbreaks
Thucydides has been dubbed the father of scientific history as he gathered evidence and
used it to make an analysis of cause and effect, attributing processes to physical reality
instead of some god’s wrath. However, the history of modern epidemiology and public health
typically begins in 1854 in London, where John Snow investigated a cholera outbreak that
was happening at the time: his revolutionary idea consisted of using maps and numbers to
describe the epidemic [220].
John Snow did not know what caused a disease, as the microscope made its first appear-
ance around that time, nonetheless he speculated that cholera was water borne. He figured out
that London neighborhoods were served by different water pumping stations and identified
which pumping station was providing water to each neighborhood. He then counted the
number of deaths from cholera experienced by those neighborhoods, and divided the number
of deaths by the number of houses being served by each pump, obtaining an incidence ratio.
His investigation led him to conclude that one particular pumping station, the Broad Street
pump, was likely responsible for the majority of cholera deaths in the city. When presenting
his results he advised the removal of the pump handle and, despite initial skepticism, his
request was granted, ending the cholera outbreak.
Even if today we know that communicable diseases are caused by microbial infectious
agents (bacteria, viruses), modern society still faces the important challenge of preventing
outbreaks. Like John Snow, modern epidemiologists work as medical detectors to learn
the distribution and determinants of disease in a population using non-medical tools. To
investigate if a given exposure increases or decreases the likelihood for the outcome of
interest, they collect data and formulate a mathematical relationship between exposure and
outcome. At this point public health professionals step in: when a statistical relationship
between an exposure and an outcome is identified, a control measure on the exposure, a
public health intervention, can be implemented to control the outcome. This strategy for
disease prevention, on a pragmatic basis, is a viable solution even when the mechanism of
how that exposure causes the outcome is unknown, or when it is unknown whether such a
mechanism is indeed causal [238].
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Compared to John Snow’s times, we now have vaccines available for several pathogens,
i.e. biological preparations which provide immunity for that specific pathogen. As their
administration to individuals who do not have natural immunity is the most effective way
to prevent infection, and most infections are transmitted through person-to-person contact
or droplets, mass vaccination is the most effective public health intervention to prevent
outbreaks in a population. Interestingly, not everyone needs to be vaccinated. When most
of the population is immune, the likelihood of disease transmission between non-immune
individuals becomes almost null, i.e. the vaccine has induced herd immunity. However,
when vaccines are not available, interventions to remove the source of transmission (e.g.
John Snow’s water pump), or social distancing and quarantine of infected cases to break
transmission networks are the only way to prevent and limit outbreaks.
Another major difference compared to John Snow’s times concerns data collection. The
impact of disease is now quantified not only in terms of mortality, but also in terms of
morbidity and effect on the quality of life. Conveniently, most modern countries have in
place automated surveillance systems requiring health professionals to report cases of disease
included in a list of so-called notifiable diseases to health authorities. Disease surveillance
should allow timely identification of changes in the number of cases over time, facilitating
early detection of epidemics in the monitored population. This procedure, sometimes referred
to as trend analysis, was used for the first time during the 1957-1958 influenza pandemic:
change in the national number of deaths for influenza and pneumonia recorded through
surveillance was used to estimate the impact of the H3N2 influenza virus [209]; some 60
years later, public health surveillance systems are still considered “the best weapon to avert
epidemics" [19]. This kind of information is likely to suffer from detection bias, as the more
we look for cases (e.g. swab asymptomatic people), the more we are likely to find them, yet
its contribution is essential in identifying questions that need further investigation.
In conclusion, in a run towards evidence-based medicine, epidemiology promises to
uncover some external truth through data collection and mathematical tools. Detecting the
start of an outbreak, quantifying its burden, identifying the contribution of one pathogen and
evaluating the effectiveness of an intervention are all research questions of great relevance.
The answers to these questions can assist epidemiological understanding of current and past
outbreaks to prevent future ones: findings can be employed to inform future public health
policies and to help decision-makers in arranging drug stockpiling, vaccination regimes or
non-medical interventions.
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As explained in section 1.2, surveillance systems are a major source of data on notifiable
diseases. Information routinely collected typically includes longitudinal counts of the number
of detected infections, where those detected are most likely those with symptomatic disease.
These times series are generally available only at an aggregate level, for example as weekly
counts by coarse geographical location, and they might suffer from under-reporting and
reporting delay. In fact, data on milder infections, more difficult to diagnose, are more likely
to be subject to under-ascertainment and reporting biases.
A first contribution of statistical approaches is then to make sense of this surveillance
information by correcting observational biases, to quantify the burden and identify trends
over time. A second purpose of statistical approaches is to understand relationships between
outcomes and explanatory variables of interest, i.e. to understand the association between
disease burden and covariates; or between multiple disease outcomes, i.e. to understand the
interaction between different pathogens at the host burden level. This category of analyses
may include understanding the effect of public health interventions on the burden of disease.
A final role of statistical modelling is that of using the observed data to reconstruct
the unobserved dynamics of the disease of interest. For example, the transmission process
underlying an epidemic resulting from the contact between susceptible and infected indi-
viduals over time is not observable and so not directly measurable. However, it can be
reconstructed using surveillance and other available data (e.g. from ad-hoc surveys), and
statistical approaches can assist to combine different data sources [44, 8].
Each of these contexts requires specific statistical models. There are two main types
of models: regression-type and mechanistic. The regression-type models, often referred
to as phenomenological models, are statistical models expressing the relation between the
outcome of interest (e.g. disease incidence over time) and appropriate explanatory variables.
They are typically used for the second purpose, and may require simultaneous accounting for
the reporting and other observational biases in the data, as in the first aim.
Mechanistic epidemic models, of the SIR (Susceptible, Infected, Recovered) type, ap-
proximate the spread of a pathogen in a population [224], describing it as progression through
successive disease states. They belong to the family of state-space models [49], where the
dependence across disease states is defined as a function of meaningful epidemic parameters.
Making inference on these parameters from observed data allows reconstruction of the unob-
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served transmission and recovery process, providing estimates of unobserved quantities such
as the reproduction number (R0) and the number of asymptomatic or undetected infections.
1.4 Respiratory infections and co-infections
Among many infectious diseases, this thesis will focus on respiratory infections, in particular
lower respiratory tract infections (LRTIs). This term refers to any infection affecting the
airways below the larynx, including pneumonia, bronchitis, and bronchiolitis.
LRTIs are responsible for a significant morbidity and mortality worldwide. According to
the most recent estimates of Global Burden of Diseases, Injuries, and Risk Factors (GBD)
[30], in 2016 LRTIs caused 2.38 million (95% confidence interval (CI) 2.15–2.51) deaths,
being the top cause of death in low-income countries, where access to immunisations and
antibiotics was limited. LRTIs are a threatening presence in high-income countries too: im-
munisation is not a solution for newly emerging pathogens, as the SARS-COVID-2 example
currently shows us, and the increasing number of drug-resistant pathogens is narrowing the
choice of antibiotics that were previously efficacious.
LRTIs can be the result of a broad number of respiratory pathogens, including viruses,
bacteria and fungal agents, that can cause both seasonal endemic infections and periodic
unpredictable pandemics. The most studied respiratory pathogens, including viruses such
as Influenza, Respiratory Syncytial Virus (RSV) or Rhinovirus and bacteria such as Strepto-
coccus Pneumoniae or Staphylococcus Aureus, are endemic in the human population. Their
activity cyclically increases in the autumn and winter months in temperate countries of the
world, but thanks to existing immunity their transmission is naturally limited to controlled
epidemics. A recent collaboration [30] estimated the contribution of specific pathogens to
LRTI burden, concluding that Streptococcus pneumoniae was the leading cause of LRTI mor-
bidity and mortality globally, contributing to more deaths than all other aetiologies combined.
Infants, people of 65 years of age and above, or individuals with weakened immune systems
and other health conditions are typically most at risk for complications. For these groups,
immunisation via influenza vaccine and pneumococcal vaccine is recommended in several
countries.
Novel respiratory pathogens that have the potential to spread among humans can also
emerge: this mostly happens via zoonosis, i.e. when an animal pathogen "jumps" to the hu-
man species. Due to non-existing immunity in the human population and absence of vaccines,
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transmission can happen very effectively, making containment challenging. Recent examples
include the 2009 H1N1 swine flu and three coronaviruses-related illnesses: the severe acute
respiratory syndrome (SARS) in 2002, the Middle East respiratory syndrome coronavirus
(MERS-CoV) in 2012 and the ongoing SARS-CoV-2. These respiratory pathogens have
high pandemic potential, causing significant morbidity and mortality, not only among groups
considered to be at a higher risk of complications, but also in young, healthy individuals.
In addition to public health burden, the restrictions on travel and trade imposed to achieve
containment are likely to have significant economic, social, and political consequences.
In the interest of reducing burden and pandemic preparedness, therefore, understanding
the burden of LRTIs, how different LRTI-causing pathogens might interact, and the effect
of public health interventions such as vaccination on the burden remain crucial subjects of
much research.
1.5 Challenges in estimating LRTI burden
Two similarities in LRTI-causing pathogens result in challenges in identifying the pathogen
responsible for an LRTI and estimating its burden on healthcare: similar, largely unobserv-
able, transmission routes, via droplets and aerosols [196]; and non-specificity of symptoms
of LRTI [22]. In the first place, since most symptoms of respiratory infection are mild, many
individuals will not access any healthcare and hence will not appear in surveillance data. For
the minority of cases where infection manifests as a severe LRTI, whose symptoms include
fever, a severe cough, difficulty breathing or chest pain, the diagnostic process is generally
limited to a physical exam through a stethoscope by your General Practitioner (GP) and
chest X-rays. It is rare that blood or mucus samples are taken to test for specific bacteria
and viruses. As symptoms are not pathogen-specific, the pathogen responsible for infection
is rarely detected in routine clinical practice, resulting in substantial under-reporting of
disease incidence. It is therefore a challenge to disentangle the burden on healthcare contacts
(GP consultations, hospital admissions) and mortality attributable to different LRTI-causing
pathogens.
However, integrating routine surveillance data on a non-specific LRTI outcome, e.g.
GP consultations for influenza-like-illness (ILI), with some accurate measure of pathogen-
specific incidence is often a possibility. A number of ad-hoc studies have been implemented
across countries to complement the missing information. For example, a sentinel virological
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testing scheme in England, run by the Royal College of General Practitioners [34], routinely
tests a proportion of patients consulting for ILI symptoms for a set of respiratory viruses, so
that a proxy for seasonal circulation of viruses such as influenza, RSV and rhinovirus can be
inferred.
A second challenge concerns understanding how different LRTI-causing pathogens might
interact in affecting transmission and host susceptibility when co-infecting the host. “Coinfec-
tion" is broadly defined as the condition where a host is simultaneously infected by multiple
pathogen species or strains, but the term is more often used to imply the presence of interac-
tion between infectious agents. They might act synergistically, leading to a superinfection
(i.e. the burden of one pathogen is enhanced by the other), or they could compete, with one of
them suppressing the second (antagonist interaction) [88]. The host’s immunity also appears
to play a key role in coinfection, as an over-regulation of the inflammatory response might
exacerbate the damages due to the infectious agents, leading to increased disease severity [73].
The particular role of influenza virus and its underpinning mechanisms in LRTIs have
been extensively investigated by biologists since the 1918 pandemic [144, 189], as post-
mortem examinations at the time revealed the presence of bacterial infection in the lungs of
many influenza-infected individuals [148]. A synergistic interplay between influenza and
Streptococcus pneumoniae, graphically represented in Figure 1.1, is considered to be one of
the main drivers of severity [201]: this has been validated in animal models [132], however
the underlying biological mechanism is still poorly understood and empirical measures
remain difficult and expensive to obtain in humans [43]. Severity is not the only possible
consequence of coinfection: one infection might precede the other, enhancing susceptibility
to the second one by impairing immune response and facilitating the entrance of pathogens
that are usually cleared by the natural defense system. For example, Shrestha et al. [189]
found increased susceptibility to bacterial infections after influenza.
Longitudinal cohort studies carrying out individual-level testing for multiple pathogens
are one possibility for improving the current incomplete understanding of the biological inter-
play between different pathogens. However, such studies are expensive and time-consuming,
with only a few available to understand, for example, carriage and transmission. In the case
of S.Pneumoniae, nasal carriage, an initial asymptomatic stage, has been identified as a
necessary but not sufficient condition for the development of disease [191]: most people will
not develop systemic disease after carrying pneumococci, and especially in early childhood
this condition has been observed to be particularly common and long-lasting [120]. Car-
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Fig. 1.1 Process of bacterial progression from upper to lower respiratory tract triggered by
viral infection [132]
riage studies have been performed on children across several countries and helped unravel
dynamics of these infection stages [136]. However, modelling pneumococcal dynamics in
carriage studies, and in particular understanding the interaction with other pathogens such
as influenza, raises several challenges. These include intermittent observation schemes,
potential informativeness of observation times, and lack of biological understanding limiting
the formulation of transmission models without strong assumptions [162].
An alternative is to use phenomenological models for population-level aggregate data
on multiple pathogens to attempt to disentangle their interaction from common confounders
and drivers such as meteorological processes. However, such an approach brings its own
challenges, the biggest one being the observational nature of the available information, as
anticipated in section 1.3. The absence of randomisation, and the presence of confounding, do
not allow making the causal statements that might be needed for the understanding of disease
determinants. However, in the field of burden estimation and public health interventions,
improvements to currently and routinely employed approaches to attribution in the presence
of confounding (often limited to conclusions of association only) can be envisaged through
the estimation of what is known as a “counterfactual”. As David Lewis puts it, “We think of a
cause as something that makes a difference, and the difference it makes must be a difference
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from what would have happened without it. Had it been absent, its effects – some of them, at
least, and usually all – would have been absent as well” [116]. This leads to another challenge
in both estimating LRTI burden and evaluating the effect of public health interventions on
LRTI burden: how to estimate such a counterfactual, since it can never be observed?
In this thesis, motivated by substantive problems in understanding LRTI burden, we
critically appraise currently used methodologies, identifying shortcomings and proposing
improved approaches. We give particular emphasis to phenomenological time series models
for burden estimation and intervention evaluation, where the common theme is the estimation
of counterfactuals in the presence of observed and unobserved confounding: a challenging
task.
1.6 Aims of the thesis
This thesis proposes and investigates statistical models to quantify burden of respiratory
disease and evaluate effectiveness of public health interventions while accounting for the
challenges posed by surveillance data (section 1.5), and applies them to different study
designs. A variety of data on respiratory disease incidence, typically of longitudinal nature,
are used to achieve these aims.
First, in chapter 2, a reconstruction of pneumococcal disease progression from asymp-
tomatic to severe phase is attempted. Data from a cohort study, which enrolled children in
a developing country and actively ascertained disease status and measured individual risk
factors, provided individual-level information about pneumococcal carriage and LRTI. We
model the stages of disease from asymptomatic to invasive through a multi-state model,
accounting for viral circulation and climatic factors. Exploring the factors triggering pneu-
mococcal disease progression in a vaccine-free setting can improve our understanding of
pneumococcal disease dynamics and the interaction with viruses such as influenza and RSV.
Next, in chapter 3 we review the literature on phenomenological models, focussing
on aggregate outcome data. With the scope of clarifying the role of viral coinfection and
meteorological conditions in the development of invasive pneumococcal disease (IPD), in
chapter 4 we propose a novel multivariate linear regression to quantify the contribution of
respiratory viruses on the incidence of severe pneumococcal infections by age group. The
approach integrates GP consultations for influenza-like-illness with RCGP viral positivity to
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obtain proxies of viral circulation; whereas IPD incidence data are obtained from the national
surveillance system. The results provide crucial evidence to support decisions on antibiotic
stockpiles in view of a future influenza pandemic.
Chapter 5 presents statistical methods for the evaluation of interventions, with a focus on
public health examples, and chapter 6 inspects the changes in pneumococcal disease incidence
following the introduction of pneumococcal conjugate vaccines. Using serotype-specific
information on IPD counts, we quantify the impact of pneumococcal vaccine introduction
using interrupted time series and Bayesian structural time series methods. We disentangle
the contribution of serotype replacement across age groups by separately estimating the
reduction in vaccine-targeted serotypes and the increase in non-vaccine types. Measures of
effectiveness of the recently implemented vaccination strategies and quantification of their
side effects are fundamental to inform health policy, in particular to support future decisions
on the introduction of higher-valency vaccines.
In chapter 7, we quantify the excess all-cause mortality by age and by region during the
COVID-19 pandemic period in England. A counterfactual is estimated including control
time series through a dynamic regression model, using again a Bayesian structural time series
approach.
Finally, chapter 8 presents an alternative empirical dynamical modelling (EDM) method-
ology to quantify causal interactions between time series. The method is applied to the IPD
and influenza time series data used in chapter 4 to understand their interaction.
Chapter 9 wraps up with some final discussion.

Chapter 2
Individual-level dynamics of disease
2.1 Introduction
Longitudinal studies are occasionally run on population subgroups to track disease evolution,
especially for pathogens characterised by an asymptomatic carriage phase, such as the pneu-
mococcus. When available, individual-level data can be analysed to provide useful insights
about the viral-bacterial coinfection process.
In this chapter we use data from a cohort of children followed up for two years, to infer
pneumococcal disease incidence as a function of seasonality and viral circulation. The
information available allows modelling within-subject pneumococcal dynamics over time,
as the asymptomatic carriage state (colonisation) with the pneumococcus is ascertained
at predefined times and LRTIs are identified due to self-reporting to healthcare due to the
severity of symptoms.
Research questions in this chapter are: do viral circulation, wet season and high tempera-
ture facilitate or protect from acquisition of pneumococcal carriage? Is clearance affected
to the same extent? A question regarding the progression from carriage to LRTI is also of
interest: do these factors trigger the occurrence of LRTIs? In other words, how many of
these are bacterial infections secondary to influenza? These questions can be addressed by
approximating the natural history of pneumococcal disease through a multistate model, as
we elaborate in what follows [138].
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2.2 Multistate models
Multistate models allow the disease history of an individual to be expressed as a series of
states. Each state represents the possible disease condition at a given time, and the movement
through states indicates disease progression [4]. The simplest example of a multistate model
is the survival model, which only has two states, alive and dead. After defining the set of
allowed transitions from each state, we are interested in estimating the time spent in each
state before the transition happens, the probability of moving to a specific state, and the
proportion of individuals who are in each state at any given time.
Ideally, the disease history would be entirely described by observed transition times
of each individual between states, however in many practical applications information is
not available in such detail, and only the current state can be observed. This is the case
for chronic or asymptomatic conditions, when the clinical state is typically ascertained at
predefined follow-up visits [95]. Reconstruction of the movement between states can be
considerably more challenging when based on such panel data, as evolution of the process is
effectively unknown between the observation times.
In the next sections we introduce the notation and the key features of the most commonly
used multistate models, delineate the structure for likelihood-based inference in the general
case, and finally focus on inference from panel data.
2.2.1 Notation and assumptions
Consider a system characterised by a finite number of states s ∈ S = {1,2,3, . . . ,k}. S is
called the state space. Define {Yi (t), t ≥ 0} to be a random variable denoting the state
occupied by subject i at time t. Also, denote by H(τ) the clinical history up to time τ , i.e.
H(τ) = {Yt , 0 ≤ t < τ}. The process is uniquely characterised by the transition intensity
function qr,s (τ, H(τ)), that defines the set of possible states the process may move to when
it leaves state r
qr,s (τ, H(τ)) = lim
dt→0
Pr{Y (τ +dt) = s | Y (τ) = r, H(τ)}
dt
(2.1)
where (r,s) identifies any pair of states, and qr,s (τ, H(τ)) is the element in position (r,s) of
the k× k transition intensity matrix Q(τ, H(τ)) [36].
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In formula 2.1, the probability distribution of the future state Y (τ + dt) is a function
of both the present state Y (τ) and the past disease history H(τ). The process is said to be
Markovian, or memoryless, if such a probability does not depend on disease history. Transi-
tion intensities are functions of the current state r and time τ only: qr,s (τ, H(τ)) = qr,s (τ).
A further simplification in a Markov model is to assume that the transition intensities
are constant over time, i.e the process is time-homogeneous: qr,s(τ) = qr,s. To relax the
assumption of time-homogeneity, some time-varying covariates zt can be incorporated in the
model to make it more flexible. The transition intensities are usually modelled as a function
of such time-dependent variables under the assumption of proportional hazards:
qr,s (zt ) = qr,s (0) exp(β Trs zt ) (2.2)
where qr,s(0) represents the nonparametric baseline hazard and β Trs are the transition-specific
regression coefficients.
From the specification of the transition intensities qr,s, the one-step transition probabilities
of moving to state s when starting from r at two arbitrary points in time are defined as
pr,s(τ,τ +dt) = P(Y (τ +dt) = s | Y (τ) = r),∀τ ∈ (0,∞). (2.3)
Transition probabilities can be calculated by solving the Kolmogorov differential equation:
P′(dt) = P(t)Q. where Q is the matrix whose generic element is qr,s and P is the matrix
with entries pr,s. This equation has a solution through matrix exponentiation: P(dt) = eQdt ,
however it becomes computationally intractable as the number of states and transitions
increases [76].
2.2.2 Estimating transitions using panel data
In longitudinal cohort studies of the type considered here, the exact time of transition will
not be observed. This panel data structure is represented in Figure 2.1.
Denoting by ti j, j = 1,2,3, . . . ,J the sequence of time points where the state Yi j for
individual i is observed, we are interested in reconstructing the entire disease history, i.e.
estimating the transition intensity matrix Q. In order to make inference from such incomplete
information, some assumptions are usually imposed to obtain a tractable likelihood. Several
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Fig. 2.1 Example of process observed under a panel data scheme
.
estimation methods are based on the assumption that times ti j at which observations happen
are not informative about the state observed [32]. Among them, Kalbfleisch and Lawless
[107] proposed a method to estimate transition intensities from the transition probabilities
of the discrete-time Markov chain embedded in the Markov process studied. Namely, the
likelihood function for the entire process, based on the series of Yi j, i.e. the state in which















p(Yi j,Yi, j+1)(ti, j+1 − ti j), (2.4)
i.e. the product over all the individuals and observation times of the probabilities of transition
between the observed states.
2.2.3 Mixture of observed and unobserved transition times
If a state v is exactly observed, thanks to Markovianity and time-homogeneity, the Chapman-
Kolmogorov equation allows us to write:
pr,v(ti, j+1 − ti, j) = ∑
s ̸=v
p(r,s)(ti, j+1 − ti, j−)qs,v (2.5)
We are factorising the transition probability pr,v in two components, based on the fact that
the state immediately before transitioning to v is unknown. We consider the probability of
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moving from r to any state s, and the instantaneous transition from s to v, summing over all
the possible states s ̸= v.
The same patient might be characterised by a mixed observation scheme, with some
states only observed at predefined visits, and other states whose transition is exactly observed.
To make efficient use of all the information, these heterogeneous transitions are combined in
a single model, so that the likelihood L(Q) will be a mixture of terms described in equations












p(r,s)(ti, j+1 − ti, j−)qs,v
]
. (2.6)
2.3 Application to pneumococcal disease
An application of multistate models to pneumococcal disease dynamics is considered in this
section. We first present a brief review of the literature and the data at hand. We then discuss
modeling considerations, that is, how to build a sensible model for the problem of interest.
At last, we present and discuss results on the selected models.
2.3.1 Previous multistate models for S. pneumoniae
Several longitudinal studies have been established to inspect pneumococcal dynamics, in
particular the unobservable processes of colonisation acquisition and clearance: samples
have been typically collected at regular pre-defined time intervals (e.g. every month), and
transition rates have been estimated from panel data under continuous-time Markov models
[138, 74, 91, 2]. After the introduction of the Pneumococcal Conjugate Vaccines (PCV) in
several countries, much attention has been paid to the behaviour of different serotypes, with
disease status more often defined by distinguishing colonisation with vaccine (VT) or not
vaccine type (NVT)[218]: importantly, Auranen et al. [5] and Mehtälä et al. [137] have inves-
tigated competition among serotypes. However, to our knowledge, no study has combined
information about upper respiratory tract carriage and LRTI. An improved understanding of
probability and timing of disease progression with respect to seasonality would shed light on
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the coinfection process.
2.3.2 Source of data
The pneumococcal data of interest refer to the study conducted in the refugee camp of
Maela, on the Thai-Myanmar border. We thank Prof Paul Turner and Prof Claudia Turner for
sharing the data. A total of 999 children have been recruited at birth, from October 2007 to
November 2008, and followed for 24 months. A nasopharyngeal swab has been taken and
tested monthly by healthcare professionals of US Centers for Disease Control and Prevention
(CDC) and Shoklo Malaria Research Unit. Serotyping has also been performed on a portion
of the samples, but that information will not be included in our analysis.
This study is nested within a longitudinal study designed to establish the epidemiology
and etiology of pneumonia in children [211]. As primary health services were not provided
to refugees outside the camp, all the clinical cases were referred to a field hospital and two
outpatient clinics. This situation enables us to reconstruct a complete disease history for each
child, including both the asymptomatic and symptomatic phases.
Details about meteorological conditions in the camp, such as monthly rainfall, average,
minimum and maximum temperature, have also been recorded for the entire study period
(October 2007 to October 2010). The same researchers have also measured viral positivity
in the pneumonia cases associated with a suspected upper respiratory tract viral illness
(symptoms like cough, sneeze, runny nose, strep throat) [212]. Figure 2.3 summarises the
dynamics of the described phenomena at the Maela camp over time.
Finally, we gather information about viral positivity collected through the ILI sentinel
surveillance (in 11 sites throughout the country) established in 2004 by the National Institute
of Health in Thailand (NIH), in collaboration with the CDC. While the system was intended
to monitor the frequency of influenza virus infection and describe seasonality, testing for 6
additional respiratory viruses is also performed [23]. Information is presented in Figure 2.4.
2.3.3 Analysis strategy
When using a multistate model to describe disease dynamics over time, the state structure
must be defined in the first place. Assuming that every child is born healthy, our model is
made of three states which define pneumococcal disease progression: uncolonised, colonised
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and infected with pneumonia.
In the next stage, allowed transitions must be identified: we are interested in modelling
the time to pneumococcal carriage acquisition from uncolonised. Once colonisation has
been acquired, the stay in this state is temporary: the body immune response might clear
the bacteria, or it might lead to a respiratory infection, generally pneumonia. Therefore,
we assume that, instantaneously, individuals can move from uncolonised to colonised and
move back, while the progression to pneumonia necessarily happens from carriage. Finally,
we consider pneumonia to be an absorbing state, as we are interested in the etiology of
pneumonia but not strictly in recurrent pneumonias, that could have different etiological
mechanisms (Figure 2.2).
Lastly, proposing realistic model assumptions is necessary. In the highlighted situation it
is reasonable to assume that our model is Markovian, i.e. the next disease stage only depends
on the current clinical condition, regardless of the past history. From available medical
knowledge, we are confident that previous exposure to carriage does not provide immunity
to subsequent carriage nor facilitate it, and presumably chances of developing pneumonia do
not depend on duration of carriage. Markovianity facilitates the inference and also allows for
an intuitive graphical understanding of the model.
Uncolonised Pnc carriage Pneumonia
Fig. 2.2 Transitions between states that are instantaneously possible
As described in section 2.2.3, our data are a mixture of observed and unobserved tran-
sition times: colonisation can be detected only when a nasopharyngeal sample is taken
and cultured, hence information on the presence of S.Pneumoniae was actively looked for
through a program of monthly swabbing. Information is available on the prevalent condition,
but acquisition and clearance times are unobservable. However, as times of visits were
predefined, and remembering that carriage is an asymptomatic condition, we are confident
these observation points are uninformative about the actual presence or absence of bacteria.
On the other hand, pneumonia is a severe condition, especially in infants. We assume the
transition from carriage to pneumonia is exactly observed, as parents would immediately
seek healthcare when the symptoms appear. Therefore, the likelihood takes the mixed form
expressed in equation (2.6). Maximum likelihood estimates for the transition intensities are
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obtained using the msm R package.
Finally, covariates about national surveillance for viral infections and about weather
conditions in the Maela camp are sequentially added to the model, using the Cox regres-
sion structure presented in formula (2.2). The rationale for such choice is that we want to
investigate if pneumococcal disease, and in particular the progression from colonisation
to pneumonia, is in any way influenced by Influenza or RSV circulation, after taking into
account shared drivers such as temperature variations. Formal model comparison is per-
formed using likelihood ratio tests, starting from the model with no covariates and adding
the most significant predictor at each stage. Minimum temperature is included as a con-
tinuous variable, whereas indicator variables, as a proxy for viral circulation, are defined
as “Flu season" if at least 20% of the tested samples resulted positive to the virus, and
“RSV season" if at least 5% of the samples tested positive to it (considering that RSV pos-
itivity reaches a maximum of 15% in the general population). Similarly, a dichotomous
indicator for wet season is defined according to the Köppen climate classification ?? for tropi-
cal climates: any month when average precipitation is below 60 millimetres is considered dry.
2.4 Results
2.4.1 Descriptive analysis
A total of 740 subjects are included in the analysis, i.e. all the children who had at least
one swab. 15282 records are available, with a median number of 25 clinical observations
per child (IQR 13-26, min 2, max 37). 14197 records refer to regular swabs, of which 9895
resulted positive (69.7%). 1085 observations identify pneumonia episodes, of which 488
refer to a first pneumonia episode, while the remaining 597 concern recurrent pneumonias in
the same subjects (up to 12 per child over 24 months).
Figure 2.3 summarises weather and disease conditions for the Maela cohort. In the first
panel, meteorological conditions at the camp during the study period are displayed: the
wet season repeats cyclically between April and September, with rainfall amounts not too
dissimilar across years. The dry season, between October and March, is instead characterised
by lowest minimum temperatures, with monthly averages below 20. The second panel
presents carriage prevalence: except for the first semester of the study, when children were
still being recruited, carriage prevalence fluctuates around 60% over the entire observed
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Fig. 2.3 Weather conditions, carriage prevalence, median cohort age, pneumonia incidence
and viral circulation.
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period, with no obvious seasonal patterns except for some reduction between the end of
the wet season and the start of the dry one (August-November). Finally, the third panel
presents incidence of pneumonia, that peaks yearly between September and November. High
prevalences of RSV and Influenza are identified at the same time, however we consider this


































Fig. 2.4 Viral positivity obtained from the national surveillance system of Thailand.
Finally, Figure 2.4 presents viral positivity obtained from the national surveillance sys-
tem: the timing of influenza seems to vary across seasons, with the peak occurring between
October and December in 2007 and 2008, whereas an earlier peak, around August, can be
observed for 2009 and 2010, with an intermediate wave in spring, realistically the second
2009 flu pandemic wave. RSV positivity is not as marked in the first two seasons (possibly
due to recent introduction of its viral testing), however some epidemic behaviour can be
identified around October-November in 2009 and around August-September in 2010.
2.4.2 Multistate model
After limiting the follow-up to the first pneumonia episode, we are considering a cumulative
time of 740 person-years, ending with a pneumonia episode for 488 children (66% of the
cohort), while the remaining 252 subjects are censored for the purposes of our analysis. 8628
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swabs were tested during the study time, with positivity to pneumococcal carriage in 67.2%
of instances.
Observed transitions are presented in table 7.3: having multiple observations of carriage
in a sequence looks very common, but also staying uncolonised at subsequent occasions is
common, while clearance is less frequent. Transition to pneumonia is more common from
carriage than from uncolonised, and an intermediate unobserved transition via carriage state
is assumed for the latter. Importantly, this table does not provide information about time of
stay in each state.
Uncolonised Pnc carriage Pneumonia
Uncolonised 1183 1440 121
Pnc carriage 911 4354 367
Table 2.1 Observed transitions across states from the dataset considered.
Uncolonised Pnc carriage Pneumonia
Uncolonised -1.004 (-1.069,-0.942) 1.004 ( 0.942, 1.069) 0
Pnc carriage 0.304 ( 0.281, 0.329) -0.382 (-0.408,-0.357) 0.077 ( 0.071, 0.084)
Pneumonia 0 0 0
Table 2.2 Estimated transition intensities (and 95% confidence intervals) for the multistate
model in Figure 2.2.
The multistate model in Figure 2.2 is initially fitted without covariates in order to describe
the general disease dynamic. Time is expressed in months. Maximum likelihood estimates
for the transition intensities are shown in table 2.2. This first inference suggests that the
instantaneous hazard of carriage acquisition is quite high, i.e. an infant becomes colonised
on average within one month from birth. However, after onset of carriage, children are 4
times more likely to clear colonisation than to develop pneumonia: probability of transi-
tioning to the pneumonia state is 0.201 (95% CI 0.184, 0.224), compared to probability of
clearing carriage being 0.798 (95% CI 0.776, 0.816). The rate of pneumococcal clearance is
low, suggesting that, after pneumococcus is installed in the upper respiratory tract, a long
permanence in that condition is expected. Finally, rate of pneumonia onset is even lower,
indicating that carriage can persist for over one year before pneumonia is developed.
An estimated mean sojourn time per visit, by state but not specific to the state of destina-
tion, is presented in the first column of table 2.3. The other two columns summarise, over
24 Individual-level dynamics of disease
Sojourn duration (months) Number of visits Length of stay (months)
Mean 95% CI Mean 95% CI Total 95% CI
Uncolonised 1.00 (0.94; 1.06) 2.98 (2.73; 3.25) 3.91 (3.68; 4.15)
Pnc carriage 2.62 (2.45; 2.80) 3.92 (3.67; 4.18) 9.80 (9.27; 10.30)
Pneumonia - - 0.76 (0.73; 0.79) - -
Table 2.3 Estimated mean sojourn for each state visit, expected number of visits to each
state in the two years of follow-up, and forecast total length of time spent in each state in the
two years of follow-up for the multistate model in Figure 2.2.
the two-year follow-up, the mean number of visits to each state and the total length of stay
in each stay: after being born uncolonised, children on average clear carriage another two
times, spending under four months in total in this condition. Conversely, permanence in the
carriage state sums up to almost ten months on average before pneumonia is developed, with
an average of four visits.






































































Fig. 2.5 In the first three panels: observed and estimated prevalence across different states
over study time. In the last panel: survival function for time to pneumonia.
Figure 2.5 summarises how prevalence of each state varies over the study time, with the
first panels comparing the observed numbers of individuals occupying each state and the
numbers estimated from the fitted model. The proportion of uncolonised children reasonably
diminishes as they progress towards carriage and then pneumonia. For example, only 20%
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of children are still uncolonised at four months from birth, while 60% of them have some
carriage and the remaining 20% has already developed pneumonia. These plots also provide
an approximate indication of the goodness of fit of our model: from a graphical inspection
we can see how distances between the curves are quite small in all panels, suggesting a good
fit.
Finally, the fourth panel shows the survival function for transition from uncolonised to
pneumonia: from the survival curve we can see that, after taking censoring into account, the
median time to pneumonia onset is 10.61 months (95% CI 9.89-11.86). We can also see that
25% of children develop pneumonia in the first five months of life, and just over 30% of
them do not develop any pneumonia during the study time. Aiming to assess goodness of fit
once again, we are reassured to see that our model prediction closely follows the estimated
Kaplan-Meier survival curve.
The results presented above are obtained under the assumption that transition intensities
are constant over the entire study period. Since this assumption may not hold, we allow
calendar-time variations by introducing some time-dependent covariates in the model. We fit
the models sequentially, adding one covariate at a time and testing its significance compared
to the model fitted at the previous stage using a likelihood ratio test. Table 2.4 summarises
the model selection steps:
Selected var -2 log LR df p
One var Flu season 66.1793 3 ≤ 0.001
Two vars Wet season 50.5304 3 ≤ 0.001
Three vars Min temperature 61.3549 3 ≤ 0.001
Four vars RSV season 14.2728 3 0.0026
Table 2.4 Model selection steps: LR test for addition of covariates to the model in Figure
2.2.
The selected model includes indicator variables for influenza, RSV and wet seasons, and
the continuous measurements of minimum temperature. The estimated hazard ratios (HR)
are presented in table 2.5. Firstly, the acquisition of carriage does not seem to be affected
by any covariate. Secondly, chances of clearing carriage are significantly lower during wet
season (HR=0.707, 95% CI 0.515;0.972) and in months with higher overnight temperature
(HR=1.078, 95% CI 1.026;1.133), but they are not affected by viral circulation. Thirdly, all
the considered covariates affect the chances of leaving carriage state to develop pneumonia:
the predominant factor is the wet season (HR=5.792, 95% CI 3.723; 9.011), followed by
influenza circulation (HR=1.67, 95% CI 1.353; 2.062) and RSV season (HR=1.47, 95% CI



















































































1.101; 1.964) and lower temperature (HR=0.818, 95% CI 0.771; 0.869).
Finally, Table 2.6 shows a comparison between instantaneous transition rates and length
of stay by state across seasons. In particular we compare a period of wet season with high
Influenza circulation with a dry time of the year when influenza isn’t circulating. As expected,
humidity and viral circulation impact the risk of developing pneumonia, hence the main
difference between the two scenarios refers to the instantaneous transition from carriage
to pneumonia state, almost 10 times bigger. However, confidence intervals are quite wide.
Correspondingly, the estimated duration of carriage is cut by a factor of 10 in the wet season,
while the time spent in the uncolonised state is slightly longer in the wet season (approx 27
days instead of 20) compared to the dry one.
2.5 Discussion
These results give us an example of how partial information can be used to reconstruct
pneumococcal disease dynamics and assess the impact of potential risk factors. Importantly,
our results highlight how wet season and low temperatures are important factors both for
persistence of pneumococcal colonisation and for its progression to the lower respiratory
tract. Even more importantly, our model estimates that the risk of developing pneumonia
is 67% higher during the influenza season, and 47% higher during the RSV season, after
taking into account meteorological variations. This result still stands out after considering
the factors altogether in the same model, and uncertainty around the coefficient estimates is
quite small despite estimating fifteen parameters.
Lack of typical seasonality for influenza and RSV is an advantage to our model, as it
allows us to better disentangle the contribution of meteorological factors from viral impact.
However, RSV contribution might be diluted due to poor detection: ILI case definition and
other aspects of influenza virus surveillance may not be optimally suited for other respiratory
viruses. Furthermore, we are using positivity in ILI patients in the general Thai population, as
we lack age-specific information, but we can imagine RSV incidence to be higher in children.
Our modelling choices might have some limitations: firstly, we are assuming that our
variables are observed without error, whereas for example swab tests could suffer from
some false positives or false negatives. A hidden Markov model would allow specifying
misclassification probabilities. Further, we are considering temperature as a continuous
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variable, implying linearity of effects, and cut-offs to define viral seasons were chosen based
on data inspection. Other predictors have been deliberately left out: age, for example, could
have been an important factor if we assumed immunity was built over time. Similarly, details
about household size and structure, information about pregnancy and delivery, location
of the house, presence of animals etc have not been investigated, for the sake of model
interpretability and computational power. Finally, more work would be needed to assess the
adequacy of assumptions in our model: proportionality of hazards does not always hold, and
the time-homogeneity assumption may be violated as well. However, alternative models do
not have easy implementation for panel data.
More generally, identification of the etiologic agents of pneumonia remains a diagnostic
challenge due to the difficulty in obtaining adequate samples for culture from the infection
site [222], and this has hampered understanding of the relationship between pneumococcal
carriage and pneumonia. We cannot rule out whether other pathogens were responsible for
some of the observed episodes, however pneumococcus is recognized as the most important
cause of bacterial pneumonia in children aged less than 5 years [159]. Further, generalization
of these results to other populations might not be straightforward, as it has been previously
observed that prevalence of pneumococcal carriage is much higher in developing countries,
and the first acquisition happens at a much younger age compared with the industrialized
settings [141].
Finally, information about serotypes could be modelled in the future, as it has been
speculated that colonisation with some types is more likely to lead to severe disease, or be























































































































































































































































































Models for burden estimation from time
series counts
3.1 Introduction
This chapter contains a brief review of the time series methods to estimate burden of a disease
(e.g. morbidity, mortality) attributable to a specific pathogen when dealing with count data. In
fact, these methods are part of a broader class of models aimed at quantifying the association
between two time series. Section 3.2 reviews the most important burden-estimation methods
found in the literature, two of which are analysed in more depth in sections 3.2.1 and 3.2.2.
Further, section 3.2.3 introduces the HHH modelling framework and its multivariate version,
explaining how it addresses limitations of the previous two. Lastly, section 3.3 describes
different model assessment approaches and section 3.4 introduces Granger causality.
3.2 Ecological studies
Ecological studies, i.e. observational studies analysing data at the population level rather
than individual level, are often used to measure incidence and to identify drivers of a disease
[177]. This choice is mainly made when individual-level data on the exposure are difficult
to acquire, and population-wide routinely recorded measures can be taken as proxies for
individual exposure. This is the case, for example, for studies on climate, that can be seen as
a risk factor to which everyone is exposed equally and simultaneously.
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With specific reference to respiratory infections, as anticipated in section 1.4, individual-
level tests for the causing pathogen are not usually performed in LRTI patients, hence
assessment of pathogen-specific burden relies on statistical inference. This analysis generally
involves modelling time series of deaths or counts of syndromic healthcare contacts due
to generic LRTIs with the aim of attributing a proportion of these cases to one or multiple
pathogens.
However, LRTI incidence is characterised by strong seasonal patterns, with cyclic winter
peaks in temperate areas of the world. An increased risk of LRTI is expected from a transient
exposure to some viral or bacterial pathogen that exhibits the same seasonal variation. Hence,
it is difficult to disentangle the natural LRTI burden, driven by meteorological factors, from
that of viral and bacterial pathogens that also have a seasonal pattern of variation [100]. For
example, as seasonal influenza viruses circulate every winter in temperate regions, the level
of LRTI incidence in absence of flu is never observed. Such a quantity, sometimes called
‘baseline’, refers to the number of LRTI cases due to causes other than influenza. Tempera-
ture, humidity, pollution, sunshine hours and increased contact networks (e.g. schools) have
all been identified as factors able to explain the annual fluctuations in respiratory disease
incidence [46, 230], thus disentangling the contribution of each pathogen from a “seasonal
confounding" adds to the challenge. A variety of regression methods have been proposed
to estimate pathogen-specific excess morbidity and mortality, with a particular focus on the
influenza virus [209, 104].
Beyond estimating pathogen-specific burden, a well-established problem, we consider
these methods also with the aim of uncovering a possible interaction between pathogens
using time series of population-level counts. Identification of co-infections at the individual
level is unfeasible in routine clinical practice, due to the need for a time- and resource-
consuming testing of respiratory specimens on all patients. However, for both viral and
bacterial pathogens, aggregate information on positivity in the population can be retrieved
from surveillance systems. Disentangling real interactions from spurious correlations due to
shared driving variables is a common problem in ecology, where weak to moderate coupling
is often observed in time series of species abundance. However, such an apparent synchrony
might characterise also non-interacting species which share similar environments and are
subject to forcing by environmental variables, e.g temperature and precipitation.
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In the following sections we will review three categories of methods that have been used
for this purpose in epidemiological settings, highlighting their advantages and limitations.
3.2.1 Cyclic regression models
In the general framework of burden estimation, population-level rates of non pathogen-
specific outcomes are traditionally modelled by regression. Out-of-season outcome rates are
used as a baseline for seasonal periods, so that the difference between observed rates and such
baseline can be attributed to the circulating pathogen during a seasonal period [185, 194, 203].
The cyclic regression model was first introduced by Serfling [185]. Weekly counts Yt
are modelled as a function of calendar time t, including sine and cosine terms to represent
seasonality, i.e.:








+ εt , (3.1)
α is the offset term for weekly person-time, k is the periodicity, generally selected so that
the sine and cosine terms have a full period in one year, and εt is the error term, assumed
to be normally distributed with constant variance. Coefficients α , β1, . . . , β3 can then be
conveniently estimated by ordinary least squares (OLS).
For example, the European Centre for Disease Control (ECDC) uses this method to
estimate influenza excess mortality: the model is fitted to counts of deaths from weeks where
influenza is not circulating, and such non-influenza mortality is then extrapolated to the
influenza season [146]. The discrepancy occurring between the observed and estimated
baseline during the excluded weeks is attributed to the influenza virus.
Several variations have been applied to this model, such as changes in the trigonometric
functions to incorporate bi-annual periodicity [125] or the inclusion of a quadratic term for
calendar time [193]. However, it is worth noting that the presence of trigonometric functions
of time implies two assumptions: firstly, due to periodicity, the predicted outcome is forced
to peak at the same time each year. Secondly, the winter increase in incidence must be equal
in amplitude and duration to the summer decrease, relative to the yearly average, due to
the functions’ symmetry. To circumvent this limited flexibility, other factors that exhibit
annual variation in intensity or timing, such as meteorological conditions or circulation of
respiratory viruses, can be included in the model [103]. Explicitly adjusting for such factors
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allows the strength and timing of incidence to vary across calendar years. Alternatively,
indicator variables for month or season can be used in place of cyclic functions of time [184],
even though such models may be overparameterised.
Beside the original limited flexibility, the Serfling model has a number of other weak-
nesses. First of all, information from some parts of the year, which could help better predict
the winter baseline, is ignored in the estimation. To avoid the exclusion of such time periods,
the virological regression model [27] is a generalisation of the Serfling model which includes
information on the circulation of the pathogen of interest, z, as a covariate in equation (3.1):








+β4zt + εt (3.2)
Thanks to the presence of a proxy for pathogen circulation in the model, not only coefficients
are now estimated using all the time points, but also z-related incidence can be directly
inferred from the complete model, rather than extrapolated. Also, the ‘baseline’ can be
obtained from the same model by setting z = 0.
Including a proxy for pathogen-specific circulation accounts for the presence and magni-
tude of that pathogen in the community more precisely than previous approaches. However,
the validity of this strategy relies on the assumption that surveillance is consistent over time
and adequately represents the true burden in the population [105]. If this assumption does not
hold, apparent trends over time might be due to improved diagnostics or enhanced reporting
rather than to a real spike in incidence. Finally, lagged effects of pathogen circulation can
also be included, as a delay between infection and health-care contact is likely to occur, as
symptoms are not developed immediately. However, this requires knowing the size of such
time lag, or making a choice based on the model fit.
Thompson et al. [203] suggested that the outcome variable, weekly counts, could be more
adequately modelled as Poisson distributed employing a log-link function, rather than using
linear regression. The model is expressed as Yt ∼ Poi(µt) where









Such a link implies multiplicative effects of respiratory viruses on the outcome: the number
of deaths increases exponentially with the number of laboratory reports, and the effects of
different viruses and baseline are multiplicative on the number of deaths. As these assump-
tions are quite unrealistic, the plausibility of such a choice has been long debated. Gay
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et al. [62] and Simonsen et al. [192] claimed that the model can only be linear and additive,
since “total number of deaths is expressed as sum of the contributions from each pathogen,
plus the seasonal background of deaths due to other causes". They suggested to use instead
a generalized linear model (GLM) with a Poisson error distribution but identity link, so
that the number of cases attributable to any virus are kept proportional to the laboratory
reports. Multiple authors have then compared the estimates obtained with identity or log-link
[204, 156], along with suggestions on use of splines to replace trigonometric functions and
replace Poisson distribution with negative binomial to account for overdispersion [70, 33].
The model in (3.3) is routinely used to estimate the burden of influenza by the CDC [239] and
elsewhere (e.g. [228]), nonetheless a discussion on the need of validation for such models is
still ongoing [68, 236].
Finally, an important limitation of regression models is the assumption of independence
among errors, unlikely to hold in this setting. When correlation in time series is not properly
taken into account, variance is underestimated and confidence intervals are artificially nar-
rower [164]. Hence, further precautions should be employed: seasonal block bootstrapping
allows a correction of confidence intervals [172], whereas time-series methods are specifi-
cally tailored to deal with autocorrelation.
3.2.2 Time series methodology
Time series analysis includes a branch of statistical models that focus on temporal ordering
of the observations and on their dependence over time. In fact, a time series is defined as a
collection of observations made sequentially in time.
Let Yt and Yt−h be random variables describing the outcome of interest at time t and
t −h respectively. The quantity h ∈ {0,1,2, . . .} is known as a lag [20], and the interest is






where µt and σt represent the outcome mean and standard deviation at time t. If Yt is sta-
tionary, i.e. µ and σ do not depend on time, the autocorrelation becomes only a function
of the lag h. In other words, the autocorrelation for a given lag h will be the same for
any t. A trend in the mean or a cyclical variation in time are the most common causes
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of violation of stationarity. A visual diagnosis is facilitated by the correlogram, a plot of
observed autocorrelation coefficients Rh against the lag h. In the presence of a trend Rh will
not rapidly tend to zero as the lag increases, whereas it will show a sinusoidal pattern in case
of seasonal data [20].
Since stationarity is a desirable property for most of the procedures used in time series
analysis, preliminary ad-hoc transformations are often applied when non-stationary behaviour
is detected, the most common methods being simple exponential smoothing [83] and the
Holt-Winters procedure [93]. This is often needed when dealing with surveillance data,
typically characterised by the replication of similar patterns across seasons. Once a stationary
time series is obtained, the outcome at time t is generally regressed on its lagged values. An
auto-regressive moving average (ARMA) model [12] is often employed for this purpose, and
it was first used to model excess influenza mortality by Choi and Thacker [25]. The model
takes the form
Yt = ϕ1Yt−1 + · · ·+ϕpYt−p +θ0εt +θ1εt−1 + · · ·+θqεt−q. (3.5)
In the autoregressive component, the dependence of Yt on the outcomes at the p previous
time points is expressed through weights ϕp (usually decreasing going back in time). In
the second part of the model, the regression error is replaced by a moving average term:
the presence of a random disturbance at times t −q, persisting until time t, is expressed as
a linear combination of current and past values of error variables {εt , . . . ,εt−q}, weighted
by θq and assumed to be white noise (i.e. independent, identically distributed with zero mean).
An alternative approach through non-stationary time series is the autoregressive integrated
moving average (ARIMA) model. This involves a two step procedure [20]. The dependent
variable is first differenced to stabilize the mean, i.e. a new outcome variable is defined as
Dt = Yt −Yt−d , where d represents the order of differencing. In a second step, the ARMA
model described in equation (3.5) is estimated. ARIMA models are thus characterised by
three parameters (p,d,q) identifying the order of autoregression, differencing and moving
average terms respectively. Choice of the model order is made via an empirical procedure
based on model fit. This makes ARIMA methods more suitable to the retrospective analysis
of time series data rather than forecasting [213].
Beside the difficulty in model selection, inference for ARIMA models is not straight-
forward. Progressive transformations of the original data to achieve stationarity limit the
interpretability of the coefficients, and maximum likelihood estimates are often obtained
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assuming gaussianity of errors [20]. Finally, other important constraints include equally
spaced data points and events occurring frequently, as the regression may perform poorly
when trying to model data characterised by long gaps and sparsity [105].
ARIMA is a univariate technique, each time series being modelled separately. However,
multiple series might relate to each other or to the same underlying process, and further
methods are available to describe such relationships [143]. Given two time series Yt and Xt ,
if the interest is on investigating the dependence of Yt on Xt , we might simplistically include
Xt as a covariate in model (3.5). The coefficient associated with Xt now expresses the effect
of Xt on Yt conditional on all the Yt−p. More generally, ARIMAX models are an extension of
ARIMA models allowing the inclusion of other time series as independent variables: Yt is
predicted from past lags of Yt together with current and past lags of Xt [167]. They belong to
the family of dynamic regression models.














where the noise terms εt−i are assumed to be independent from the input series Xt−i. If Yt
and Xt are not stationary, they are differenced before fitting the model with ARMA errors.
As many correlated covariates lead to collinearity problems, lags of Xt that usefully
predict Yt are preliminarily chosen. The cross-correlation function, formally defined as the
correlation between Xt−h and Yt for h = {0,1,2, . . .}, is usually employed for this purpose.
For example, Gilca et al. [68] investigated the lag between influenza positivity and hospital
admission, whereas Hendriks et al. [89] recently worked on ILI and IPD. Lagged variables
best expressing the relation between the two time series are then included the regression
model. For example, Hubert et al. [96] first estimated seasonal patterns of meningococcal
counts, and in a second step regressed the detrended series on the relevant lags of ILI counts
using an autoregressive error component. Similarly, Jackson et al. [104] added weekly counts
of positive influenza tests as covariates after fitting an ARIMA model to the weekly incidence,
nonetheless they found Serfling and virological regression models to be more accurate than
the ARIMAX model when predicting the outcome.
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3.2.3 Poisson branching processes
A third category of models derives from the theory of branching processes, through which
dynamics of populations are modelled using generations as the time unit [78]. Let Yt denote






where Z j,t−1 is the offspring of member j at generation t −1. The process Yt only depends on
Yt−1 and not on previous Yt−p, hence it can be conveniently described through the conditional
distribution Yt |Yt−1, with mean µt and variance σ2t . In particular, if the total population
offspring Yt is assumed to be Poisson distributed, Yt−1 acts directly on the conditional mean
through an autoregressive parameter λ expressing the temporal dependence. In formulae,
Yt |Yt−1 ∼ Poi(λYt−1). (3.6)
Model (3.6) has been widely employed in modelling infectious disease data [55], since λ can
be thought as an approximation for the average number of secondary infections generated
by an infectious case in a totally susceptible population. Within branching processes theory,
Held et al. [86] developed a new flexible modelling framework specifically for disease
surveillance data, with the aim of retrospectively characterising epidemic evolution, in
particular identifying the role played by covariates (e.g. seasonality), as well as prospectively
forecasting outbreaks. They extended model (3.6) to a branching process with immigration
component νt , i.e. Yt |Yt−1 ∼ Poi(µt) where
µt = νt +λtYt−1. (3.7)
In equation (3.7), counts are modelled as the sum of two independent components: νt , en-
demic, and λtYt−1, epidemic. In the simplest case both νt and λt can be kept constant over
time, however it might be of interest to further expand these terms. The average number of
endemic cases νt can be parametrically modelled e.g. as a log-linear predictor that, multiplied
by an offset such as population size popt , describes incidence due to regular trends and
seasonal variations. Further, λt could also be time-varying, as the transmission of infection
from time t −1 to time t might change over time, for example across seasons.
The decomposition of the contribution of several phenomena in additive components,
along with the small number of parameters, makes interpretation very straightforward.
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Compared to models presented in section 3.2.1, characterised by trigonometric functions,
the presence of an autoregressive component in model (3.7) has the potential to better de-
scribe occasional outbreaks, as λt expresses the additional temporal dependence beyond
the seasonality explained by νt [35, 85]. Moreover, the identity link allows preserving
biologically-meaningful relationships among the quantities of interest.
Model (3.7) is further extended in Paul et al. [166] to analyse data from several pathogens.
Denote by Yi,t the random variable representing the number of cases for pathogen i observed
at weeks t = 1, . . . ,T . Let’s assume for simplicity that there are only two pathogens, i.e.
i={1,2}. Paul et al. [166] assume that Yi,t |Yi,t−1 ∼ Poi(µi,t) for both diseases, where each
conditional mean is written as
µi,t = νi,t +λiYi,t−1 + τiY j ̸=i,t−1. (3.8)
The τi parameter expresses the association between the two time series and, if adjust-
ments for seasonality are added in the endemic component, the interpretation of τi can more
specifically refer to the association between the two pathogens after taking into account
shared drivers. This setting can be generalised to incorporate more than two time series,
estimating the association of the outcome of interest with more than one pathogen.
Furthermore, the Poisson distribution for the observation model can be replaced by a
negative binomial for situations of overdispersed counts:
Yt |Yt−1 ∼ NegBin(µt ,ψ). (3.9)
where ψ is the overdispersion parameter. Models (3.7) and (3.8) are both implemented in the
R package surveillance [140] through the hhh4 function, named after the authors Held, Höhle
and Hofmann, where maximum likelihood estimates are obtained via a (globally convergent)
Newton-Raphson type algorithm.
More recently, Bracher and Held [13] suggested the inclusion of multiple lags for covari-
ates, relaxing the assumption of temporal dependence limited to one week. Denoting by Q
the number of lags considered, the mean is written as
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where wq(y) and wq(x) are normalized lag weights defined according to a geometric structure,








The model in equation (3.8) can be also extended to deal with stratified time series: Meyer
et al. [139] implemented a multivariate version for spatial disease spread. Let a be the group
indicator, then two transmission components must be specified at this stage:
µt,a = popt,aνt,a +λaYt−1,a +φa ∑
k ̸=a
ck,aYt−1,k ̸=a + τaXt−1,a. (3.12)
In addition to the transmission of one pathogen within group a, quantified by λa, the
transmission of the same pathogen across groups is explicitly incorporated: the coefficient
φa, paired with the linear combination of disease cases in groups k ̸= a weighted by a factor
ck,a, represents the contribution of transmission from other population subgroups to disease
in group a. Both transmission coefficients can be group-specific.
3.3 Predictive model assessment
In classical statistical theory, a probability distribution p(Y | θ0) is generally proposed to
represent the process that generated the data y. Maximum likelihood estimates θ̂0 for the
parameters are obtained in order to maximise the probability that data y have been observed
under the assumed statistical model, nonetheless such a representation is almost never exact.
Model assessment involves measuring the discrepancy between the observed data, yi
for unit i, and the values fitted by the model, g(yi|θ̂0) for some function g(), making use of
a loss function d. Such a measure of distance between observed and fitted values can be






When considering a continuous random variable, a linear regression model is often
employed to predict ŷi, and the difference (yi − ŷi) is called a residual. This quantity is
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typically made positive through a quadratic loss function, and its sum over all data points i is
called the residual sum of squares: RSS = ∑ni=1(yi − ŷi)2. Equivalently, the expectation of








As a small RSS (or a small MSE) indicates a tight fit of the model to the data, this
can be used as an optimality criterion in model assessment. More generally, when model
parameters θ̂0 have been estimated via maximum likelihood, the maximum value of the
likelihood function L̂n(θ̂0 | y) = p(y | θ̂0) is itself a measure of goodness-of-fit, as we have
derived θ̂0 such that θ̂0 = arg max
θ∈Θ
L̂n(θ ;y). However, beyond assessing a model’s absolute
goodness-of-fit in relation to particular data, we also want to assess the performance of that
model in relative terms with respect to other models (model comparison).
We usually assume that the underlying model generating the data belongs to a family of
models p(y,θ), and we are interested in selecting the formulation within that family which
fits our set of observations y best. As any measure of goodness-of-fit is a monotonically in-
creasing function of the number of parameters added to the model, an issue called overfitting,
the statistics presented above cannot be used as a meaningful comparison of models with
different numbers of independent variables.
In order to find a trade-off between the goodness-of-fit of the model and its simplicity, the
model performance can be assessed on out-of-sample prediction instead. Such a process of
measuring how well the model will generalize to an independent data set is called predictive
assessment. Since new data are not often available, predictive assessment generally relies
on cross-validation: if we call yfit the portion of y used to fit the model, ycrit can denote
the portion used for model criticism. Within the time series framework (leave-one-out)
cross-validation translates into (one-step-ahead) forecasts, as the natural aim is finding the
model that best predicts future outcomes based on the present and on the past.
Model performance is then measured in terms of the prediction errors (ycriti − ŷcriti ). Best
predicting models have smaller prediction errors, i.e. higher agreement between predicted
and observed values of ycrit. For example, a model can be chosen as having the smallest the
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(ycriti − ŷcriti )2.
Among statistical methods for the assessment of predictive performance, Akaike in-
formation criterion (AIC) [181] combines a measure of model fit, the maximum value of
its likelihood function L̂, with a measure of model complexity, the number of estimated
parameters k:
AIC = 2k−2log(L̂)
This is asymptotically equivalent to a cross-validatory loss function: a penalized loss function
based on the deviance, with a penalty derived from a cross-validation argument.
Up to this point we have considered the model output to be a point estimate g(y | θ̂0),
generally the expected value of the outcome Y. Other measures of goodness-of-fit are
based instead on the the predictive distribution p(y, θ̂0), which contains the complete set of
probabilities associated to a number of different outcomes around the mean of the observed
outcome [115].
Probabilistic modelling aims to maximise the sharpness of the predictive distribution
while accounting for accuracy of the probabilistic predictions, i.e. the statistical consistency
between the predictions and the observations. This procedure is often referred to as model
calibration. Any loss function used to maximise calibration is then a function of the observed
count ycrit and of the predictive distribution Q = p(Y crit | θ̂0), and it is referred to as scoring
rule s(ycrit,Q). The model minimizing the expectation of EYcrit s(y
crit,Q) will be closer to
reporting the true probability for the prediction.
The logarithmic score log(s(ycriti ,Q)) =−logQ(ycriti ), i.e. the log-transformed predictive
distribution evaluated at the observed outcome, is a standard choice in many situations,
including when dealing with count data [40, 87]. It can also be written as cross entropy, a
measure of divergence between the distribution of the observed outcome, pi, and distribution






3.4 Granger causality 43
3.4 Granger causality
All the methods presented in section 3.2 are based on cross-correlation, i.e. they quantify
the magnitude of the linear dependence between two time series Yt and Xt−k, for some
lag k = 0, . . . ,K possibly while taking into account the dependence from Yt−p (p ≥ 1) or
from confounders Zt−k. In 1969 Granger [75] suggested an alternative framework that uses
predictability as opposed to correlation to identify relationships between time series variables.
Variable Xt−k is said to “Granger cause” Yt if the predictability of Yt in some model declines
when Xt−k is removed from the universe U = {Xt−k,Zt−k,Yt−p} of all possible predictors.
This implies that Xt−k contains unique information, i.e. not found in other variables, that can
improve the prediction of Yt .
In practice, Granger causality is usually tested based on linear regression models, even
though extensions to nonlinear cases exist. An F-test is employed to compare the two models
p(Yt | Xt−k,Zt−k,Yt−p) and p(Yt | Zt−k,Yt−p), testing the null hypothesis that Xt−k’s coeffi-
cients are not significantly different from zero. Granger causality can be inferred if the null
hypothesis is rejected, i.e. Xt−k occurs before Yt and the optimal model for Yt improves when
Xt−k is included. Such a definition strongly relies on the idea of directionality of time: any
predictive factor can be a cause only if it occurs before the effect.
The key requirement of Granger causality is separability, namely that information about
a causative factor is independently unique to that variable and can be removed by eliminating
that variable from the model ??. Such a requirement may not be met in dynamic systems
with behaviors that are at least somewhat deterministic: if X is a cause for Y, information
about X will be redundantly present in Y itself, which implies that the causal variable X
cannot contain unique information, and that such information cannot be removed from U
simply by eliminating X. A more detailed discussion of nonlinearity will be presented in
chapter 8.
Moreover, the Granger-causality tests are designed to handle pairs of variables. Mislead-
ing results can be obtained when the true relationship involves three or more variables. For
example, if both X and Y are driven by a common third process, we might get to a false
positive conclusion of Granger causality, yet manipulation of one of the variables would not
change the other. Similarly, in stochastic feedback systems it might result that Yt Granger
causes Xt−k but also Xt Granger causes Xt−k.
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3.5 Conclusions
This chapter serves as a review of currently available methods aimed at estimating association
between two or more time series, hence all the methods proposed and reviewed are applicable
to surveillance data. When aiming to disentangle the contributions of different seasonal
components, associations can be hard to identify in terms of linear correlations. Granger
causality sets itself as a test for causal relationships beyond linear correlations.
We explore their application in the next chapter, investigating the interaction between
viral and bacterial respiratory pathogens across age groups in England. This adds to existing
evidence, that uses simpler models, and provides crucial evidence on age-specific pathogens
interaction to inform stockpiling of antivirals and antibiotics.
Chapter 4
Estimating age-stratified
influenza-associated IPD in England
4.1 Introduction
As introduced in sections 1.4 and 3.2, LRTIs are still responsible for a significant morbidity
and mortality worldwide despite the availability of immunisation and antibiotics, and the
contribution of each specific pathogen to LRTI burden must be estimated due to non-pathogen
specific routine diagnostic practices. Counts of syndromic healthcare contacts for LRTI and
pathogen-specific surveillance counts of detected infections can be combined for this scope
via time series models: extensive efforts have been directed towards estimation of influenza
burden [189, 39, 129].
However, especially in temperate countries of the world, widely studied respiratory
pathogens such as Influenza virus, RSV, Rhinovirus and Streptococcus Pneumoniae are
characterised by cyclical increases in autumn and winter months. Hence, investigation of
the role of the interaction between pathogens relative to shared seasonality remains an open
challenge [112, 230, 189]. We focus on the choice of a suitable methodological framework
to address this question: Nicoli et al. [156] estimated the percentage of IPD cases attributable
to influenza and RSV using a cyclic regression model, however the independence among
observations they assume is unlikely to hold when modelling incidence of a transmissible
pathogen. Hendriks et al. [89] proposed instead an ARIMA model, nevertheless preliminary
transformations to the original counts limits interpretability of coefficients and the necessity
of choosing model order via an empirical procedure based on model fit preclude ARIMA
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methods as a sensible choice for our scope [213].
We proceed to investigate respiratory viral-bacterial interaction by using the flexible
regression model introduced in section 3.2.3: weekly IPD counts are decomposed into an
endemic component, with sine-cosine waves describing cyclic winter outbreaks, and an
epidemic autoregressive component, where lagged IPD counts enter the model linearly using
an identity link function. Time-varying covariates are also linearly added to the model, with
the corresponding coefficients expressing the association between the outcome and each
covariate after taking into account shared seasonality. We are interested in investigating the
contribution of several pathogens to the incidence of IPD, as viruses other than influenza
(RSV, rhinovirus) have been speculated to interact with S. pnuemoniae [195, 114]. Finally,
as there is evidence that meteorological conditions such as temperature and humidity affect
seasonality and intensity of outbreaks [187, 48], we replace sinusoidal functions with ob-
served weather information.
As associations between pathogens have been suggested to be heterogeneous across age
groups [151], we also consider the multivariate version of the modelling framework pre-
sented in 3.2.3. Beyond allowing estimation of age-specific associations, such a multivariate
structure also permits decomposition of IPD transmission between and across age groups
by incorporating contact patterns. In summary, compared to previous work [162, 190], we
propose a phenomenological model that expresses IPD dynamics as a function of autoregres-
sive components, viral infections, age-specific contact patterns and seasonal confounders
without making strong assumptions on the transmission mechanism, aiming to provide a
parsimonious characterisation of the drivers of IPD patterns over time.
4.2 Data
Influenza is generally diagnosed based on ILI, defined as the simultaneous presence of signs
and symptoms such as high fever, cough and myalgia, however only virological testing
allows the ascertainment of the responsible pathogen. For this reason, we estimated influenza
incidence by combining two data sources. The RCGP RSC collects weekly numbers of
GP consultations for several clinical diagnoses of communicable and respiratory diseases,
including ILI. The population monitored by the RCGP RSC practices covers an average
population of ≈ 1.4 million persons, 2.6% of England, considered to be representative of the
national population in terms of age, gender, deprivation index and prescription patterns [34].
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As part of routine virological surveillance, in general practices participating in the RCGP
RSC scheme, a proportion of ILI cases is swabbed and the samples are tested for Influenza
A (H1 or H3 subtypes), Influenza B, RSV and Human Metapneumovirus (hMPV) by the
Public Health England (PHE) reference laboratory [34]. The number of specimens tested,
and the number of positives for each virus, are stratified by week of test and age group to
derive the proportion of virologically positive specimens. This proportion is then multiplied
by ILI counts to compute the corresponding age and time specific consultations attributable
to influenza.
S.pneumoniae (the pneumococcus) infection is often asymptomatic, as this is a commen-
sal bacterium of the human nasopharynx, nonetheless its progression to the lower respiratory
tract and blood can cause severe disease, namely IPD. In the UK, counts of positive iso-
lates for a number of clinically significant pathogens are reported weekly to PHE by all
the microbiology laboratories included in the national surveillance system, and stored in
the Secondary Generation Surveillance System (SGSS) database. Counts of IPD, RSV and
rhinovirus infections are extracted from SGSS. Consistency in testing over time and space is
guaranteed by the “United Kingdom Standards for Microbiology Investigations", a diagnostic
algorithm applied across laboratories to patients presenting with different clinical syndromes
[51]. Finally, estimates of the population of England by age group, during each season, are
obtained from the Office for National Statistics [161] while weather information such as daily
Central England Temperature and daily England and Wales precipitation are downloaded
from the MetOffice HadCET Data repository [165].
The time period considered ranges from 1st January 2009 to 31st December 2017, with
the 2009 pandemic period defined to include the three waves, from week 15/2009 to week
26/2011 [174]. Disease incidence is categorised into five age groups: 0-4, 5-14, 15-44, 45-64
and 65+ years old, as in similar studies [156].
A total of 62,679 ILI consultations within the sentinel scheme and of 45,601 IPD cases
nationwide have been notified over 9 years. The top panel of Figure 4.1 displays the temporal
trend of all ILI and influenza-confirmed consultation rates respectively, where influenza-
confirmed counts (referred to as “Flu" from now on) are obtained as just described. A clear
seasonal pattern is visible, with regular outbreaks in the winter months and epidemics lasting
10-15 weeks, except for 2009 when the A/H1N1 pandemic started in spring. Virological
testing is not systematically performed during the summer, hence the Flu data are quite
sparse off-season. Nonetheless, it is evident how, even during winter, the influenza cases































































































































































































































































Fig. 4.1 ILI and Flu incidence rate in the top panel, IPD incidence rate in the bottom one.
do not closely mimic the ILI curve, confirming the non-specificity of the ILI diagnosis. In
the IPD time series (Figure 4.1, bottom panel), peaks appear to be similar across seasons
both in terms of amplitude and timing, with a gradual increase of cases from autumn to a
winter peak, followed by a decline in summer. The incidence rate per 1,000,000 population
is plotted in this case, as IPD is rare. The observed time series for RSV and rhinovirus are
plotted in appendix A, Figure A.2.
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Fig. 4.2 Cross-correlation between each virus and IPD for up to 15 weeks of lag. Top panel:
flu and IPD. Middle panel: RSV and IPD. Bottom panel: rhinovirus and IPD.
4.2.1 Bivariate time series analysis
Cross-correlations between each virus and IPD are plotted in the three panels of Figure 4.2: a
strong correlation between flu and IPD with no clear lag is detected, confirming the overlap-
ping trends of Figure 4.1. Correlation with RSV is equally strong but for negative lags, while
correlation with rhinovirus is smaller, yet more marked for negative lags. Cross-correlation
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Fig. 4.3 Cross-correlation between weather variables and IPD for up to 15 weeks of lag.
between weather variables and IPD is plotted in Figure 4.3: a strong negative correlation is
detected for temperature in correspondence of negative lags, whereas correlation is barely
significant for rainfall. We then test for the presence of Granger causality, i.e. compare the
model in which IPD is explained by k lags of IPD only, with the same model to which k lags
of one explanatory variable are added. P-values of each test are summarised in Table 4.1: in
the top half of the table we see that including 1 to 5 lags of each variable, except for rainfall,
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improves model fit. On the bottom half of the table we test whether the opposite is true: we
model each explanatory variable alone, and test whether IPD lagged counts improve model
fit. The significant results for RSV and rhinovirus (feedback system) suggest that, along with
IPD, they might be driven by a common process, hence this Granger causality might be a
false positive. On the other hand, the relationship for flu and temperature is unidirectional
towards IPD, suggesting any change in their intensity might lead to changes in IPD.
k flu RSV rhinovirus temp rain
1 0.0035 0.0000 0.0001 0.0000 0.8062
2 0.0000 0.0000 0.0022 0.0000 0.8821
3 0.0000 0.0000 0.0002 0.0000 0.9226
4 0.0000 0.0000 0.0008 0.0000 0.9357
5 0.0000 0.0000 0.0027 0.0000 0.4222
1 0.5323 0.0000 0.0000 0.0043 0.4264
2 0.4217 0.0007 0.0003 0.2202 0.5959
3 0.5024 0.0009 0.0001 0.5125 0.2220
4 0.6966 0.0033 0.0000 0.1665 0.1556
5 0.7886 0.0030 0.0000 0.1739 0.2604
Table 4.1 P-values from a Granger causality test assessing the predictability of IPD as a
function the listed covariates
4.3 Analysis strategy
We propose the hhh approach presented in section 3.2.3 to model IPD and Flu counts. We
start by considering the time series referring to the entire population, without age stratification,
and we model IPDt |IPDt−1 ∼ Poi(µt) where
µt = poptνt +λYt−1 + τFlut−1 (4.1)
Alternatively, IPDt |IPDt−1 ∼ NegBin(µt ,ψ). We test the usefulness of an overdispersion
parameter by assessing which model formulation fits our data best in terms of AIC over all
the study period. Then, considering the mean is decomposed as in equation 4.1, we compare
different expressions for the endemic component νt . Yearly seasonality for weekly data is
described through the general formulation
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where α is an intercept and γs and δs quantify the amplitude of the sine-cosine waves.
We first assess the optimal number S of trigonometric functions to be included, and in a
second stage we check whether replacing the sine-cosine waves with rainfall and temperature
information better characterises differences across winters. We then consider the inclusion
of multiple lags both for Flu and IPD, following the formulation in equation 3.10: lags
q = 1, . . . ,Q where Q = 5 are assessed, i.e. including incidence of Flu and IPD up to 5 weeks
before time t. Finally, the additional contributions of RSV and rhinovirus are considered
by sequentially adding the number of detected infections to the selected model for IPD and
influenza.
We also compare the accuracy of the different model formulations in terms of one-
step-ahead forecasts using the logarithmic score, as described in section 3.3. We select 30
weeks as the initial time window of data used as training period, and for each training set of
length j = 30, . . . ,440 we refit the model, produce a one-step-ahead forecast and compute the
logarithmic score log(s j(p,x)). The best model is chosen by taking the expected value over j.
We then model IPD counts in age group a, IPDt,a, where a ∈ {0-4, 5-14, 15-44, 45-64,
65+}, using the multivariate version of the hhh model. For consistency, we use for all age
groups the distributional assumption and the endemic component that fitted the univariate
time series best, and the mean component is now formulated as
µt,a = popt,aνt,a +λaIPDt−1,a +φa ∑
k ̸=a
ck,aIPDt−1,k ̸=a + τaFlut−1,a. (4.3)
In order to account for heterogeneity of contact patterns, counts of disease in groups
k ̸= a are weighted by the element ck,a of the POLYMOD contact matrix, a measure of social
distancing between group k and a [149]. We initially assume transmission coefficients to
be age-specific as, despite accounting for contact patterns, some age groups are known to
be more susceptible to infection than others. Similarly, heterogeneity across groups can
be allowed for the remaining model parameters, as the interaction between influenza and
S.pneumoniae has also been suggested to vary with age [43]. We then use model selection via
AIC and log(s(P,x)) to evaluate whether some coefficients could be shared across age groups:
model fit is assessed in a sequential way, testing at each stage which of the components leads
to a larger AIC reduction when associated with non age-specific coefficients.
The model in equation (4.3) is simultaneously fitted to the five age groups, and code
was not available for the situation where multiple covariates are added. We developed our
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own algorithm, simultaneously fitting models for different strata incorporating the contact
structure. Similarly to the hhh4 function, we also obtained maximum likelihood estimates
via a (globally convergent) Newton-Raphson type algorithm. To ensure positivity, parameters
are optimized on the log-scale, i.e. log(ψ) and log(λ ) are used. Uncertainty about the pro-
portions of IPD cases attributable to each virus is estimated by resampling n=10,000 datasets
from the fitted model and taking the 95% confidence intervals (CIs) to be the empirical 2.5%
and 97.5% percentiles across the resampled datasets.
4.4 Results
4.4.1 Model choice: endemic waves and lagged covariates
A summary of model comparison is presented in Table 4.2: starting from a Poisson dis-
tributional assumption and one set of trigonometric functions (model A), we first add an
overdispersion parameter (model B); more complicated versions of the endemic component
are then assessed by replacing trigonometric waves with weather variables (model C) and
including multiple lags for them (model D). Great improvement in model fit is obtained by
allowing overdispersion, whereas we see no gain in adding either Flu or IPD lagged counts
when the lag q > 1. Model fit is improved instead when adding lagged values for rainfall and
temperature, however the parameter representing the decline in weight attributed to lagged
values is optimally chosen to be pweather = 0.8, suggesting that only 20% of the weight is
attributed to observations more than one week before. Evaluating the model in terms of
one-step-ahead forecasts, we also find mean log(s(P,x)) to be minimum for the endemic
formulation including weather information, with lags weighted according to pweather = 0.8
(model D).
distr endemic covar AIC log(s(P,x))
A Poi S=1 Flu 5107.61 5.805
B NB S=1 Flu 4043.95 4.408
C NB rain+temp, lag=1 Flu 4029.19 4.400
D NB rain+temp, lags=5 (pweather=0.8) Flu 4027.82 4.390
E NB rain+temp, lags=5 (pweather=0.8) Flu+rhinov 3997.93 4.361
F NB rain+temp, lags=5 (pweather=0.8) Flu+rhinov+RSV 3992.95 4.334
Table 4.2 Model comparison in terms of AIC and one-step ahead forecast (log(s(P,x)))
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4.4.2 Estimated influenza impact
Fitted values for all components according to model formulations B and D are shown in
Figures 4.4 and 4.5, whereas predictive distributions for one-step-ahead forecasts of model D
are presented in Figure 4.6. The number of IPD cases attributed to Flu during the entire study
period is as low as 199 according to model D including weather variables, i.e. 0.45% (CI
<0.01%-1.59%) of all the IPD cases. However, 100 of these cases happened during the three
pandemic waves, 0.83%, CI <0.01%-2.94%, of all the observed IPD cases in that period,
suggesting that the pandemic strain might have been responsible for an increased incidence.
As a sensitivity analysis, we select Flu counts referring only to the three pandemic waves:
the increase in AIC is minimal compared to model D including Flu counts over all the study
period, suggesting that the role of seasonal Flu is marginal. We also consider each season as
a separate covariate, with results plotted in Appendix A, Figure A.1.
4.4.3 Rhinovirus and RSV
Finally, we investigate whether other viruses also interact with S.pneumoniae: the number of
rhinovirus (model E in Table 4.2) and RSV (model F) infections are sequentially added to the
selected model D. Rhinovirus alone greatly enhances the fit to the data, and the inclusion of
RSV on top of Flu and rhinovirus still results in model improvement. Hence, the best fitting














+λ IPDt−1 + τFlut−1 +θrhinovirust−1 +ζ RSVt−1
(4.4)
with overdispersion parameter ψ and decay parameter for wq(weather) fixed to pweather=0.8.
Point estimates and standard errors for the coefficients are reported in Table 4.3, while rela-
tive contributions are pictured in Figure 4.7: rhinovirus explains 6.97% (CI 4.27%-10.28%)
of all the IPD cases, 2.48% (CI 0.51%-4.52%) are attributed to RSV and only 0.67% (CI
<0.01%-1.69%) to Flu. Overall, the three viruses account for 10.12% (CI 7.18%-13.77%) of











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4.5 Model (D) of IPD and Influenza with rainfall and temperature
4.4.4 Age-specific analysis
Selected plots displaying age-specific incidence can be found in Appendix A, Figures A.3-
A.5. For consistency, we use for all age groups the distributional assumption and the endemic
component that fitted the univariate time series best (model D). Thus, when considering
attribution of IPD to Flu, model selection starts by considering the model in equation (4.3):






























































































































log(ζ ) 1.8944 0.0742
log(λ ) 5.8521 2e-04
Table 4.3 Coefficient estimates for model (I), including Flu, rhinovirus and RSV as covariates.




















However, this requires estimating 35 coefficients, not a very parsimonious option. Hence,
we try model reduction by testing whether any of the coefficients could be the same across
groups. Full model comparison is reported in Table 4.4. AIC decreases from 13218.85
(model G, with all age-specific coefficients) to 13216.32 by using a shared rainfall coefficient







































































































































































































































































































































































































































































































Fig. 4.7 Model (F) including Influenza, rhinovirus and RSV
sidered, but once again a benefit from including past values only pertains to weather variables.
covar shared pars AIC
G Flu all age-spec 13218.85
H Flu δa = δ 13216.32
I Flu δa = δ , τ<5 = τ65+ = 0 13212.32
J Flu+rhinov δa = δ , τ<5 = τ65+ = θ5−14 = θ15−44 = 0 13160.70
K Flu+rhinov+RSV δa = δ , τ<5 = τ65+ = θ5−14 = θ15−44 = 13143.67
= ζ5−14 = ζ15−44 = 0
Table 4.4 Multivariate model comparison in terms of AIC
Estimated coefficients and standard errors for model H are shown in Tables 4.5 and
4.6. The τa parameters associated with influenza are quite heterogeneous across age groups,
showing an inverse-U shaped tendency: almost null in young children and the elderly, and
more prominent in other age groups. However, due to the very small size and associated large
uncertainty of the parameters τ<5 and τ65+, we refit the model fixing them to zero (model I).
The attributed proportions of IPD cases estimated from this model are reported in Table 4.7,
estimated coefficients and standard errors are shown in Tables 4.8 and 4.9, fitted values for
all age groups are plotted in Figures 4.8-4.10 and predictive distributions in the Appendix,
Figures A.6 and A.7.













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4.8 Model I: Fitted IPD values for infants and school-age children
Importantly, according to model I, IPD is driven by Flu in school-age children (8.40%,
CI 4.12%-13.66%) and adults aged 15-44 (3.55%, CI 1.64%-5.76%), and these components
are strikingly higher in the pandemic period: 18.30% (CI 9.43%-28.16%) and 6.07% (CI
2.83%-9.76%) respectively.
Adding rhinovirus in the best fitting model I leads to the biggest AIC reduction, from
13216.32 to 13167.31, when its contribution is quantified by an age-specific coefficient θa.




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4.9 Model I: Fitted IPD values for the 15-44 and 45-64 age groups
model takes the form





where νt,a = exp
[
αa + γa ∑
5





for the model with only Flu, due to large uncertainty about coefficients close to 0, the
coefficients θ5−14, θ15−44, ζ5−14 and ζ15−44 are fixed to zero (models J and K). Fitted values
for all age groups are plotted in Appendix A, Figures A.8-A.12, coefficients and standard
errors are listed in Tables A.1 and A.2 while the relative contribution of the components is de-





















































































































































































































































































































































































































































































































Fig. 4.10 Model I: Fitted IPD values for the elderly
Age α γ δ log(ψ) log(τ) log(λ ) log(φ)
<5 -2.282 -0.317 -0.037 2.513 -13.847 2.182 1.291
5−14 -4.422 -0.369 -0.037 1.590 -3.262 2.283 1.364
15−44 -4.035 -0.477 -0.037 3.024 -1.629 3.729 4.093
45−64 -2.776 -0.342 -0.037 3.173 -2.150 3.479 3.610
65+ -1.938 -0.464 -0.037 3.188 -6.714 3.423 4.246
Table 4.5 Model I: Coefficient estimates for the age-specific model of IPD including Flu.
Since Flu coefficients τ<5 and τ65+ were very small, we refit the model fixing them to 0, to
make sure the other parameter estimates are not sensitive to such an assumption.
scribed in Table 4.10. Model K shows that the association between RSV and IPD is strongest
in the elderly (3.91%, CI 1.83%-6.38%, of cases in 65+ and 4.18%, CI 1.58%-6.91% of
cases in 45-64), and rhinovirus plays an important role in the same age groups: 5.43% (CI
2.23%-8.91%) in 45-64 and 5.68% (CI 3.03%-8.32%) in 65+.
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Age α γ δ log(ψ) log(τ) log(λ ) log(φ)
<5 0.126 0.040 0.024 0.197 177.157 0.179 0.398
5−14 0.254 0.086 0.024 0.269 0.354 0.301 0.482
15−44 0.182 0.063 0.024 0.148 0.307 0.264 0.127
45−64 0.119 0.039 0.024 0.126 1.048 0.221 0.141
65+ 0.111 0.034 0.024 0.101 - 0.158 0.147
Table 4.6 Model I: Standard error estimates for the age-specific model of IPD including Flu.
Uncertainty around coefficients τ<5 and τ65+ was not well estimated.
Age Pnc transm Influenza A
within group across groups overall AH1N1pmd09
< 5 26.42 (16.16 - 34.49) 18.73 ( 4.67 - 33.14) 0.00 0.00
5−14 15.70 ( 5.32 - 24.17) 27.32 ( 2.18 - 55.97) 8.40 ( 4.12 - 13.66) 18.30 ( 9.43 - 28.16)
15−44 19.47 (10.33 - 27.07) 50.67 (38.79 - 63.16) 3.55 ( 1.64 - 5.76) 6.07 ( 2.83 - 9.76)
45−64 23.65 (14.79 - 31.03) 41.64 (31.61 - 51.49) 0.92 (<0.01 - 2.94) 1.19 (<0.01 - 3.78)
65+ 33.02 (24.89 - 39.88) 34.45 (26.02 - 43.24) 0.00 0.00
Table 4.7 Model I: Relative proportions (%) of IPD cases attributed to pneumococcal
transmission within and across age groups, and to influenza overall or in the pandemic period
4.5 Discussion
Using English surveillance data, we quantify the magnitude of the interaction between
influenza virus and S.Pnuemoniae in seasonal and pandemic settings by proposing a multi-
variate extension of the hhh modelling framework. Such interaction is estimated to be quite
small when looking at population-wide counts (model D). These results are consistent with
previous research, showing a small association at aggregate level [112]. Interestingly, we
find evidence to support the hypothesis of an age-specific interaction [151], the contribution
of Flu towards IPD being significant in school-age children and adults aged 15-44 but not in
other age groups (model I). Moreover, the components of IPD explained by influenza are
strikingly higher during the 2009 pandemic period in the same age groups. This supports the
findings of Weinberger et al. [232]. Other viruses also appear to interact with S.pneumoniae
with various intensities across age groups: both RSV and rhinovirus play an important role in
45-64 and 65+ year-olds (models F and K respectively). Such findings support previous ev-
idence of interplay among these pathogens, with differential behaviour across ages [109, 231].
Compared to Serfling-type models, an important advantage of the modelling framework
used here is the potential to account for correlation between observations thanks to the
inclusion of an autoregressive term. The importance of such a component, which represents
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Age α γ δ log(ψ) log(τ) log(λ ) log(φ)
<5 -2.2818 -0.3173 -0.0372 2.5131 - 2.1816 1.2908
5-14 -4.4221 -0.3688 -0.0372 1.5905 -3.2617 2.2835 1.3644
15-44 -4.0347 -0.4770 -0.0372 3.024 -1.6285 3.7285 4.0934
45-64 -2.7756 -0.3419 -0.0372 3.1729 -2.1502 3.4786 3.6104
65+ -1.9382 -0.4640 -0.0372 3.1881 - 3.4232 4.2462
Table 4.8 Model I: Coefficient estimates for the age-specific model of IPD including Flu
Age α γ δ log(ψ) log(τ) log(λ ) log(φ)
< 5 0.0033 0.0017 0.0012 0.0385 - 0.0109 0.0142
5−14 0.0145 0.0092 0.0012 0.0718 0.1035 0.0517 0.0222
15−44 0.0063 0.006 0.0012 0.0220 0.0661 0.0068 9e-04
45−64 0.0128 0.0113 0.0012 0.0158 0.7316 0.0036 0.001
65+ 0.0017 0.0011 0.0012 0.0101 - 0.0018 0.0012
Table 4.9 Model I: Coefficient standard errors for the age-specific model of IPD including
Flu
pneumococcal disease transmission, is undoubted: our findings suggest that 50.70% (CI
38.19%-63.20%) of pneumococcal disease in adults aged 15-44, potential parents of young
children, is transmitted from other age groups. Transmission within group, on the other
hand, prevails in pre-school children and 65+ year-olds: 26.32% (CI 16.24%-33.95%) and
23.75% (CI 14.97%-30.68%) respectively (model K). We speculate this could be due to
higher incidence of IPD in care homes or in immunocompromised people.
Further, the additive structure of the model allows us to quantify the contribution of
multiple viruses to the IPD counts, and at the same time the multivariate age-specific model
allows a better characterisation of each of these interactions. Finally, the endemic compo-
nent captures considerable proportions of IPD incidence in all age groups. We can think
of this seasonal background as the proportion of disease probably due to some common
environmental factors. The adequacy of temperature and rainfall observations to replace
trigonometric functions, supported by enhanced model fit both at aggregate and age-specific
level, reinforces this hypothesis and allows relaxing the assumption of fixed periodicity, with
similar amplitude and timing across seasons. The appropriateness of shared coefficients for
rainfall also suggests that disease seasonality has similar timing across the entire population.
As described in section 1.5, the data used might hide some biases. Despite integrating
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assumption that viral surveillance is consistent over time and adequately represents the
true burden in the population [105]. Further, we simply multiply the proportion of positive
samples by the ILI rates, whereas a joint modelling approach would take uncertainty into
account. In terms of IPD data, we believe that testing policies must be consistent over time
due to the life-threatening nature of such a condition, and that reporting along UK-wide
guidelines [51] was relatively stable over time. Nonetheless, the limited numbers of cases,
especially in the age-specific analysis, made the resulting estimates uncertain.
Despite our efforts to mimic disease mechanisms, a number of assumptions are made
in our analysis that might be inaccurate or introduce some bias. Linearity between disease
incidences is assumed, however interaction between pathogens could be resulting from more
complex nonlinear dynamics. The assumption of one week lag between events is the best
approximation given weekly data, however the infectious time might be shorter than that
[131]. Autoregressive coefficients fixed over time keep our model easy to interpret and avoid
overfitting, however such an assumption implies that both pneumococcal transmission and its
interaction with influenza have no seasonal behaviour; as a consequence, any season-specific
variation is included into the endemic component, summarising unknown aspects such as
climatic influence on disease susceptibility. The use of age-structured contact patterns leads
to improved model fit compared to an assumption of random mixing between age groups
(results not shown), nonetheless the used contact patterns are approximated by a matrix
estimated in 2005-06 [149]. Finally, we assume pneumococcal infection to follow from
transmission, yet we are aware that pneumococcus can be carried asymptomatically, and that
those individuals also contribute to the transmission.
Chapter 5
Time-series methods to assess the impact
of an intervention
5.1 Introduction
Public policies or interventions are implemented to improve the health of the public, and the
extent to which they achieve their aim should be measured using suitable statistical methods.
Quantifying the effects of a policy is of primary importance not only to make a decision on
its continuation. Evaluation of an intervention can be also an important ex-ante policy impact
assessment tool, as it can provide evidence for similar policies that might be implemented in
similar populations in the future.
Assessing the impact of an intervention is often a non-trivial task. An adequate policy
evaluation analysis generally involves measuring the resulting outcome of a policy and
comparing with the expected outcome in the absence of any intervention. But how should
the expected outcome be defined? Let us consider the example of publicly-provided vacci-
nation, offered to healthy individuals in order to prevent infections and mortality: should
the outcomes of the participants be compared to their pre-intervention situations, or instead,
compared with those of the non-participants [169, 37] ?
Several methodologies have been proposed to identify the intervention effects [122], with
the intervention evaluation literature gaining increasing importance in recent years. This
chapter introduces a general framework for the evaluation of public health interventions and
describes some of the methods currently used to measure their impact.
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5.2 Intervention evaluation framework
Our discussion focuses on measuring the causal effect of a non-randomised binary inter-
vention on an outcome of interest, Y . We adopt the potential outcomes framework [179],
also known as the Rubin causal model [92]. Under this model, for each treated unit i there




i represents the outcome that would be ob-
served if intervention were not applied, and Y (1)i is the outcome that would be observed if
the intervention were applied. The intervention’s causal effect is defined as the difference
between these two quantities. The fundamental evaluation problem is that we cannot observe
simultaneously the same unit in the two scenarios; the scenario in which the intervention is
not implemented, the counterfactual, is always missing. Therefore, evaluating the impact of
an intervention involves in the first place estimation of the counterfactual [122].
For the scope of this thesis we focus on the situation where the outcome of interest is
measured at several time points, before and after the intervention, and the intervention is
implemented at population level. Hence, an aggregate entity (e.g. hospital, city, region)
is the treatment unit, and accordingly, the outcome is reported in the aggregate form of a
time series Yt , for t ∈ {0,1, . . . ,T} (e.g. disease incidence). We assume the intervention is
introduced at a known time t1 ≤ T . The counterfactual Y
(0)
t is then estimated for t > t1, and
the causal effect of the intervention is defined as τ̂t = Y
(1)
t − Ŷt
(0). Given the widespread
availability of aggregate data and the fact that many policy interventions take place at popu-
lation level, examples of studies modelling the counterfactual for aggregate outcomes can
be found across research areas, from public health (e.g. mortality rates [180]) to economics
[101] and sociology (e.g. crime rates [182]). In the next sections we present selected sta-
tistical methods that have been developed to model the counterfactual in the described setting.
5.3 Before-and-after designs
Before-and-after designs approximate the counterfactual Y (0)t by using the outcome observed
in the same population in the pre-intervention period, Yt for t ≤ t1, as a control. While such a
comparison might sound naïve, it has one main advantage: the studied population acts as its
own control, hence time-invariant factors are controlled by design and there is no need to
adjust for differences between groups [123].
5.3 Before-and-after designs 67
5.3.1 Interrupted time series analysis
When multiple pre-intervention observations are available, a before-after design is the
interrupted time series (ITS) regression model:
g(Yt) = α + f (zt1)+κ t + s(t)+βXt + εt (5.1)
where:
• g(·) is an appropriate link function
• α is an intercept term, potentially including the population offset
• f (zt1) defines the impact model, dependent on the binary intervention indicator zt1 ,
which is function of time t1
• κ t and s(t) are the linear trend and seasonal components
• βXt defines contributions of other time-varying factors X jt
While the intervention is expected to “interrupt” the level and/or trend of the observed
outcome Y (1)t in the post-intervention period, the counterfactual Y
(0)
t is estimated by as-
suming the pre-intervention seasonality, linear trend and relationships of covariates remain
unchanged [123, 225]. In summary, this model allows making a pre-post comparison while
accounting for observed time-varying factors in the population, i.e. explicitly modelling the
contribution of underlying trends and measured time-varying confounders.
While there is general agreement on defining baseline trends as simple means or linear
functions of time, specifying the form of f (zt1) can be a less-straightforward choice. Further,
the fact that such a choice must be made a priori makes the model inflexible to account for
data-driven evidence. Finally, history bias remains a threat, i.e. other events occurring around
the same time as the intervention of interest (cointerventions) or unobserved time-varying
confounders might affect the outcome, but not be captured by the trend model [123]. Hence,
attributing to the intervention any unaccounted change in the outcome might be unreasonable.
On the other hand, even when no apparent change in the outcome is observed, the inter-
vention’s effect might have been confounded by unobserved factors [118]. To address this
limitation, methodologies for counterfactual analysis presented next will focus on controlled
designs.
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Fig. 5.1 Difference-in-difference estimation, graphical explanation [Columbia University]
5.4 Controlled designs
Methodologies for counterfactual analysis including a control group span across several
families of controlled designs, including randomised controlled trials as well as also ob-
servational studies [178]. Controlled studies have greater potential to make strong causal
statements, as a lack of effect in a well-chosen control can provide stronger evidence to
support a causal relationship between the intervention and outcome [123]. For example,
the difference-in-difference (DID) method [235] compares the outcome of a treated and a
control unit in two time periods (pre- versus post-intervention), assuming that the average
outcomes of control and treated units in the absence of an intervention would follow parallel
trends (Figure 5.1). The mean change in the control group’s outcome from the pre- to the
post-intervention period is then used as the counterfactual against which the mean change in
the treatment group is evaluated.
Control groups should be chosen to be as similar as possible to the treated group, except
for exposure to the intervention [179]. Specifically, controls should not be indirectly affected
by the intervention of interest (assumption of no interference), nor exposed to other inter-
ventions or events impacting on the control series alone. They can be selected based on a
different geographic area, a population subgroup not targeted by the intervention (e.g. gender,
age group), or again another outcome unaffected by the intervention. While randomised
studies ensure that any differences between groups are at random, randomisation is mostly
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infeasible in public health interventions. In observational settings treated and untreated units
can be inherently different, particularly when the units can select themselves into partici-
pation or when the intervention is targeted towards units at higher risk. Attempts to take
differences between groups into account include adjusting for fixed measurable confounders
via regression or matching, yet residual confounding due to unknown variables remains
unaccounted for [11].
5.4.1 Synthetic controls
In practice, it is often difficult to find a single untreated unit that approximates the most
relevant characteristics of the unit exposed to the intervention, and there is often some degree
of ambiguity about the chosen measures of affinity between treated and untreated units. As
an alternative, multiple control units can be identified. Abadie et al. [1] advocated the use
of data-driven procedures to construct suitable control groups, proposing the idea that a
combination of untreated units could provide a better comparison for the treated unit than any
untreated unit alone. These so-called synthetic control methods combine multiple controls
by identifying the weighted average of untreated units that best reproduces characteristics
(including observations of the outcome) of the treated unit before the intervention. These
weights are then used to estimate the counterfactual in the post-intervention period. Suppose
that we observe J+1 units, and Yj is the outcome observed for unit j
• unit 1 is exposed to the intervention at time t1 ≤ T
• the remaining J units are untreated units, potential controls
• X1 is a (k×1) vector of pre-intervention characteristics for the treated unit and X2:(J+1)
is a (k × J) matrix which contains the same variables for the untreated units.
If w = (w2, . . . ,wJ+1) is a collection of weights such that ∑J+1j=2 w j = 1, with each w j ≥ 0,
then w∗ = (w∗2, . . . ,w
∗
J+1) is chosen to minimise the distance ||X1 −X2:(J+1)w||, commonly
evaluated by a weighted Euclidean norm. Then, the synthetic control estimator of the effect
of the intervention for the treated unit in a post-intervention period is





i.e. the difference between the observed and the counterfactual.
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5.4.2 Controlled interrupted time series (CITS)
As for before-and-after designs, our focus is on the situation where multiple pre-intervention
observations are available. CITS, also called comparative time-series design, are an extension
of ITS that model the outcome of the treated unit, Yt,1, while considering outcomes of one or
more contemporaneous control groups Yt, j for j = {1, . . . ,J}. Controls should be exposed
to any co-interventions or events that affect the treated group: the simultaneity guarantees
that any time-specific confounders affecting outcomes of both treated and control units are
controlled for. However, controls should not be indirectly affected by the intervention of
interest, nor exposed to other interventions or events impacting on the control series alone.
The counterfactual is now defined both on a before-after and on a treated-control com-
parison. Depending on the situation, different models can be formulated. A single model
including indicator variables for the intervention or control series as interaction terms, for
example, provides a test of the differential effects of the intervention (level or slope change)
across the groups [123]. In the simplest case, a generalisation of the DID seen above, one
parametric linear model for the outcome of units j = {1, . . . ,J} is formulated assuming that
the treatment and control groups follow parallel trends:
Y j,t = µt +κ j + τ j,td j,t +βXt,j + ε j,t (5.2)
where:
• µt describes the common trend and seasonal components
• κ j is a fixed effect of unit j
• d j,t is the binary intervention indicator, positive for t > t1 in the treated unit j = 1
• τ j,t is the intervention effect for j = 1
• βXt, j adjusts for group-specific time-varying covariates Xt, j
In this case, if a change over time is detected in the intervention group but not in the
control, then such an effect is attributed to the intervention. In other words, the intervention
effect is evaluated by looking at whether the treatment group deviates from the baseline levels
by a greater amount than the controls group(s). More complicated models can be formulated
to account for differential changes in covariates between the treated and the control series
throughout the study period [186, 123]. However, the more complex the trend, the more
difficult it becomes to differentiate intervention effects from natural underlying fluctuations.
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5.4.3 The Causal Impact method (CIM)
When multiple controls are considered, synthetic control approaches can be applied to CITS
studies, with the general idea of obtaining a weighted average of the controls such that their
characteristics are as similar as possible to the ones of the study group. Taking ideas from
the synthetic control framework, Brodersen et al. [15] introduced the CIM. They model
the outcome of the treated unit, Yt,1, including a time-series component that relates Yt,1 to
previous outcomes on the same unit, Yt−p,1, and a regression component that uses the con-
temporaneous outcomes on control units as covariates. Furthermore, instead of performing
a constrained maximisation to match covariates as in section 5.4.1, Brodersen et al. [15]
make use of a ‘Bayesian structural time series’ (BSTS) model including a Bayesian variable
selection technique to choose and weight the control outcomes Yt,2:(J+1). In the next sections,
we briefly introduce the BSTS model and variable selection in general, before specifying the
CIM.
Structural time series models
Structural time series models, also called dynamic linear models (DLM), are univariate time
series models widely used in the econometric literature. They describe the evolution of a
time series as the sum of a number of independent components, typically a trend component
and a random component; a seasonal component is often added. Compared to the static
regression models presented in chapter 3, where parameters were fixed for all time, here
each component is allowed to evolve randomly over time: a model is specified to decompose
it into the sum of an unobservable state variable and a random error. The general DLM
formulation, for t = 1,2, . . . ,T , consists of a set of two equations, called the observation and
evolution equation respectively:
Yt = Ftθt + εt
θt = Gtθt−1 +ηt
(5.3)
where Yt is the observed outcome at time t; θt is an unobservable (latent) state vector rep-
resenting the outcome trend; and Ft are possibly time-dependent coefficients for the latent
state. Such a latent state is itself dynamically modelled through the evolution equation: the
evolution matrix Gt deterministically maps the parameter space from one time step to the
next, so the states at time t are temporally related to those before and after. A seasonality
component γt can also be added to the observation equation, and a corresponding evolution
equation specified for it.
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Both equations include error terms, εt being the observation error and ηt the evolution
error, which are assumed mutually independent. DLMs are a special case of state-space
models, a general class of non-stationary time series models [168], which assume linearity
and Gaussianity of errors. Generalised DLMs relax the assumption of normality by allowing
the distribution to be any of the exponential family of functions (typically Bernoulli, binomial
and Poisson distributions, useful in particular for count data).
Bayesian variable selection via the spike-and-slab prior
When estimating time series models over relatively short time periods with multiple variables
and large numbers of parameters, multicollinearity and overfitting can be problematic. As an
alternative to regularisation techniques such as Lasso and Ridge regression [60], a Bayesian
approach allows imposing priors on the regression coefficients to select the predictors in a
robust and automatic way. Here we focus on the spike-and-slab prior approach to sparsity
in Bayesian variable selection [145, 65, 66].
Let δ denote a vector, of the same length as β , that indicates whether or not a particular
covariate is included in the regression. In formulae, δi = 1 indicates βi ̸= 0 and δi = 0
indicates βi = 0. Let βδ indicate the subset of β for which δi = 1, and let σ2 be the residual
variance from the regression model. A spike-and-slab prior for the joint distribution of
(β ,δ ,σ2) can be factorised in the usual way:
p(β ,δ ,σ2) = p(βδ | δ ,σ−2)p(σ−2|δ )p(δ ).
• for the “spike” part of a spike-and-slab prior, which refers to the point mass at zero, a










When detailed prior information is unavailable, it is convenient to set all πi equal
to the same probability, π . The common prior inclusion probability can easily be
elicited from the expected number of nonzero coefficients. If k out of K coefficients
are expected to be nonzero, then set π = k/K in the prior.
• The “slab” component is a prior for the values of the nonzero coefficients, conditional
on knowledge of which coefficients are nonzero. Let b be a vector of prior guesses for
regression coefficients, let Ω−1 be a prior precision matrix, and let Ω−1
δ
denote rows
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and columns of Ω−1 for which δi = 1. A conditionally conjugate “slab” prior is

















It is conventional to assume b = 0 (with the possible exception of the intercept term)
and Ω−1 ∝ XT X . The final values that need to be chosen are d f and ss. These can be
elicited as a function of the R2 statistic you expect to obtain from the regression, and
the weight you would like to assign to that guess, measured in terms of the equivalent
number of observations. The df parameter is the equivalent number of observations,
and ss = d f (1−R2)σ2y .
This leads to a posterior distribution with positive mass at zero for sets of regression
coefficients, while Bayesian model averaging smooths the predictions over a large number
of potential models, as well as providing the posterior inclusion probability for each predictor.
The CIM as a BSTS
The BSTS model proposed for the CIM by Brodersen et al. [15] takes the form
Yt,1 = µt + γt +Xtβ + εt








• Yt,1 is the observed outcome in the treated unit j = 1;
• µt is the latent state, i.e. Ft = 1 and θt = µt in equation 5.3;
• γt is a seasonal component, which can be expressed via trigonometric functions ac-
cording to the periodicity s, using two time-varying harmonic components γ j,t−1 and
γ∗j,t−1 evolving through time as























• Xtβ is a static regression component with time-varying covariates Xt and time-fixed
coefficients β . Specifically, we define Xt = Yt,2:(J+1), i.e. the X2:(J+1) matrix of
section 5.4.1 is now time-dependent and contains J columns consisting of the observed
outcomes Yt,2:(J+1) in potential control units. These candidate predictors are selected
and combined into a single synthetic control based on their ability to predict the
outcome of the treated unit prior to the intervention, via a spike-and-slab prior for β ;
• εt , ηt and ωt are incorrelated Gaussian error terms.
Several choices can be considered for the evolution matrix Gt , which describes the
evolution of the latent state vector µt from one time step to the next. The most commonly
used state models are:
• local level model, i.e. a random walk
µt = µt−1 +ηt ;
• local linear trend, i.e.
µt = µt−1 +φt +ηt ,
φt = φt−1 +υt ,
with an additional error term υt ;







– for large p, a spike and slab prior could be applied on the autoregression coeffi-
cients, so that some coefficients might be set to zero.
After fitting the model to the observed data yt,1 for t ≤ t1, the counterfactual y
(0)
t,1 is forecast
for the post-intervention period t > t1 assuming that the relationship between the treatment
and the control series (equation 5.4) that existed prior to the intervention continues afterwards.
Thus, the observed outcomes for the control units y(0)t,2:(J+1) in the post-intervention period
are employed to predict the counterfactual y(0)t,1 , and a posterior distribution for the causal
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effect at each time point t > t1 is then obtained by the posterior samples of yt,1 − y
(0)
t,1 .
5.5 Predictive model assessment
As anticipated in section 3.3, model assessment is essential to quantify the goodness of fit
but also to identify the best performing model among a set of choices. Ideally we should
check the performance of our model on new data, as evaluating the model on the data used to
train it would lead to a biased estimate of performance. In practice, new data are often not
available, and a new dataset can be artificially created by splitting the available data in two
portions: if we call yfit the portion of y used to fit the model, ycrit can denote the portion used
for model criticism.
Cross-validation is a standard way to split the dataset: when independence between
observations holds, the k% of the data left out from yfit is chosen at random. In time series
settings, due to the inherent temporal dependence, splitting of the data must respect the
temporal order in which values are observed: the training set can consist of observations
up to a given time point yk, and any future observation with respect to yk can form the test
set. Depending on the situation, forecasting performance can be assessed by looking at
one-step forecasts or multi-step forecasts. This approach, often referred to as out-of-sample
prediction, provides a good proxy for how the model will perform in a real world forecasting
environment, in which we stand in the present and forecast the future [9].
To obtain a more robust estimate of the expected performance of the chosen method, the
process of splitting the time series into train and test sets can be repeated by choosing differ-
ent splitting points, varying the number of records used to train the model. Typical splits are
50-50, 70-30 and 90-10, however the minimum number of observations required to train the
model must be carefully chosen so that yfit is large enough to be representative of the original
problem. Moreover, it is worth noting that different lengths of the test set must be taken into
account in order to obtain performance statistics that can be meaningfully combined and
compared. For example, forecast accuracy can be computed by averaging over the test sets.
This procedure is sometimes known as “evaluation on a rolling forecasting origin” because
the “origin” at which the forecast is based rolls forward in time. Some authors also talk about
nested cross-validation, as this comes with an additional computational expense of training
and evaluating multiple models, selecting parameters that minimise the prediction error for
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Fig. 5.2 Graphical representation of evaluation on a rolling forecasting origin
.
each choice of training-test set [9].
In a Bayesian setting, model criticism typically analyzes the posterior predictive distri-
bution [63]: instead of simply considering a point estimate for ŷcrit, typically its mean, we
look at the distribution of unobserved data ycrit, conditional on the observed values yfit. It is
an average of conditional predictions of the new data, averaged over the posterior distribution
of parameters θ , so that uncertainty about θ is taken into account:
p(ycrit | yfit) =
∫
p(ycrit | θ ,yfit)p(θ | yfit)dθ .
Comparison between observed and predicted values can be done using multiple checking
functions. We consider here the Bayesian Mean Squared Prediction Error (MSPE)∫
(ycritpred −y
crit)2 p(θ | yfit)dθ
where ycritpred is a vector of replicates drawn from p(y
crit | yfit).
5.6 Conclusions
In this chapter we have presented two classes of methods that have been used to model
intervention effects, playing a prominent role in identifying the causal effects of interventions
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in many institutions and international organisations. Each of them has advantages and limita-
tions, in particular the ITS relies on a pre-chosen function for the intervention effect, whereas
the CIM is more flexible but nevertheless requires specification of priors for the models.
We explore their application in the next chapter, investigating the impact of pneumococcal
vaccine introduction in England. This adds to existing evidence produced by PHE, that uses
the counterfactual analysis somewhat parsimoniously in its evaluation and ex-ante policy
impact assessment guidelines, relying on simple impact indicators [113].

Chapter 6
Application to Pneumococcal Conjugate
Vaccine
6.1 Introduction
Streptococcus pneumoniae is an important cause of severe infection and death worldwide,
especially in children: according to the Word Health Organisation it is associated with about
5% of the global infant mortality [234]. Since resistance of S.Pneumoniae to multiple classes
of antibiotics has increased in recent years [21, 221], prevention of disease via pneumococ-
cal immunisation has become a public health priority [29]. Two classes of pneumococcal
vaccines are available: pneumococcal polysaccharide vaccines (PPVs) and pneumococcal
conjugate vaccines (PCVs). The first PPV version was licensed as early as 1946 in the United
States [127], however the type of antibody response that it induces (T-cell-independent) [6]
makes it ineffective in children younger than 2 years of age. Hence, attention has shifted
towards PCVs when planning infant immunisation programs, since PCVs can provide protec-
tion against nasopharyngeal carriage and disease in vaccinated individuals of any age, and
consequently reduce the overall transmission of the pneumococcus, leading to herd immunity
[111].
S.Pneumoniae, as many other disease-causing bacteria, coats itself with a polysaccharide
capsule to hide from the human immune system. Since the early 20th century it has been
shown that the type of capsule determines the virulence and propensity to cause invasive
disease [47], to such an extent that a famous immunology book states: "from the point of
view of the adaptive immune system, each serotype of S.Pneumoniae represents a distinct
organism" [106]. Over 90 capsule serotypes have been identified as of today [90, 64], and
80 Application to Pneumococcal Conjugate Vaccine
efforts have been put into developing vaccines that could prevent disease caused by the most
clinically relevant serotypes. A seven-valent formulation first became available in 2000
and included the seven serotypes most commonly isolated in children under 5 years in the
pre-PCV era, while PCV10 and PCV13 were developed soon after [58].
Efficacy of these vaccines has first been assessed in pre-licensing randomized clinical
trials: up to 97% IPD reduction was observed in the first vaccinated individuals [10, 158].
However, an increase in carriage due to some non-vaccine serotypes (NVT) has also been
observed since the early PCV trial phase [157, 130, 41], reducing the benefits of vaccination.
This happened because protection against nasopharyngeal carriage for serotypes included
in the vaccine, an advantage of PCVs compared to PPVs, opened an ecological niche that
altered carriage epidemiology, a phenomenon known as serotype replacement.
Since PCVs have become part of the routine infant immunization schedule in several
high income countries [59], further work in ecological settings has confirmed the decline
in pneumococcal disease burden in terms of bacteraemia, pneumonia and otitis media
[10, 171, 7, 188, 163]. Nonetheless, a precise characterisation of serotype replacement would
be helpful to clarify past changes in pneumococcal disease epidemiology and to inform the
likely impact of future vaccines containing additional serotypes (higher valency). A few
studies have investigated the magnitude of serotype replacement in carriage, showing that the
total prevalence of pneumococcal carriage was left unchanged due to complete replacement
by pneumococci expressing NVT [57, 42]. Likewise, most surveillance studies assessing the
impact of PCVs on serotype-specific IPD identified a reduction in the number of infections
caused by vaccine serotypes (with the exception of serotype 3 [119, 113]) and increased rates
of NVT disease due to the high invasiveness potential of some NVTs of increased carriage
[57].
Yet, the estimated magnitude of serotype replacement varied from country to country:
in England, Ladhani et al [113] recently concluded that "6 years after the introduction of
PCV13, the additional benefits of this higher-valent vaccine have been nearly abolished by
replacement disease", while the USA [117] did not identify the substantial NVT increase
observed in other countries [215, 223, 7, 77]. Changes in surveillance practices, transmission
dynamics, population risk factors, and pathogen evolution have all been speculated to play a
role in such differential replacement disease across populations [216], nonetheless none of
these factors individually appears sufficient to account for the observed differences.
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We believe that the significant challenge of choosing sound statistical methodology to
evaluate the impact of PCVs introduction may also be playing an important role in find-
ing the disagreement over quantification of serotype replacement. Simplistic before-after
models have often been employed in previous work, producing incidence rate ratios (IRRs)
to summarise changes in yearly incidence of serotype-specific IPD after PCV introduction
[142, 226, 113]. Firstly, despite availability of multiple pre-intervention observations, occur-
rences of incidence were assumed to be independent and no time-series component was used,
hence underlying trends were not adequately modelled. Secondly, aggregating incidence
to year level might result in irregular patterns of difficult attribution, whereas modelling
monthly counts allows a finer detail of time-varying covariates. Finally, no control group was
considered: these type of analyses assume that no factors other than the intervention might
have affected the outcome of interest, i.e. they attribute any change in the outcome to the
vaccine introduction, completely neglecting the importance of time-varying confounding.
An evaluation method that makes use of control time series to model counterfactuals
would produce a more reliable inference: Thorrington et al. [205] first estimated changes in
incidence of pneumonia, sepsis and otitis pre-PCV and post-PCV comparing them to changes
in incidence of a composite control, obtained by calculating the geometric mean of the IRRs
of five control conditions. Yet, an integrated time series approach where selected controls for
IPD are combined using synthetic controls methodology instead of a geometric mean would
be more robust to the choice of controls.
Following the work of the previous chapters, where we estimated the impact of seasonal
and pandemic flu on IPD at a time when PCV7 and PCV13 were introduced in England
and Wales (2006 and 2010 respectively), we use serotype-specific IPD incidence rates to
better understand the role of PCV7 and PCV13 in shaping overall IPD trends and serotype
replacement in England. We select the period 2000 to 2018 in order to distinctly assess
changes related to PCV7 and PCV13 introduction, disentangling their different contributions,
and we employ and compare both an ITS model and a synthetic control method to adjust for
testing and reporting trends.
6.2 Data
As described in section 4.2, counts of positive isolates for a number of clinically significant
pathogens are reported weekly to PHE by all the diagnostic microbiology laboratories in-
cluded in the national surveillance system, and stored in the SGSS database. Notification
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of all confirmed IPD cases has been enforced with the 2010 Health Protection Legislation,
whereas reporting was voluntary before 2010. Information is presented in terms of incidence
rate per million residents, both at population level and by age group, where we consider five
age groups defined as 0-4, 5-14, 15-44, 45-64 and 65+ years old. Information about influenza












































































































Fig. 6.1 Monthly IPD incidence rate per million residents
.
A total of 96,852 IPD cases have been notified to PHE during the 18 years study pe-
riod, from July 2000 to June 2018, with a mean incidence rate of 8.1 cases per million
residents each month. Figure 6.1 displays the overall temporal trend of monthly incidence
rate, characterised by sharp winter peaks not too dissimilar across seasons both in terms of
width and timing. However, the amplitude of the peaks saw some variations in the observed
period, as summarised by the loess (locally weighted smoothing) function in red: it gradually
increased from 2000 to 2006, then decreased until 2013, and surged again in the last five
years, overtaking the maximum levels of 2006.
Age-specific IPD incidence is inspected in Figure 6.2, showing very diverse trends across
groups. Please note that scale differs across panels. In young children, the vaccinated group,
the detected IPD incidence reached a maximum of 219 cases/year per million residents
in 2006 and steadily decreased until 2012, when it stabilised at 76 cases/year per million
residents until 2018: overall IPD incidence was down to a third within six years from the









































































































































Fig. 6.2 Monthly age-specific IPD incidence rate per million residents
.
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is much lower: it peaked at 19.7 cases/year per million residents in 2007 and stabilised at
8.4 cases/year per million residents from 2013 onwards; compared to infants, the decrease
kicked in one year later, and the pre-vaccination incidence was halved. In adults aged 15-44
the detected IPD incidence did not decreased until 2011, when it reached a maximum of
45 cases/year per million residents, and after a minimum in 2014-2015 it raised again in
2017-2018 to the same levels of 2007-2008. A similar trend was observed in adults aged
45-64 and 65+: after a modest decrease in 2014-2015, detected IPD incidence showed an
upward trend, reaching its highest levels in 2016, 2017 and 2018.
Additionally, serotyping of isolates positive for S.Pneumoniae is performed at the Pneu-
mococcal Reference Laboratory at PHE, Colindale, London. We first look at monthly
numbers of samples positive for each serotype, and we then aggregate such counts by "PCV
group". Incidence for each serotype, divided in three panels according to the PCV group, is























































































Fig. 6.3 Monthly IPD incidence rate per million residents by serotype
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PCV7 serotypes refers to serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F, covered by PCV7
vaccination: these serotypes accounted for 51.3% of IPD cases up to 2006, but they saw a
sharp decrease after that, becoming responsible for a negligible number of IPD cases (2.65%
of cases in the last five years) within less than two years from vaccine roll-out (top panel of
Figure 6.3). PCV13 serotypes refers to the 6 serotypes added to PCV13 and not included in
PCV7, namely 1, 3, 5, 6A, 7F, and 19A. Incidence of IPD due to PCV13 serotypes (middle
panel of Figure 6.3) saw an increase reaching its maximum levels around 2010 and 2011,
when it represented 48% of total incidence, and then steadily decreased afterwards (with
the exception of serotype 3, for which PCV13 effectiveness is debated [134, 69]). All the
remaining serotypes are classified as non-PCV7/13 serotypes (NVTs). In the bottom panel
of Figure 6.3 we can observe important increase in the IPD incidence due to several NVT,
which in the last five years have been responsible for 79% of total incidence, with serotype 8
alone reaching the highest serotype-specific incidence for the entire study period.
Age-specific incidence by PCV group is presented in Appendix B. In all age groups
pcv7-IPD incidence reduced importantly after the introduction of PCV7 (Figure B.1), in
a more timely manner in the vaccinated group and with some years of lag in the other
groups. Pcv13-IPD (Figure B.2) also saw a modest reduction after PCV13 introduction,
with constantly decreasing trends across age groups. Finally, NVT-IPD (Figure B.3) stably
increased in all groups from 2000 until 2014, however it seems to have stabilised since then.
6.2.1 Selection of controls
Control time series that received no treatment are critical for obtaining accurate counterfactual
predictions of what IPD incidence would have been observed had PCV not been introduced
in England, since they allow adjusting for effects of confounders otherwise unaccounted for
[15]. In absence of serotype replacement, time series of IPD incidence due to serotypes not
affected by the intervention would provide a natural counterfactual. However, in practice,
serotype replacement showed that such incidence was indirectly affected by the intervention.
Similarly, incidence of disease in unvaccinated age groups is indirectly affected due to herd
immunity, so they do not make good counterfactuals either.
We thus consider pathogens other than S.Pneumoniae, subject to the same SGSS report-
ing rules and likely to be identified in similar clinical conditions and testing indications.
They are selected a priori with the criteria of not interacting with the pneumococcus and not
having been the focus of other public health interventions. After discussing with experts, we
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extract from SGSS isolates positive for Haemophilus Influenzae, Klebsiella Pneumoniae,
Pseudomonas Aeruginosa, Staphylococcus Aureus and Staphylococcus Coagulase Negative
and Escherichia Coli, when identified from normally sterile sites (invasive cases).
STAPHYLOCOCCUS AUREUS STAPHYLOCOCCUS COAGULASE NEGATIVE
KLEBSIELLA PNEUMONIAE PSEUDOMONAS AERUGINOSA


























































































































Fig. 6.4 Control time series - incidence rate per million residents
.
Raw trends of recorded invasive bacterial infections in the years immediately before
(2000–06) and after (2010-18) introduction of PCV7 and PCV13 are presented in Figure
6.4, using aggregate rates per million residents in England. While IPD rates showed a rather
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flat trend, growing modestly until 2006, declining until 2014 and raising again afterwards,
national monthly rates of other invasive pathogens increased steadily during this period,
registering a 3-fold to 10-fold increase in incidence. Although all trends suggest an increased
testing and reporting over time, such increase does not appear to follow a common pattern
for the different pathogens. Age-specific incidence for the control time series is plotted in
Appendix B, Figure B.4.
6.3 Analysis strategy
6.3.1 ITS regression
We start by considering ITS regression models, with the aim of estimating the impact of
PCV7 and PCV13 introduction in September 2006 and April 2010 respectively. Since we are
dealing with counts, we use a Poisson regression model: yt ∼ Poi(µt) where
log(µt) = log(popt)+ f (PCVt)+ s(t) (6.1)
following the general formulation in equation 5.2. In order to characterise the natural time-
varying behaviour of IPD incidence, we model the s(t) component as a linear function of
influenza, temperature and rainfall observations, that have previously shown to effectively
mimic IPD seasonal behaviour in a rigorous model selection in section 3.3. In formulae,
s(t) = γ1 flut + γ2 tempt + γ3 raint . No additional covariates are included.
We explore different model choices for the impact model f (PCVt): despite not knowing
the shape of intervention effect, a limitation of this regression framework is the requirement to
specify the impact model a priori, as explained in section 5.3. The simplest model considered
is the so-called interrupted intercept model, which assumes that intervention alters the level
of incidence by a constant κ1, but does not affect its trend. In formulae:
log(µt) = log(popt)+κ1 postPCVt + s(t) (6.2)
We then compare it to a model that introduces a time trend and also tests whether such trend
differs before and after vaccine introduction, i.e.
log(µt) = log(popt)+κ1 postPCVt +κ2 t +κ3 t postPCVt + s(t) (6.3)
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In order to inspect how results differ across model choices, we compare goodness of
fit in terms of likelihood ratio tests since we are looking at nested models: we first test the
significance of a time component, and then the relevance of the time-intervention interaction
term. In all the models, the counterfactual is obtained by assuming that underlying trends
estimated in the pre-intervention period remain the same afterwards, i.e. κ1 = κ3 = 0.
The different models considered are summarised in Table 6.1. We first perform this anal-
ysis on the IPD time series pertaining the entire population, without serotype stratification,
to investigate any change in IPD incidence overall (model A). In the following step, we
disentangle the vaccine’s direct effect from serotype replacement by slicing IPD incidence
in two groups: effect of the vaccine can be quantified by modelling the time series of IPD
incidence in the "treated" group, i.e. IPD cases due to serotypes targeted by the vaccine
(model B for PCV7, model D for PCV13). Impact of serotype replacement, on the other
hand, can be quantified by modelling time series of IPD incidence due to the remaining
serotypes (model C for PCV7, model E for PCV13).
name outcome var "untreated" period "treated" period
model A IPD Jul 2000 - Sept 2007 Oct 2007 - Jun 2018
model B PCV7-IPD Jul 2000 - Sept 2007 Oct 2007 - Apr 2011
model C nonPCV7-IPD Jul 2000 - Sept 2007 Oct 2007 - Apr 2011
model D PCV13-IPD Sept 2007 - Apr 2011 May 2011 - Jun 2018
model E NVT-IPD Sept 2007 - Apr 2011 May 2011 - Jun 2018
Table 6.1 Summary of pre- and post-intervention periods considered for different outcome
variables. One year lag was considered between the policy enactment date and the start of
the "treated" period, hence we have Sept 2007 instead of Sept 2006 and Apr 2011 instead of
Apr 2010.
6.3.2 CIM
The second approach proposed for our analysis involves BSTS models, described in equation
5.4. In their univariate form, they are defined by equations
IPDt = µt +γt +XtXtXt Xt β + εt µt = Gt µt−1 +ηt γt = ∑s/2j=1 γ j,t +ωt We model IPD incidence rates by making an assumption of Gaussian distributions for εt , ηt and ωt . The matrix
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Fig. 6.5 Model A: fitted IPD counts based on three ITS models
6.3.3 ITS analysis
Throughout the ITS analysis, results are plotted using blue lines to display fitted counts
under the different impact models and red lines to indicate the counterfactual. In the main
text the post-intervention period is considered to start with one year of lag from the inter-
vention date, to allow for one full cohort of children to receive vaccination; a sensitivity
analysis on results including a two-year lag is shown in appendix B, Figures B.5, B.6 and B.7.
Results from the regression model on overall IPD incidence are shown in Figure 6.5
(model A): we can see how, under all the three impact models, the observed IPD incidence is
lower than the counterfactual, meaning that vaccine introduction had a positive impact on
IPD incidence. The percentage of averted cases, i.e. the proportion of cases not observed
with respect to the counterfactual, is estimated to be 17.3% (CI 16.1%-18.4%) under the
first model, 25.2% (CI 23.2%-27.1%) and 38.8% (CI 33.4%-43.7%), for a total number of
averted IPD cases equal to 11702, 18950 and 36138 respectively. As expected, this gap is
estimated to be larger when we introduce a time-intervention interaction that allows for an
increasing trend until September 2007 and a decreasing trend afterwards. Likelihood ratio
90 Application to Pneumococcal Conjugate Vaccine
tests suggest that this third impact model also fits the data best.
Further, in order to quantify to which extent the small decrease in IPD incidence is
confounded by serotype replacement, we separately model IPD incidence due to PCV7 and
non-PCV7 serotypes. For this analysis we need to restrict our observation period up to April
2011, i.e. when we expect the impact of PCV13 to become visible on some of the non-PCV7
serotypes. The top three panels of Figure 6.6 picture the impact on PCV7 serotypes (model
B) by model formulation. A large gap between fitted and counterfactual levels for all the
three models is estimated, suggesting that they all agree on an important benefit attributable
to PCV7 vaccination: estimated proportions of averted cases are 56.6% (CI 54.6%, 58.5%),
65.6% (CI 63.4%-67.6%) and 97.0% (CI 94.3%-98.4%) respectively, with the third model
fitting the data best.
On the other hand, when looking at IPD incidence due to non-PCV7 serotypes (model
C), different models show disagreement, as represented in the bottom three panels of Figure
6.6: the model in the first panel, that does not include a linear time trend, determines that
levels of non-PCV7 IPD have almost doubled, +99.3% (CI 94.4%-104.4%), compared to
what would have happened without vaccine. However, when IPD incidence is assumed to
linearly increase in time before the intervention, then observed and counterfactual estimates
almost coincide: the observed incidence after PCV7 introduction only exceeds by 2.5% (CI
-2.0%; 7.3%) what would have happened regardless of vaccine introduction. Once again, the
third model fits the data best, estimating a 42.7% (CI 23.8%-57.0%) reduction in non-PCV7
IPD incidence, yet we might question whether we aren’t overfitting.
Similarly, the impact of PCV13 introduction is assessed by looking at IPD incidence
due to the six additional serotypes covered by PCV13 but not PCV7 (model D): the pre-
intervention period is defined from September 2007 (one year after PCV7 introduction),
and the counterfactual is modelled from April 2011 onwards, allowing one year lag from
PCV13 introduction. Serotype replacement is quantified modelling counts of IPD due to NV
serotypes in the same period (model E). Results on the effectiveness of PCV13, reported in
the top three panels of Figure 6.7, agree on a significant reduction of PCV13-IPD incidence
(model D), with the proportion of averted cases ranging between 47.6% (CI 45.7%-49.4%),
22.2% (CI 17.0%-27.1%) and 51.2% (CI 22.1%-69.5%) respectively. As for the PCV7
analysis, estimation of serotype replacement is the most challenging (model E): the first
model estimates a 72.4% increase (CI 67.6%,77.3%) in NVT-IPD incidence, the second
model a 8.1% reduction (3.8%,12.3%) and the third one a 35% increase with large uncertainty
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Fig. 6.6 Top three panels: model B, fitted PCV7-IPD counts. Bottom three panels: model C,
fitted non-PCV7-IPD counts, based on three ITS models
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Fig. 6.7 Top three panels: model D, fitted IPD-PCV13 counts. Bottom three panels: model
E, fitted IPD-NVT counts, based on three ITS models
.
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(CI -11.4%,108.2%) (bottom three panels of Figure 6.7).
6.3.4 CIM
0.0198 0.0169 0.0178 0.0167 0.0176
0.0194 0.0169 0.0199 0.0172 0.0175
0.0193 0.0166 0.0194 0.0171 0.0174
0.0128 0.0119 0.0119 0.0118 0.0111
0.0128 0.0119 0.0119 0.0118 0.0112




















Observational model with Gaussian assumption
Fig. 6.8 Heatmap of MSPE for different state models and training sets
.
We then model the overall IPD counts using the CIM regression described in section
6.3.2 and, in order to identify the best suited state model, we compare the different fits in
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terms of MSPE. Results of the model comparison are presented in Figure 6.8: regardless
of the length of the training period (50%, 67%, 75%, 83% or 90%), the smallest MSPE are
identified for the models including a trigonometric component, with negligible differences
if the trend evolves as a random walk or according to an autoregressive term. Hence, we




































































































































Fig. 6.9 Model A: impact of PCV introduction on the overall IPD incidence rate
.
The estimated impact of PCV introduction on overall IPD (model A) is presented in
Figure 6.9. For all graphical representations of the CIM results, the full black line indicates
observed incidence while the blue one presents the counterfactual and its credible intervals.
Results are plotted in two panels, the top one picturing observed and counterfactual incidence
over time, whereas the bottom one shows the discrepancy between them, cumulated over time.
Model A (Figure 6.9) shows that the IPD incidence rate is lower than the estimated
counterfactual in the post-vaccine period, but not significantly so (-18.60%, 95% credible
interval (CrI) -40.90%, +6.00%). Figure 6.10 summarises the posterior probability for each
control time series to be included in the model thanks to the spike-and-slab prior: the trend for
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the observed Haemophilus Influenzae rate matches the IPD rates best in the pre-intervention
period, with posterior probability over 90%. Other control time series are only included with









0.0 0.2 0.4 0.6 0.8 1.0
Fig. 6.10 Posterior probability of inclusion for each control time series
We perform the same analysis (model A) across age groups to disentangle whether
vaccine introduction has impacted them to a different extent. Results are summarised in
Table 6.2: as expected, we find the impact of vaccine to be largest in the children younger
than 5 years of age, i.e. the group that did receive vaccination (-49.50%, 95% CrI -64.80%,
-40.40%). Reduction in IPD incidence is smaller in non-vaccinated children (5-14), but still
significantly bigger than zero. In other groups, instead, the indirect effect due to reduced
transmission of S.Pneumoniae after vaccinating children (herd immunity) did not lead to a
significant reduction. Age-specific plots are reported in Figures 6.11, 6.12 and 6.13: from
the cumulative panel in each plot we can notice how the effect of PCV introduction had
immediate effect in children younger than 5, whereas a tendency towards decreasing trends
only appeared after a few years in other age groups.
CIM analysis by serotype
When analysing IPD time series by PCV group, we first model the impact of PCV7 introduc-
tion on incidence of PCV7-IPD and nonPCV7-IPD (models B and C).
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IRR IRR_lb IRR_ub % change % lb % ub
all_age 0.81 0.58 1.48 -18.60 -40.90 6.00
0-4 0.50 0.24 0.92 -49.50 -64.80 -40.40
5-14 0.56 -1.65 3.09 -43.70 -55.80 -31.40
15-44 0.86 -0.07 2.16 -13.50 -38.70 6.00
45-64 1.03 0.42 2.06 2.70 -23.50 22.00
65+ 0.90 0.62 1.89 -10.30 -36.10 19.50
Table 6.2 Model A: IRR and relative effects (% change), with 95% CrIs, for the impact of
PCV introduction on IPD incidence for different population subgroups.
As shown in Figure 6.14, we find the decline in disease due to pcv7 serotypes to be
immediate and substantial in the population overall (model B, top panel), however such a
decrease is paired with an increase in nonPCV7-IPD incidence (model C, bottom panel).
Table 6.3 summarises PCV7-IPD decrease: -63.9% (CrI -81.0%, -47.6%) overall, with
significant effects in all age groups. On the other hand, Table 6.4 presents the magnitude of
serotype replacement: a 36.9% (CrI 15.0%, 65.8%) increase is estimated overall, however
all age-specific measures fail to show significance, due to the small observed incidence.
Age-specific plots are listed in Appendix B, Figures B.8, B.9, B.10, B.11 and B.12.
IRR IRR_lb IRR_ub % change % lb % ub
all_age 0.36 0.25 0.67 -63.90 -81.00 -47.60
0-4 0.36 0.34 0.44 -63.50 -72.00 -53.30
5-14 0.68 -5.38 7.09 -32.50 -66.50 -3.10
15-44 0.70 0.65 0.89 -29.90 -42.40 -17.70
45-64 0.84 0.77 0.95 -15.90 -28.90 -8.80
65+ 0.91 0.86 0.98 -9.00 -15.20 -2.30
Table 6.3 Model B: IRR and relative effects (% change), with 95% CrIs, for the impact of
PCV7 introduction on IPD-PCV7 serotypes across population subgroups
Secondly, we assess the impact of PCV13 introduction on PCV13-IPD (model D) and
NVT-IPD (model E) incidence rates. Results are shown in Figure 6.15. Disease due to pcv13
serotypes shows a sharp decrease (model D, top panel) in the overall population, and once
again such a decrease is paired with an increase in NVT-IPD incidence (model E, bottom
panel). Table 6.5 summarises impact of PCV13 introduction across age groups: -65.6%
(CrI -85.6%, -42.2%) overall, with large and significant impact in all age group. Finally,
from Table 6.6 we identify an estimated 31.8% (CrI 6.7%, 63.5%) increase in NVT-IPD
incidence overall, however age-specific estimates have substantial uncertainty, and all the































































































































































































































































Fig. 6.11 Model A: impact of PCV introduction on the overall IPD incidence rate in children
younger than 5 (top panel) and aged 5-14 (bottom panel).



































































































































































































































































Fig. 6.12 Model A: impact of PCV introduction on the overall IPD incidence rate in adults




































































































































Fig. 6.13 Model A: impact of PCV introduction on the overall IPD incidence rate in the
elderly (65+).
corresponding CrIs do include 1. Age-specific plots are listed in Appendix B, Figures B.13,
B.14, B.15, B.16 and B.17.
6.4 Discussion
In view of the considerable burden of disease caused by S. pneumoniae infection, especially
in developing countries, precise evidence on vaccine effectiveness and serotype replacement
are needed to make decision on vaccine policies. The impact of pneumococcal vaccines
on IPD incidence has been questioned worldwide, however accurate estimates of averted
disease burden can be difficult to obtain. Measured IPD incidence exhibits complex temporal
dynamics under the effect of changing disease incidence, testing and reporting. In England,
an increase in the rate of blood culture sampling over time has been speculated [99]. Fur-
ther, even before PCV introduction, the distribution of major serotypes responsible for IPD
showed temporal variations, likely related to changes in the population immunity. Finally,














































































































































































Fig. 6.14 Top panel: model B, impact of PCV introduction on the PCV7-IPD incidence rate.
Bottom panel: model C, impact of PCV7 introduction on the nonPCV7-IPD incidence rates.
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IRR IRR_lb IRR_ub % change % lb % ub
all_age 1.37 0.85 2.93 36.90 15.40 66.20
0-4 0.78 0.41 1.81 -22.20 -39.40 -3.90
5-14 0.94 -3.52 6.21 -6.30 -26.00 13.90
15-44 0.85 -0.65 3.29 -14.80 -34.90 10.10
45-64 0.82 -0.03 2.60 -18.10 -55.50 14.40
65+ 1.04 -2.83 5.91 4.00 -33.90 36.50
Table 6.4 Model C: IRR and relative effects (% change), with 95% CrIs, for the impact of
PCV7 introduction on non-PCV7 serotypes across population subgroups
IRR IRR_lb IRR_ub % change % lb % ub
all_age 0.34 0.24 0.67 -65.60 -85.60 -42.20
0-4 0.50 0.46 0.76 -49.80 -63.80 -32.20
5-14 0.53 -1.00 2.90 -46.90 -66.10 -29.10
15-44 0.64 0.59 0.95 -36.50 -57.40 -12.70
45-64 0.81 0.63 1.57 -19.30 -52.80 4.70
65+ 0.72 0.64 0.98 -27.60 -46.20 -8.10
Table 6.5 Model D: IRR and relative effects (% change), with 95% CrIs, for the impact of
PCV13 introduction on PCV13 serotypes across population subgroups
the proportion of isolates that were fully serotyped also increased over time [208].
In this study, we provide empirical evidence of the effectiveness of a nationwide pneumo-
coccal infant vaccination programme, which led to a 18.6% (CrI -6.0%, 40.9%) reduction
in IPD incidence in the population overall, being as high as 49.50% (CrI 40.4%, 64.8%) in
children younger than 5 years in England. Such estimates are adjusted for changes in testing
and reporting trends, however they are confounded by serotype replacement: the significant
impact of the vaccine on the number of infections due to vaccine-targeted serotypes (-63.9%,
CrI -81.0%, -47.6% for PCV7-IPD, -65.6%, CrI -85.6%, -42.2% for PCV13-IPD) was com-
pensated by an increase in non-vaccine serotypes. In particular, a 36.5% increase (CrI 15.0%,
65.8%) was estimated following PCV7 introduction, and an additional 31.8% (CrI 6.7%,
63.5%) following PCV13.
Addressing the vaccine effects on the population overall ignores the difference between
the direct effects on vaccinated children and indirect effects due to herd immunity: we
successfully estimated age-specific effects on vaccine-targeted serotypes, however bigger
uncertainty did not allow to make conclusions about different magnitudes of serotype re-
placement across groups, except for the increase in NVT in children younger than 5, +58.8%




































































































































































































Fig. 6.15 Top panel: model D, impact of PCV13 introduction on the PCV13-IPD incidence
rate. Bottom panel: model E, impact of PCV13 introduction on the NVT-IPD incidence rates.
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IRR IRR_lb IRR_ub % change % lb % ub
all_age 1.32 -1.00 4.20 31.80 6.70 63.50
0-4 1.59 -6.88 8.65 58.80 24.40 105.00
5-14 1.17 -9.47 10.38 16.90 -19.70 49.10
15-44 1.06 0.92 1.52 6.10 -17.40 21.00
45-64 1.25 -0.96 4.30 25.20 -12.40 49.50
65+ 0.88 0.77 1.05 -12.10 -31.50 2.30
Table 6.6 Model E: IRR and relative effects (% change), with 95% CrIs, for the impact of
PCV13 introduction on NV serotypes across population subgroups
(CrI 24.4%, 105.0%).
Compared to previous studies modelling the overall IPD incidence rate in England
[226, 113, 142], our work shows how diversely the serotype-specific dynamics have been
unwrapping across seasons over the last 18 epidemic years. Few studies had previously
quantified the magnitude of serotype replacement, but there has been a lack of consistency
in the way incidence has been modelled and impact of intervention evaluated across differ-
ent countries, making generalisations around results difficult. For the sake of comparison
with previous work, we initially propose an ITS analysis, with a detailed model to estimate
monthly IPD counts, accurately describing seasonality with observed influenza and climate
variability, and adjusting for population increases. We also performed a sensitivity analysis
to assess robustness of our assumption of one year lag from introduction of vaccination to
significant population-wide effects. Despite making full use of the longitudinal nature of the
data and accounting for pre-intervention trends through regression modelling, the arbitrary
choice of impact model limits robustness of our results. Moreover, due to the considerable
length of the study period and to changes to disease surveillance during such period, we
acknowledge that an ITS analysis is not the most appropriate research design to account for
time-dependent confounding.
In the second part of this work we propose a BSTS, following the CIM. A controlled
design proves more useful in evaluating the public health impact of PCV introduction over a
long time period, as it allows for simultaneous comparison of the pneumococcal incidence
with temporally related infections due to other pathogens, instead of a comparison with
previous epidemic years. Moreover, the proposed model incorporates a data-driven approach
to select control time series, making the analyst blind and limiting the problem of choosing
the impact model arbitrarily.
104 Application to Pneumococcal Conjugate Vaccine
Both methods lend support to the positive PCVs effects after their introduction in 2006
and 2010, but only the CIM is helpful in discarding the hypothesis that serotype replacement
has importantly eroded the benefit of PCV introduction. Since the two classes of models are
operating under different assumptions, no direct comparison is possible, however, the CIM
methodological framework is more robust, as it does not rely on a pre-defined model choice.
Further, sensitivity analyses showed that our results are not sensitive to the choice of priors
(results not shown), hence we recommend the use of the CIM methodological framework to
evaluate the impact of public health response to constantly changing pneumococcal epidemi-
ology.
Our statistical analyses have a number of limitations. First, we analyse the PCV pro-
gramme implemented in England and look at data from the past two decades, hence con-
clusions might only be applicable to other countries with similar pneumococcal dynamics,
where no other interventions tackling respiratory pathogens has been introduced. However,
the CIM method can be usefully employed using country-specific control time series, to
estimate the relevant intervention impact. Second, the choice of pathogens to be used as
control time series was made with UK surveillance experts, and it could be questioned when
considering a different surveillance system. Nonetheless, the flexibility of the modelling
framework, allowing for data-driven selection of the most relevant controls, makes the pro-
posed strategy extremely adaptable. Third, the use of microbiologically confirmed cases does
not fully capture the burden of pneumococcal disease, as only invasive disease confirmed by
culture from sterile sites is identified. A recent case-only study found increasing trends in
hospital pneumonias due to NVT [170]. Further work might be needed to assess the impact
of PCV introduction on hospital admissions for respiratory illness, adjusting for time-varying
confounding. Thorrington et al. [205]’s study is a first step in that direction, but uses geomet-
ric mean to combine control time series instead of a more flexible Bayesian variable selection.
Our findings suggest that the PCV programme is worthwhile in reducing IPD burden at
the current rate of serotype replacement, however concerns about a more important serotype
replacement in the long term are worrisome.
The variability of serotypes emerging in different countries remains a major challenge
in selecting the most beneficial serotypes to add to licensed PCVs. Further work is needed
to bridge serotype-specific information from carriage and invasive disease surveillance to
genomic studies in order to provide a greater understanding of the post-vaccine adaptation of
Streptococcus pneumoniae and offer new solutions for future immunisation strategies [98].
Future work might be also needed to investigate whether, reducing carriage of vaccine-type
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pneumococci, PCVs are creating an ecological niche favoring colonization by alternative res-




Estimated excess all-cause mortality in
England during the COVID-19 pandemic
7.1 Introduction
SARS-COV-2 is the newly emerged virus responsible for the current pandemic of COVID-19
disease. It was first detected in early December 2019 in Wuhan, China, and it has quickly
spread worldwide. As of June 6th 2020, 6,577,161 cases and 390,748 fatalities associated
with COVID-19 disease have been reported globally, however the real magnitude of the
SARS-COV-2 burden is still unknown.
Such a burden extends beyond people contracting disease or dying after being infected
with SARS-COV-2. Changes in healthcare activity to tackle COVID-19 and interventions
implemented by governments during this pandemic are also having an impact on the popula-
tion’s health and mortality. Estimates of excess all-cause mortality can help quantifying the
toll of this pandemic. This is not only important retrospectively: sequential quantification
of excess mortality is crucial to describing how the epidemic is evolving and to informing
decisions on public health strategies for the months to come.
To derive an estimate of such excess deaths, PHE has been using regression models
along the lines of the methods described in section 3.2.1: the Euromomo algorithm and
a threshold-based outbreak detection method through a Poisson regression model. The
Euromomo algorithm [146], adopted by the European Centre for Disease Control, is an
approach to quantification of excess mortality due to influenza during the winter period
across European countries. This method is based on fitting a Serfling model to weekly counts
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of deaths observed in spring and autumn over the past 5 years. This allows estimation of
baseline mortality during a period not affected by winter-specific factors such as extreme
temperature and influenza circulation through the estimation of a sine wave. This estimated
trigonometric function is then used to derive, through extrapolation, the baseline mortality
during winter, and excess mortality is estimated as a difference between observed deaths
and such a baseline. The second approach uses a Poisson regression [54]: weekly baseline
counts are assumed to be independently distributed with mean µt , modelled log-linearly as
a function of a linear time trend (adjusting for changes in reporting trends) and of death
counts in the past 5 years. An overdispersion parameter is estimated when low counts are ob-
served. The 2 and 3 standard deviation prediction intervals are computed, and daily excess is
considered to be significant whenever observed counts exceed the upper bound of the interval.
As already discussed in section 3.2.1, these methods suffer from a number of limitations,
the most important being that they assume independence among observations. Alternatively,
as discussed in section 3.2.2, models including a time series component are more suitable
to account for temporal dependence. In particular, the dynamic linear models presented in
section 5.4.3 describe the outcome dependency over time through an evolution equation.
A second important problem concerns multicollinearity: inclusion of a number of highly
correlated covariates in standard regression models leads to estimation problems. In a time
series setting, the most significant predictors and lags are often selected a priori based on
cross-correlation. A Bayesian variable selection strategy allows including many time series
as covariates without selecting them a priori: as explained in section 5.4.1, they can be
combined into a weighted average, whose weights are derived to maximise model fit to
observed data.
Finally, the estimation of baseline mortality during an outbreak can be cast in terms of
estimating a counterfactual for the evaluation of an intervention: a model for the observed
mortality before the outbreak is formulated, identifying the most suitable predictors and esti-
mating the corresponding coefficients. The counterfactual, i.e. baseline mortality in absence
of COVID-19, can then be forecast. The BSTS methods presented in section 5.4.3 estimate
the predictive contribution of multiple covariates through a spike-and-slab prior, and the same
regression coefficients are then used to forecast the counterfactual in the outbreak period.
Furthermore, the Bayesian credible intervals for the estimated cumulative excess burden
provide a natural way to identify the start of an outbreak. Estimation of a counterfactual
through a dynamic regression method including control time series, as we did in section
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6.3.2, seems a natural alternative to the more traditional regression models.
In what follows we estimate the excess all-cause mortality observed during the COVID-19
pandemic period in England up to the current time as the difference between the observed
deaths and a counterfactual estimated through dynamical regression models. We also com-
pare all-cause deaths and COVID-lab-confirmed deaths across population strata, to describe
how discrepancies between overall and virus-specific mortality differ across age groups and
regions. Finally, we estimate when the excess mortality began in each subgroup, to test
whether COVID-19 had circulated undetected in the population before testing started and
pandemic was officially declared.
7.2 Data
7.2.1 All-cause deaths
Data on death registrations until midnight on each day in England are provided daily by the
General Registry Office (GRO). The daily extract include information about age in years,
date of death, death of registration, gender and region. Region is identified according to the
district registering the death, which might differ from place of residence for the deceased.
As there is a lag between the event of a death and its registration, these data suffer from a
reporting delay: counts observed in the recent days are an under-report of the total number of
deaths occurred in any of those day. A delay-adjustment procedure through re-weighting of
the observed counts, where weights are estimated based on the reporting patterns of the past
5 years, is implemented. The proportion of cases registered at a lag of k weeks (k=0,1,2,3,4,
. . . , 52) is estimated through a regression model stratified by age and region to obtain weights
for delay correction. Such weights are then applied to death counts for the corresponding
age, region and interval from death to the day of the last registrations.
For the scope of the current analysis, daily counts for the epidemic years 2015-2020 are
considered, where each epidemic year is defined as starting on the 1st July. The last observed
day for the current epidemic year is 29th May 2020. Mortality rates per 100,000 residents
are computed for England overall, by gender, by age group (0-24, 25-44, 45-64, 75-84, 85+)
and by region (East of England, East Midlands, London, North East, North West, South East,
South West, West Midlands, Yorkshire and the Humber).










































































































































Fig. 7.1 Observed mortality rate in the past 5 epidemic years in England
All-cause mortality rates per 100,000 residents over the study period are presented in
Figure 7.1, overlapping the epidemic years for comparison: while the general trends in
mortality followed similar patterns across seasons, with only small discrepancies in the
amplitude of winter peaks, the epidemic year starting on the 1st July 2019 is characterised
by a considerably lower mortality in the months of January and February, followed by an
unprecedented spike in mortality in the months of March, April and May 2020, during the
first wave of the COVID-19 pandemic. The mortality rate has been increasing steadily until
the 8th April, and constantly decreasing from there.
When looking at population subgroups, we see that such an excess of deaths compared
to the previous years is equally observed in males and females (Figure 7.2), even though
excess mortality in females seems to have a flatter peak and a longer duration. Further, when
comparing mortality rates across regions (Figure 7.3), it is evident that the excess emerged in
London first, but importantly affected all regions of England. Finally, Figure 7.4 shows the
excess deaths across age groups: except for people under 25 years of age, where observed
mortality was extremely low at any time, a clear excess in correspondence of the COVID-19
pandemic is identified for all the other age groups.


















































































































































Fig. 7.2 Observed mortality rate in the past 5 epidemic years in England by gender
7.2.2 COVID-lab-confirmed deaths
COVID-lab-confirmed deaths are provided by PHE and include deaths in those with a lab-
oratory confirmed infection. A delay adjustment is performed along the lines of the one
described for all-cause deaths, and rates per 100,000 residents are presented for the same
groups as above. Plots are shown in the results section (7.4). We set the start of the COVID-19
pandemic in England to the 2th March 2020, the day of the first COVID-lab-confirmed death.
7.3 Analysis strategy
We propose a BSTS regression to model Yt , daily mortality rates of the 2019-20 epidemic year,
up to t < t1, where t1 =2nd March 2020. A counterfactual for daily baseline mortality rates
Y (0)t where t ≥ t1, i.e. mortality that would have been observed in absence of the COVID-19
epidemic from that date to present, is then forecast from such a model. Excess mortality is

































































































































































































Fig. 7.3 Observed mortality rate in the past 5 epidemic years in England by region
derived as the difference between the observed Y (1)t and the estimated counterfactual Ŷt
(0).
Our BSTS model assumes a random walk in the evolution equation and a Gaussian noise
both in the evolution and the observation equation (details of model formulation have been
presented in section 6.3). In formulae:
Yt = µt +Xtβ + εt
µt = µt−1 +ηt
(7.1)
A number of control time series are included through the matrix Xt , selected with the
rationale of being potentially good predictors of mortality in absence of the COVID-19
pandemic, and not being affected by COVID-19 pandemic: daily death rates in the past four
epidemic years, daily weather conditions such as temperature and rainfall, and counts of
other viral infections, such as influenza and RSV, are considered. Their lagged values up to 7
days are also included, as some covariates might lead to delayed effects. This makes a total










































































































































































Fig. 7.4 Observed mortality rate in the past 5 epidemic years in England by age group
of 64 predictors.
The control time series are selectively included in the regression component Xtβ thanks
to a spike-and-slab prior on the β coefficients, which allows identification of the most
relevant predictors to fit the observed Yt . We elicit priors by setting the expected model
size to be 7, so that the prior probability of each control time series j being included is a
Bernoulli(π j = 7/64). For the slab component, the prior for β coefficients is centered on
zero, whereas the Gamma prior for the variance is elicited as a function of the sample variance.
Cumulative excess mortality is quantified as the difference between cumulative observed
rates Yt and the estimated counterfactual Ŷt
(0), for t > t1. The threshold date for outbreak
start, i.e. when the excess mortality started being significantly greater than zero, is then
identified as the date at which the 95% credible interval for the estimated cumulative excess
mortality started being consistently above zero.
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This analysis is first performed on the time series of all-cause deaths referring to the
entire population, and then replicated for each population subgroup, i.e. by gender, age and
region.
7.4 Results
Table 7.1 summarises the excess mortality estimates by age groups and region. An overall
cumulative excess of 100.8 (95% CrI 95.8-106.4) deaths per 100,000 residents has been
estimated from 2nd March until 29th May 2020 in England. In relative terms, this excess
corresponds to an estimated 147% (95% CrI 145%-150%) of the mortality expected during a
corresponding spring period, as shown in Table 7.1. This excess represents 164% (95% CrI
156%-173%) of the official COVID-lab-confirmed deaths, that sum up to 34,830 as of 29th
May 2020.
Rate lb ub %baseline lb ub %covid lb ub
100.8 95.8 106.4 147 145 150 164 156 173
F 96.3 90.4 103.2 145 142 148 187 176 201
M 102.8 97.6 108.2 147 145 150 143 136 151
F_65. 434.9 406.6 462.3 143 140 145 178 167 190
M_65. 518.5 490.8 546.5 146 143 148 138 130 145
0_24 0.7 -0.1 1.6 111 98 126 265 -50 620
25_44 7.8 6.5 9.0 143 136 150 264 222 304
45_64 40.0 37.0 42.9 140 137 143 140 130 151
65_74 132.4 122.1 142.7 136 133 139 120 110 129
75_84 473.3 443.6 503.2 142 139 145 127 119 135
85. 1912.4 1559.1 2263.9 144 136 153 189 154 224
EE 69.0 62.8 75.5 141 137 145 108 98 118
EMids 74.6 65.4 83.5 134 130 138 139 122 156
LON 110.9 105.9 116.4 178 175 182 158 150 165
NE 109.7 95.8 124.0 142 137 148 142 124 161
NW 110.8 98.3 121.1 145 140 149 144 128 158
SE 109.8 101.6 118.5 144 141 147 223 206 240
SW 64.2 54.3 74.4 126 122 130 198 168 230
WMids 116.1 107.4 125.1 149 146 153 156 144 168
YH 98.2 87.7 109.3 142 138 147 167 149 186
Table 7.1 Cumulative excess: rate per 100,000, %excess above baseline and %excess above
COVID-lab-confirmed, with 95% CrI lower bound (lb) and upper bound (ub).
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The posterior probability for each control time series to be included in the model thanks
to the spike-and-slab prior is presented in Figure 7.5: among the 64 considered control time
series, the model that best predicts the observed mortality rate in the pre-pandemic period
more often includes simultaneous counts for mortality rates observed in 2016 and 2017, the
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Fig. 7.5 Posterior probability of inclusion for each control time series
7.4.1 Results by gender
The excess all-cause mortality is slightly higher in men compared to women, amounting
to 102.8 (95% CrI 97.6-108.2) estimated excess deaths per 100,000 men, and 96.3 (95%
CrI 90.4-103.2) per 100,000 women. However, when considering the % excess above the
counterfactual, the difference between genders is negligible (results in Table 7.1, column
5). Interestingly, such excess represents 143% (95% CrI 136%-151%) of the COVID-lab-
confirmed deaths in men, whereas in women excess all-cause deaths are 187% (95% CrI
176%-201%) of COVID-lab-confirmed deaths. This discrepancy across genders could reflect
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a bias in testing, i.e. more men get to hospital and get tested, or could suggest an increased
mortality in women for causes other than COVID19.
This result is graphically presented in Figure 7.6, panels 2 and 3, where the blue and
red curves are much further apart for women than for men. More in detail, the summary
plot for each population subgroup is articulated in three panels: the top panel shows daily
observed mortality rates and the estimated counterfactual. The blue area represents the 95%
credible intervals around our estimate. In the middle panel the excess death rate is presented
in blue, and the COVID-lab-confirmed deaths are superimposed in red; finally, the bottom
panel presents the cumulative excess both for all-cause and for COVID-19-confirmed deaths.
7.4.2 Results by age
The estimated excess of deaths is largest for the older age groups, amounting to 473.3 (95%
CrI 443.6-503.2) deaths per 100,000 residents aged 75-84, and 1912.4 (95% CrI 1559.1-
2263.9) per 100,000 residents 85+ years old (Table 7.1, column 2). It decreases linearly with
age, being as low as 0.7 per 100’000 (95% CrI -0.1-1.6) in people younger than 25 (Table
7.1 and figure 7.7). However, these discrepancies across age groups are proportional to the
corresponding baseline mortality rates: comparing excess during the COVID epidemic to
the counterfactual (Table 7.1, column 5), it is clear that deaths have been between 36%
and 44% higher than expected in all age groups except for the youngest, with minor
differences across groups.
On the other hand, the proportion of excess all-cause deaths with respect to the COVID-
lab-confirmed deaths differ greatly across groups: it is smallest in 65-74 and 75-84 years old,
being 120% (95% CrI 110%-129%) and 127% (95% CrI 119%-135%) respectively. Blue
and red curves are very close to each other in figure 7.7. Instead, it is much larger in 25-44
and 85+ years old, covering 264% (95% CrI 222%-304%) and 189% (95% CrI 154%-224%)
of COVID-lab-confirmed deaths (figure 7.7). Confidence intervals are wide due to small
numbers, however a potential bias, either with less testing and hospital admissions, or more
deaths due to other causes, could be suspected for these age groups.
Finally, important differences can be seen across age groups also in terms of when the
excess deaths started (Table 7.2): the age group 25-44 signals an early start (14th March),




































































































































































































































Fig. 7.6 Excess all-cause mortality for men (top panel) and women (bottom one)
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last (26th, 25th and 27th March respectively).
7.4.3 Results by region
116.1 (95% CrI 107.4-125.1) extra deaths per 100’000 residents have been estimated for West
Midlands, the most affected region, with a rate that is almost two times the one observed
in the South West (64.2, 95% CrI 54.3-74.4). Other heavily impacted regions are London,
North West and South East, with 110.9 (95% CrI 105.9-116.4), 110.8 (95% CrI 98.3-121.1)
and 109.8 (95% CrI 101.6-118.5) extra deaths per 100’000 residents respectively.
However, when comparing the proportion of deaths with respect to seasonal baseline,
London emerges with a strikingly high 178% (95% CrI 175%-182%), while all other regions
report excesses between 34% and 49%. Finally, the largest excess of all-cause mortality
with respect to COVID-lab-confirmed deaths is observed in South East and South West
(223%, 95% CrI 206%-240%, and 198%, 95% CrI 168%-230% respectively) while in East of
England the excess all-cause deaths almost overlaps with the COVID-lab-confirmed counts
(108%, 95% CrI 98%-118%).
Results for England overall and for each region are plotted in Figures 7.8, 7.9 and 7.10. In
particular, in Figure 7.8 we present the excess all-cause mortality in England and in London
to show how the excess mortality emerged earlier in London compared to England overall.
Table 7.3 summarises such a comparison across all regions: West Midlands and London saw
early increases (16th and 19th of March respectively, and the lag from the first regions was as
long as two weeks for the North East (1st April).
7.4.4 Comparison with Poisson regression
Figure 7.11 shows a comparison over time for the absolute number of excess deaths estimated
with the BSTS and the Poisson regression model. Table 7.3 shows the same comparison
across population subgroups. Making use of the BSTS modelling framework we estimate
53,476 excess deaths (95% CrI 45,912-61,154) from the 2nd March until the 29th May. Over
the same time period, the PHE Poisson regression model estimates an excess of 58,701.
When grouping by age and region, PHE point estimates lie within the BSTS credible intervals
in all cases except for London. However, we notice they generally are above the posterior










































































































































































































































































































































































































































































































































































































































































































Fig. 7.7 Daily excess in all-cause mortality by age group, per 100’000 residents











































































































































































































































































































































































































































































































































































































































































































Fig. 7.9 Excess all-cause mortality for North West, North East, East Midlands and East of
England










































































































































































































































































































































































































































































Fig. 7.10 Excess all-cause mortality for West Midlands, Yorkshire and the Humber, South
West and South East
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date N lb ub Rate lb ub
2020-03-18 601 516 687 1.13 1.08 1.20
F 2020-03-20 286 233 338 1.08 1.02 1.16
M 2020-03-19 308 258 357 1.16 1.10 1.22
F_65. 2020-03-24 257 208 307 4.89 4.57 5.19
M_65. 2020-03-22 259 217 302 5.83 5.51 6.14
0_24 2020-03-27 2 -0 3 0.01 -0.00 0.02
25_44 2020-03-14 13 11 15 0.09 0.07 0.10
45_64 2020-03-19 65 60 70 0.45 0.42 0.48
65_74 2020-03-20 83 76 89 1.49 1.37 1.60
75_84 2020-03-26 179 145 212 5.32 4.98 5.65
85. 2020-03-25 256 210 303 21.49 17.52 25.44
EE 2020-03-28 49 45 54 0.78 0.71 0.85
EMids 2020-03-26 40 26 54 0.84 0.74 0.94
LON 2020-03-19 113 108 119 1.25 1.19 1.31
NE 2020-04-01 33 28 38 1.23 1.08 1.39
NW 2020-03-24 87 64 111 1.25 1.11 1.36
SE 2020-03-23 114 102 125 1.23 1.14 1.33
SW 2020-03-26 35 19 50 0.72 0.61 0.84
WMids 2020-03-16 73 54 91 1.30 1.21 1.41
YH 2020-03-26 61 52 69 1.10 0.99 1.23
Table 7.2 First date of excess mortality and average daily excess: number of deaths and rate
per 100,000
(e.g. when only grouping by gender, age groups 75-84 and 85+, London, West Midlands).
Beyond point estimates, the two methods differ in terms of quantification of uncertainty:
the assumption of independence among observations used in the Poisson does not appro-
priately account for temporal dependence, leading to overconfident estimates, whereas the
BSTS allows propagation of uncertainty, with credible intervals becoming wider the further
ahead we forecast.
7.5 Discussion
Using English national registry data, we quantify the magnitude of all-cause excess mortality
in England, and compare our estimates with the ones released by PHE. Compared to other
methods, we get a potentially more realistic reconstruction of the baseline because we account
for time-dependence of observations. Further, we are able to include more controls, and we























































































Fig. 7.11 Observed all-cause deaths and estimated counterfactual obtained with the BSTS
model (top panel) and with the Poisson regression (bottom panel) for England up to May 29th
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Synthetic controls Poisson regr
N lb ub N
53476 45912 61154 58701
F 25436 20778 30058 28814
M 27423 22959 31762 29867
0_24 136 -11 308 93
25_44 1162 979 1341 1108
45_64 5805 5366 6218 5612
65_74 7363 6754 7935 7326
75_84 15931 12908 18892 18333
85. 22823 18646 26966 26211
EE 4380 3985 4781 4341
EMids 3603 2341 4812 4028
LON 10091 9622 10604 10880
NE 2932 2502 3353 3147
NW 7760 5673 9894 9067
SE 10151 9059 11100 10047
SW 3151 1699 4452 4312
WMids 6525 4810 8140 7696
YH 5441 4644 6160 5574
Table 7.3 Cumulative excess: number of deaths estimated using synthetic controls (with 95%
CrI) and with Poisson regression
naturally obtain uncertainty through the Bayesian posterior distribution of our counterfactual.
For age groups with lower mortality rates, where observations are volatile, our estimates
naturally reflect the uncertainty due to small numbers.
Our results show an important excess all-cause mortality over the COVID-19 pandemic
period, and comparison with the recorded COVID-19 deaths shows that the undetected excess
mortality concentrated in the early phases of the epidemic, whereas in recent weeks the two
measures match. While it is expected that the majority of excess deaths from COVID-19
in the short term are from the virus itself, further work is needed to rule out the extent to
which excess deaths are directly due to COVID-19 infection or to other causes, such as
additional pressures on the health and social care system. While the NHS has increased ICU
capacity and converted several wards to host COVID-19 patients, lower standards of care
for non-COVID-19 emergencies may be characterising hospitals at this stage. For example,
a recent study conducted in 54 Italian hospitals by De Rosa et al. [45] found that hospital
mortality from heart attack tripled from 4.1% to 13.7% in March 2020 compared to the
same period last year, suggesting that hospitals were unable to adequately treat and care for
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patients with other conditions.
As of 11th June 2020, the EuroMOMO study of 24 European countries shows that on
average the continent is returning to normal levels of mortality, with effectively no excess
mortality in France, Spain or Italy. England is still ranked as having “moderate excess”
[ECDC], however our estimates show that this is only the case in selected regions and age
groups. Moreover, the current estimates only represent a partial toll of the overall burden of
the ongoing pandemic and up-to-date estimates will be produced in the upcoming weeks.
An intriguing hypothesis about excess mortality during the COVID-19 pandemic is the
harvesting one, i.e. many individuals who died from the virus were frail, and their events were
only brought forward by a brief period of time [67]. If this is true, we should expect lower
mortality rates in the months to come. However, other factors might affect the long-term risk.
Patients may not be attending hospital from fear of contagion, reaching hospital with delays,
at increasingly serious conditions and with complications, which make life-saving treatments
much less effective. A&E attendances in England were down from 2.2m in May 2019 to
1.3m in May 2020, a drop of 42% [152], and research conducted in early May 2020 showed
that 47% of people would feel uncomfortable using their local hospital in the short term if
the need arose, three quarters of whom (76%) would be concerned about being exposed to
COVID-19 [Ipsos Mori]. The Italian study mentioned above [45] also found a reduction in
hospitalizations for heart attacks homogeneously throughout the country, despite the fact that
the COVID-19 pandemic hit Northern Italy hardest.
Further changes to healthcare activity implemented to protect patients and to free up NHS
resources, such as cancellation or postponement of elective surgeries and other non-urgent
treatments, might also have long-term effects. The number of patients admitted for routine
treatment in hospital in England was down by 85 per cent, from 280,209 in April 2019 to
41,121 in April 2020 [154]. 60% fewer people with suspected cancer were urgently referred
to a specialist in April 2020 compared to the same month in 2019, and the number of first
treatments for cancer fell by 21% [153]. The number of people having to wait more than
18 weeks to start treatment rose to 1.13 million, almost double the number in April 2019
(579,403) and the highest number for any calendar month since January 2008 [155]. Such
a re-prioritisation of non-urgent care may also result in additional deaths over the future
months depending on the length of the delay in treatment and on how such a delay would
affect the specific outcomes [133].
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Finally, factors unrelated to healthcare access but rather depending on the restrictive mea-
sures could have a potential impact on the excess deaths: a decrease in the deaths due to car
accidents, work accidents and violent crime is expected, as opposed to an increase in deaths
resulting from domestic violence and suicides due to anxiety and depression [82, 16, 147].
The negative impact of this pandemic on the economy, with rising levels of unemployment





Up to this point we have focused on stochastic methods for linear time series. Stochastic
models attribute the observed variability of an outcome of interest, pneumococcal disease
incidence in our case, to one or multiple exogenous random variables, e.g. influenza and
meteorological conditions, plus some random noise. Further, the assumption of linear de-
pendence within and across time series of interest makes them straightforward to interpret
and to use for forecasting. Section 3.2.2 presented how, in the univariate situation, linear
dependence between Yt and Yt−h can be quantified by the autocorrelation function (equation
3.4) or by including the autoregressive component Yt−h in the linear predictor of a regression
model for Yt . Similarly, when looking at multiple time series, the cross-correlation function
and inclusion of Xt and Xt−h as predictors for Yt estimate linear dependence between time
series Yt and Xt .
Despite testing the relevance of multiple lags, we have struggled in identifying strong
evidence to support such a linear relationship. Therefore, in this chapter we question the
choice of deeming a linear stochastic model appropriate to describe the underlying system.
In the next sections we introduce nonlinear time series (NLTS) theory, we describe its use
with infectious disease data, present details for some empirical dynamical models (EDM)
and conclude with an application to IPD and influenza time series.
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8.1.1 Why a nonlinear time series analysis?
In statistics, the shape of the system which produces observations is generally assumed
to be known to some degree: a model is formulated, and then inference is performed to
match such a model to observations. In the case of time series analysis, the choice of linear
stochastic models is ubiquitous, and the theory underlying the assumption of linear system
is expressed by the Wold Decomposition: any stochastic process can be separated into the
sum of two processes, a deterministic one that is a linear function of its past values, and a
stochastic one that is a linear function of previous values of an uncorrelated random variable
[175]. This implies that, when a time series shows an irregular behaviour, univariate lin-
ear time series methods can only attribute such an aperiodic behaviour to exogenous variables.
Such a priori insight about the system dynamics might be misleading: dynamical laws
governing nature or human activities are seldom linear, and complicated temporal behaviours
are exhibited by deterministic systems in the presence of nonlinearity, resulting in a condi-
tion sometimes referred to as deterministic chaos [108]. Hence, the apparent randomness
observed in one or multiple time series could be the expression of an underlying complex
deterministic process rather than stochasticity.
Further, when multiple time series are observed, absence of linear relationships between
them might induce to think that they are not related in the underlying system. For example,
the Lorenz system was first defined in 1963 by Lorenz [124] using a set of three first-order
differential equations. Such a system is an approximation to atmospheric convection : x, y
and z are underlying variables that allow describing rates of change of horizontal temperature,
vertical temperature and convection in a two-dimensional fluid layer as a function of physical











Despite the deterministic coupling expressed in equations 8.1, projections of this three-
dimensional system onto each axis X, Y and Z as a function of time result in three time series
which are not linearly correlated to each other, as shown in Figure 8.1: dependence between X
and Z is quadratic (panel 2), while no correlation can be identified between Y and Z (panel 3).
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Fig. 8.1 Correlations between all pairs of variables for the Lorenz attractor [198]
Hence, when dealing with one or multiple observed time series that have complex, highly
variable or random appearance, instead of aiming to estimate what the current state of a
known system is, how noise influences the resulting observations, and what the next obser-
vations will be, we could instead aim to learn more about the nature of such a system. For
example, it could be of interest to reconstruct how the system evolves over time, or to test
whether two variables belong to the same dynamic system and how they relate to each other.
Beyond reconstructing the system for understanding or for forecasting purposes, diagnos-
ing the structure most closely corresponding to reality would be valuable also with the scope
of designing an intervention. In particular, ascertaining whether the observed variability is
driven by stochastic or deterministic dynamics can be crucial when proposing interventions:
if you assume that you are dealing with a stable system except for exogenous shocks, you
expect such a system to self-correct, and you only consider implementing policies tackling
exogenous factors. On the other hand, if a deterministic dynamic is likely, policies that could
prevent future boom and bust cycles should be taken into consideration [97].
The branch of mathematics which analyses the long-term qualitative behavior of dy-
namical systems is called chaos theory: it aims to reconstruct the unobserved geometry of
a dynamical system in order to explore whether the system will settle to a steady state in
the long term, what is the possible underlying attractor (i.e. the set of values toward which
the system will evolve, which encapsulates its long-term dynamic behaviour), and how this
depends on the initial conditions.
A set of empirical tools for the study of complicated time series dynamics, generally
referred to as EDM, has been object of extensive research over the past 30 years. These
methods, which have been largely used in signal processing and engineering, share a philo-
sophical approach based on inductive reasoning: they process information on real-world data
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without making model assumptions explicit. Regularities as well as non-obvious patterns are
detected in the observed time series with the scope of extracting information and formulating
hypotheses, understanding if the system dynamics are linear or nonlinear, and diagnosing
presence of stochasticity [97].
This approach has proven to be fruitful in the understanding of many complex phenom-
ena, nonetheless very few natural systems have actually been found to be low dimensional
deterministic [84]. Only in those cases, i.e. when a deterministic model that describes
the system dynamics exists, other NLTS methods can assist in finding solutions for those
equations [97]. Even though identifying the governing equations of a dynamical system is a
convenient way to describe its long-term behavior, in most cases NLTS analysis gets to the
point of identifying characteristics of the underlying system without being able to explicitly
write down a model for it.
8.1.2 EDM in infectious disease
Historical analysis of ecological time series relied on modelling measurement error and
considering key information to be enclosed in the underlying smooth patterns. However, with
the emergency of chaos theory suggesting that irregularities can be an equally interesting
object of investigation, application of NLTS tools flourished in many settings[198].
In particular, the relative importance of deterministic versus stochastic forces in ecolog-
ical populations has been object of a long-standing debate, and the discussion focused in
particular on environmental versus biological factors: environmental factors were thought
to be associated with stochastic fluctuations in population density, and biological ones with
deterministic regulation [198].
Within the field of infectious disease, the apparent correspondence between real-world
epidemic time series and the chaotic properties of simple epidemiological models have
attracted considerable attention [206]: the irregularity in duration and amplitude of cycles of
measles epidemics in the pre-vaccination era has been the focus of an extensive search for
non-linearity and chaos, with many attempts of reconstructing characteristic properties of the
underlying system from a single observed time series [183, 160].
More recently, Deyle et al. [46] used novel EDM tools to investigate environmental
drivers of influenza outbreaks. They speculated that the relationship between these quantities
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might not be linear as influenza outbreaks are well correlated to the seasonality of temperature
and absolute humidity in temperate countries, while seasonality both of climate and outbreaks
is much weaker in tropical countries. In order to test for the presence of such a nonlinear
relationship they reconstructed the two-dimensional system from country-level epidemic
and climatic time series. Following their work, Cobey and Baskerville [28] investigated
from simulated data to which extent the periodic, noisy, and transient dynamics of ecological
systems could be an obstacle to system reconstruction and any deriving causal inference.
8.2 Methods
8.2.1 Dynamical systems and their geometry
In mathematics, a dynamical system is characterised by three components:
1. a state of the system at any given time, x(t), i.e. a vector containing the values assumed
by the system internal variables at time t
2. an evolution rule ẋ = v(x), i.e. a function that describes what future states follow from
the current one, typically formalized into one or multiple differential equations
3. a state space, representing the totality of states the system could visit, e.g. Rn
A geometric representation of the state space can effectively help to visualise a dynamical
system. A space of dimension n is considered, where each axis represents one of the n inter-
nal variables which uniquely define the system dynamics, and the vectors x(t) are used as
vectors of coordinates, so that each x(t) is represented by a unique point in the corresponding
state space. The system evolution over time can also be represented in the state space by
joining the sequence of states visited according to the evolution rule, an object called system
trajectory. For example, the Lorenz system trajectory is pictured in the top panel of Figure 8.2.
As anticipated in section 8.1.1, the interest is usually on the long-term behavior of the
system, when the system trajectory might converge to the underlying attractor. An attractor
can be a point, a curve, a surface, or even a complicated set with a fractal structure. However,
initial conditions can affect the long-term dynamics of a system: each trajectory represents
the set of states visited when starting from one particular initial condition, and exploring
variations entails plotting the trajectories compatible with starting from any initial condition.
Such a visualisation proves extremely useful to understand qualitative features of the system
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Fig. 8.2 Top: representation of a Lorenz system trajectory in the x,y,z space, where the
variables are temperature, pressure gradient and angular velocity. Middle: time series of
x(t), discarding any knowledge of y, z, or the governing equations. Bottom: phase-space
reconstructed by embedding x(t).
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when it is impossible to derive an explicit formula for the solution of its nonlinear equations,
elucidating qualities of the system that might not be obvious otherwise [197].
If a deterministic system is defined by ordinary differential equations, its state space is
finite-dimensional and the attractor can be represented geometrically. For example, instan-
taneous states x(t) of an idealized pendulum are uniquely defined by its angle and angular
velocity; its state space, a two-dimensional state plane, is the set of all possible pairs "(angle,
velocity)", and the path drawn by the pendulum visits converges to a closed curve, a type of
attractor typical of systems presenting periodic oscillations. On the other hand, if the system
is three- to n-dimensional, the attractor can be a manifold, as the butterfly-shaped Lorenz
attractor in Figure 8.2. However, the number of dimensions can grow unexpectedly, making
state spaces difficult to use: in more complicated cases, as in partial differential equations
and delay differential equations, the state space can be infinite-dimensional [197].
8.2.2 Phase space reconstruction techniques
A time series is a scalar sequence of observations Yt that in itself does not properly repre-
sent the multidimensional space of the dynamical system, however we can think of it as
a one-dimensional view of an unobserved process occurring in higher dimensions, from
which the observed complexity or apparent randomness arises. Since our aim is investigating
these underlying dynamics, getting information about the state space and the attractor that
produced Yt , we look at methods that allow reconstructing the state space from a single time
series.
The most important technique, proposed by Takens [200], is the method of delays, or
time-delay embedding: lagged coordinates are used to embed the observed time series in
higher dimensions. Although embeddings could be created from as many time series as the
dimensions of the state space, here we consider the worst case where only one time series is
available. This reconstruction will not retrieve the original state space, but an approximation
of it: something we shall call a phase space. Takens proved that a phase space obtained
via time-delay embedding retains essential properties of the original state space (formally
called topological characteristics), working as a surrogate for the state space of interest: it
can be used to make forecasts, and information about the original attractor can be gained by
exploring its properties. In the bottom panel of Figure 8.2 we can see a phase space of the
Lorenz attractor reconstructed by embedding the time series x(t) pictured in the middle panel.
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To clarify embedding with an example, we take a time series yt = {y1, . . . ,y10} and we
set embedding dimension m = 4 and time delay τ = 2: we make m−1 copies of the observed
values yt with a fixed time delay τ .
t 1 2 3 4 5 6 7 8 9 10
yt y1 y2 y3 y4 y5 y6 y7 y8 y9 y10
yt+τ y3 y4 y5 y6 y7 y8 y9 y10
yt+2τ y5 y6 y7 y8 y9 y10
yt+(m−1)τ y7 y8 y9 y10






But how do we choose m and τ? There are no mathematical rules for selecting the ’cor-
rect’ values of the embedding parameters that ensure a faithful reconstruction of the phase
space: the theoretical requirements are quite straightforward, however in practice estimating
good values for these parameters from short and noisy time series can be challenging. Dozens
of methods have been developed in the past few decades; we cover a few representative
members of this set.
τ is usually chosen first. The original embedding theorems only require that τ is positive
and not a multiple of any orbit’s period, however this refers to the hypothetical situation
where an infinite amount of noise-free data is available. In practice, when noisy, finite-length
time-series data are available, a higher τ is needed to properly unfold the dynamics: too
small delays would lead to strong correlation among the m coordinates in each of the re-
constructed vectors, and so the embedded dynamics would lie close to the main diagonal of
the reconstruction space. Since improperly unfolded reconstructions are not topologically
conjugate to the true dynamics, this is a key problem [14].
While removing time-induced dependency is necessary, the smallest reasonable time
delay τ must be chosen, as large τ could bring distant parts of the trajectory accidentally
close together. A statistic that measures the independence of τ-separated points in the time
series is generally computed: for example, the first zero of the autocorrelation function of the
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time series would yield the smallest τ that maximises linear independence of the coordinates
of the embedding vector. However, as autocorrelation only quantifies linear dependence,
an alternative measure should be considered for nonlinear systems: mutual information is
a measure of the mutual dependence between the two variables yt and yt+τ , relating their
probability distributions as follows:






After summarising I(Yt ,Yt+τ) for each choice of τ by taking the average mutual information
(AMI) over the observed t, the optimal τ is selected as the first minimum of the AMI. When
dealing with observed time series, rather than making any distributional assumptions, AMI
can be computed using empirical probability distributions (estimated via density histograms).
After choosing a value for τ , the next step is to estimate the embedding dimension m.
The original embedding theorems require m > 2D, where D is the unknown dimension of
the underlying dynamics. In practice, as in the case of τ , we search for the smallest m that
leads to a topologically correct result. Such a ’minimal sufficient embedding dimension’
can be determined based on the false near neighbor (FNN) algorithm [110]: FNN are points
that are close to each other in the phase space because they are simply close in time rather
than because of the geometry of the phase space. The algorithm allows getting rid of them
by progressively increasing the embedding dimension: the time series is first embedded
with m = k and each point’s near neighbors are computed (spatial distance measured by
Euclidean or maximum norm), then the embedding dimension is increased to k+1 and the
near-neighbor calculation is repeated. If any of the neighbors in k dimensions are no longer
neighbours in k+1 dimensions, that is taken as an indication that the dynamics were not
properly unfolded for m = k. Noise also disturbs neighbor relationships, though, and thus
can affect the operation of FNN-based algorithms [14].
8.2.3 Convergent Cross Mapping (CCM)
Although correlation is neither necessary nor sufficient to establish causation, it remains
deeply ingrained in our thinking: one might be tempted to conclude that uncorrelated vari-
ables have no causal relation, as for the time series of the Lorenz system in Figure 8.1,
whereas in fact nonlinear dynamics could be involved. Conversely, ephemeral or “mirage”
correlations are common in even the simplest chaotic systems, but this does not imply causal-
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Fig. 8.3 Graphical representation of the correspondence of points on manifolds M, Mx and
My as presented by Sugihara et al. [199]
ity. As discussed in section 3.4, Granger causality is a well-known data-driven method that
allows inferring causality in stochastic systems, even if non linear: y Granger-causes x if the
predictability of x decreases when y is removed from a stochastic model for x. However, if x
and y deterministically interact in a dynamical system, the requirement of separability is not
met as information about y is encoded into x, so Granger causality is not applicable.
In order to test whether two time series deterministically interact in a dynamical system,
and are thus causally related, in 2012 Sugihara et al. [199] proposed CCM, a method based
on time-delay embedding that exploits an extension of Takens’ theorem. Takens showed that,
given a dynamical system, a one-to-one mapping holds between its original manifold M and
a shadow manifold Mx, an approximation of M obtained by embedding the x(t) time series.
However other manifolds reconstructed by embedding other time series originating from that
system, for example My obtained by embedding y(t), also map to M. Since both Mx and My
map one-to-one to the original manifold M, they also map one-to-one to each other. This
concept is summarised in Figure 8.3.
8.2 Methods 139
This idea was used by Sugihara et al. [199] to propose a cross mapping algorithm that
aims to tests whether two time series x(t) and y(t) belong to the same dynamical system
by testing the correspondence between phase spaces reconstructed from x(t) and y(t): if
points that are nearby on My correspond to points that are nearby on Mx, then x(t) and y(t)
originated from the same dynamical system. Detailed steps of this algorithm are enumerated
below:
1. reconstruct manifolds Mx and My from time series x(t) and y(t) using time-delayed
embedding
2. select a reference time tk and identify the corresponding points on each attractor:
Mx(tk), My(tk)
3. compute Euclidean distances between My(tk) and all the points on My, and identify
the m+1 nearest neighbouring points to My(tk), where m is the embedding dimension.
Say My(ta), My(tb), My(tc) are selected if m = 2
4. compute relative distances of My(ta), My(tb) and My(tc) from My(tk) with respect to
the total distances of all nearest neighbours, and call them e.g. dta , dtb and dtc
5. use time indices ta, tb and tc to identify the corresponding points on Mx, namely Mx(ta),
Mx(tb), Mx(tc)
6. cross map M̂x(tk) as a locally weighted mean of Mx(ta), Mx(tb), Mx(tc) with weights
dta , dtb and dtc .
7. compare the estimated M̂x(tk) and the actual value Mx(tk) by the Pearson correlation
coefficient ρ in order to measure the cross mapping predictive skill
In summary, if nearby points on My help identifying nearby points on Mx, y can be used to
cross map x, i.e. states of x can be estimated from records on y alone. Then, the ability to
estimate the values of x from y can be seen as a measure of how much information about x
has been encoded into y.
This procedure is iterated over the whole attractor by augmenting the learning set of
one period at each step: with longer time series we expect reconstructed manifolds to be
denser, nearest neighbours to be closer and cross-map estimates to increase in precision.
Convergence, i.e. increase in cross-map precision as the portion of time series used to
reconstruct My increases in size, was initially used as a practical criterion to detect causation.
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This is why the method is called convergent cross mapping: if lengthening the training set
for My led to increasing ability of y to cross map x, then this evidence would support the pres-
ence of an influence of x on y in the underlying dynamical system, i.e. a causal effect of x on y.
This theory implies that causal drivers will produce good reconstructions, but not that
non-causal drivers will not produce good reconstructions. In particular, when the dynamics
of a response variable y become dominated by those of the driving variable x, the full system
consisting of x and y collapses to just that of x (system synchronized to the driver) and,
although there is no causal effect of y on x, CCM is observed in both directions since the
states of x can also uniquely determine y. This false positive result indicates that CCM may
not be able to distinguish between bidirectional causality and strong unidirectional causality
that leads to synchrony [199].
To circumvent this issue, a new criterion for causality has been proposed by Ye et al.
[237]: since the effect of a driver x might be seen on a response y with some time delay,
they extended CCM to include the directionality of information in time, i.e. y is used to
cross map different lags of x. In the case of synchrony caused by strong unidirectional
forcing of x on y, we expect y to be better at predicting the past values x (while x would best
predict future ys), hence the true causal direction would be identified by an effective cross
mapping for negative lags. A graphical explanation is presented in Figure 8.4. This method,
that Cobey and Baskerville [28] renamed negative cross-map lag criterion, more generally
improves the understanding of time delays in causation and helps identifying the correct
ordering of variables in a transitive causal chain. Finally, it can also identify time-delayed
interactions of stochastic drivers that have no dynamics [237]. CCM has been successfully
applied in climate system, investigating the interaction between temperature and greenhouse
gases [219], galactic cosmic rays and temperature variations [210], carbon cycle and tropical
temperature variations[227] and soil moisture and precipitation [229].
In conclusion, informativeness of data is key to the success of such methods: if the time
series is too short, cycles occurring at lower frequency might not be adequately sampled, and
noisiness could obscure the resolution of the reconstructed system. To mitigate this problem,
some pre-processing of the data is generally required: this allows separating observations into
structured signal and unstructured noise. If a strong signal is detected, then EDM methods
can be applied on it; on the other hand, if signal is weak, conventional linear stochastic
models may be more effective [97].
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Fig. 8.4 Effect of time delays on cross mapping. Panel (A) shows causation for two cases: (i)
no time delay in the effect of x on y and (ii) y responds to x with a time delay of 4 time steps.
Panel (B) shows (i) cross mapping with l=0, equivalent to the original formulation by [198]
and (ii) cross mapping with l=-4, which may be expected to be better than l=0 when x acts
on y with some time delay. [237]
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8.2.4 Signal processing techniques
As anticipated in section 8.1.1, when approaching NLTS analysis we primarily want to assess
whether the data, including its observed irregularities, should be attributed to noisy (linear)
behaviour or to deterministic (nonlinear) dynamics. Such noise can be defined as unstructural
variation that doesn’t evolve systematically with time, and its presence can be an important
obstacle to identification of deterministic dynamics [214]: EDMs presented in section 8.2.2
can successfully detect the shape of nonlinear systems once noise has been eliminated.
Thus, data pre-processing techniques play a key role in unmasking components that
are more likely to describe the underlying system: they typically decompose the original
series into a sum of a small number of independent and interpretable components, such as a
slowly varying trend, oscillatory components and structureless noise, that will keep invariant
characteristics over time, i.e. X(t) = X1(t)+X2(t)+ · · ·+Xr(t). Success of this process
relies on the property of separability of these components, i.e. the possibility of extracting
them from the observed sum X(t) [72].
Among many methods we present singular spectrum analysis (SSA), a data-driven
signal processing technique able to detect structural variation in irregular time series data
without imposing theoretical assumptions on the source of irregularity [72]. For this reason,
it is also referred to as a model-free approach. Although not very popular among statisticians,
SSA is widely used in physics, meteorology and climatology: it incorporates elements of
classical time series analysis, multivariate statistics, multivariate geometry and linear algebra.
We choose SSA because it is particularly suitable to separate trend and seasonality, e.g.
by identifying underlying sine waves with different frequencies. Moreover, Hassani [79]
compared its performance to alternative methods such as Box-Jenkins SARIMA models, the
ARAR algorithm and the Holt-Winter algorithm, and concluded that SSA is more accurate
than several well-known methods in terms of forecasting results.
The algorithm of SSA consists of two complementary stages: decomposition and recon-
struction. Consider a time series xt = (x1, . . . ,xN), and let L (1 < L < N) be some integer
called the window length. Decomposition starts with embedding the original time series xt
with delay τ = 1 to obtain K = N −L+1 lagged vectors of size L that, combined by column,
form a trajectory matrix B of size L x K. Such a trajectory matrix is then subjected to singular
value decomposition, explained in detail in appendix C.1. In summary, decomposition of
matrix B, of rank r, results in the sum of r matrices of rank 1, called elementary matrices,
ordered from the largest to the smallest. Each of these matrices can be identified by a vector
8.2 Methods 143
of length 3, called an eigentriple, comprising the ith singular value, the ith eigenvector of
BBT and the ith eigenvector of BT B.
Reconstruction follows: firstly, the matrices obtained in the decomposition stage are
assigned to several disjoint groups, a step called eigentriple grouping, and summed within
group. Finally, in the last step each resultant matrix is transformed, via diagonal averaging,
into a time series.
Some recommendations on choosing values for the parameters that maximise separability
will follow. Firstly, better separability is obtained when L is large enough (L ∼ N/2) and, if
we want to extract a periodic component with known period (e.g. 52 weeks), then L should
be divisible by that period [72]. Secondly, choosing an optimal grouping for eigentriples
is crucial for a proper decomposition of the observed time series: the aim is distinguishing
eigenvectors that represent signal from the ones that represent noise, and grouping eigen-
vectors that describe similar behaviours. For example, any two sine waves with the same
frequency and phase shift, generated by the same sinusoid, should be grouped to represent a
given periodicity of seasonality.
Several leading eigentriples should be selected and visually inspected. The spectrum of
the singular values, i.e. the plot of the singular values against the index of the eigentriples,
is a good starting point to discriminate the nature of each component: singular values of
eigentriples of harmonic series are usually very close to each other (paired), hence they
can be easily spotted by a plateaux in the plot, whereas a slowly decreasing sequence of
singular values generally indicates noise Further, each eigenvector can be converted into an
elementary reconstructed time series, and both its visualisation and a matrix of weighted
correlations between them (w-correlation matrix) are helpful for separation: we want to make
sure that correlated components are not included into different groups, hence we should
focus on small correlation, indicating well separated components (if correlation is zero they
are said to be w-orthogonal).
Finally, graphs of eigenvectors can also help in the process of grouping, as their form
replicates the form of the time series component that produces them: for example, one or
more of the leading eigenvectors might be slowly varying, with no oscillatory behaviour,
hence representing the time series trend. The scatterplot of pairs of eigenvectors, which pro-
duces a more or less regular T-vertex polygon, can help to identify a sinusoid of period T [71].
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8.3 Application to influenza and IPD time series
8.3.1 SSA for IPD
We consider the time series presented in chapter 4.2, Figure 7.8, i.e. the weekly IPD incidence
rate per 100,000 residents in England from 2009 to 2018. We start our analysis by running a
singular spectrum analysis to separate unstructural noise from signal. For better separability,
we select L = 208 as the maximal window length such that L ≤ N/2 and L is divisible by 52.
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Fig. 8.5 Eigenvalue spectrum and W-correlation matrix for IPD
The ten leading eigentriples are selected and inspected. The spectrum of singular values is
presented in the left panel of Figure 8.5: one evident pair corresponds to eigenvectors 2 and 3
of the series, suggesting an important role played by a sine wave. Two important jumps divide
eigenvectors 1 and 4, probably trend components, whereas the slowly decreasing singular
values for component 5 and upwards suggest the presence of noise. A good separability
for components 1 to 4, and a bad separability for components 5 to 9, are shown by the
w-correlation matrix in the right panel of Figure 8.5, where the grey scale from white to
black corresponds to values of the correlation between eigenvectors from 0 to 1. Series 1 to 4
are not correlated with any other one (w-orthogonal) and components 2 and 3 are considered
as one group.
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Fig. 8.6 Reconstructed elementary components for IPD
The speculated forms of leading eigenvectors 1 to 4 are confirmed in Figure 8.6, which
represent reconstructed time series from each elementary component: 2 and 3 are high-
frequency components which oscillate at the same frequency, representing yearly seasonality,
while 1 and 4 are trend components. Single and paired eigenvectors plots are listed and
described in C.2, Figure C.1.
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Fig. 8.7 Signal for IPD reconstructed with SSA
Hence, we extract IPD signal as the sum of components 1 to 4, as shown in Figure 8.7:
the extracted trend+seasonality is superimposed in red on the background of the original
series, and it explains 90.3% of the variability. We also run a second SSA on the residuals
to check if other eigenvectors could be extracted, but the w-correlation matrix confirms no
further separability (Figure C.2).
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8.3.2 SSA for influenza
As for IPD, we consider the influenza time series presented in chapter 4.2, the weekly inci-
dence rate per 100,000 residents in England, and we run SSA with L = 208. The spectrum
of the ten leading singular values is presented in the left panel of Figure 8.8: as in the case
of IPD, two clear jumps divide eigenvectors 1 and 4, probably trend components, singular
values for components 2 and 3 are very similar, indicating harmonic series, while singular
values slowly decrease from eigenvalue 5 upwards, hinting at noise. From the right panel of
Figure 8.8 we see how separability is perfect for components 1, and 2-3 as a group, whereas
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Fig. 8.8 Eigenvalue spectrum and W-correlation matrix for influenza
Time series reconstructed from each elementary component, in Figure 8.9, confirm an
upwards trend in component 1, oscillatory behaviour of components 2 and 3, with the same
frequency but phases slightly shifted, and noisy dynamics for components 4 to 9. Single and
paired eigenvectors plots are listed and described in C.2, Figure C.3.
We conclude SSA by extracting influenza signal as the sum of components 1 to 3, as
plotted in red on the background of the original series in Figure 8.10: this time the selected
components only contribute 42.6% of the variability, leaving a lot of the dynamics attributed
to noise. However, a second SSA confirms no further separability in the residuals (Figure
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Fig. 8.9 Reconstructed elementary components for flu
C.4).
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Fig. 8.10 Signal for influenza reconstructed with SSA
8.3.3 Embedding of IPD and influenza signals
In order to reconstruct the underlying dynamics of IPD and influenza, we first identify
the best embedding parameters for the respective extracted signals. The time delay, τ , is
selected based on minimum mutual information, whereas the embedding dimension E is
selected as the first minimum in the percentage of false nearest neighbours when increasing
embedding dimension from m−1 to m, i.e. when the proportion of points that were identified
150 Empirical dynamical modelling
as neighbors in dimension m−1 and are no longer neighbours in dimension m is minimum.
The chosen parameters to embed IPD are τ=16 and E=3, as shown in Figure 8.11, whereas
for influenza we find τ=11 and E=3 (Figure 8.12).











































































































Fig. 8.12 Selection of time delay τ and embedding dimension E for the flu signal
For comparison, in section C.2.3 we present the embedding parameters that would have
been chosen if we had computed AMI and FNN for the original rates instead of the extracted
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signals: in both cases, we would have required a higher embedding dimension: 4 in the
case of IPD, 5 in the case of flu. Finally, 3d scatterplots of the corresponding manifolds are
presented in Figure 8.13: both of them show a spiral trend, however the time series are too
short to clearly identify the underlying attractor.






















































Fig. 8.13 Reconstructed manifolds for IPD signal (left) and influenza signal (right)
8.3.4 CCM of influenza and IPD
Despite reconstructing two separate state spaces, our question concerned whether the two
phenomena did belong to the same dynamical system. CCM allows testing for the presence
of a causal relation between influenza and IPD by using nearby points on one attractor, e.g.
MIPD, to map nearby points on the other, e.g. M f lu. In order to demystify the ordering of
variables in the causal chain, IPD can be used to predict different lags of flu as, if flu is a driver
for IPD, its effect on IPD might be seen with some time delay, and vice versa. Hence, we
cross-map IPD from influenza, and influenza from IPD, considering lags from -5 to +5 weeks.
The cross mapping predictive skills, expressed as correlation ρ between the estimated
and observed values, are summarised in Figure 8.14: we find that correlation of flu xmap
IPD is larger (ρ above 0.9 for any lag), meaning that states of IPD can be estimated very well
from records on flu alone; however, the converse is also true, as the correlation for IPD xmap
flu is also above ρ = 0.75 for any lag. Since the ability to estimate values of one variable
152 Empirical dynamical modelling
from the other can be seen as a measure of how much information is encoded in that variable,











Flu xmap to IPD
IPD xmap to Flu
Fig. 8.14 Correlation coefficients for prediction skills of time-delayed CCM
Directionality of information in time also does not help greatly: flu better cross-maps
negative lags of IPD, suggesting a potential driving role, but the difference in predictive
skill across lags is really small, so we do not feel this provides evidence towards a strong
unidirectional forcing of IPD on flu.
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For comparison, we repeat the same analysis on the original time series, and summarise
cross-map predictive skills in Figure C.7: cross-mapping skills are significantly lower when
including the component identified as noise in SSA, yet a clear maximum in correspondence
of no lag is visible, suggesting no true causal relationship between influenza and IPD but
rather a synchrony due to some shared driving factors.
8.4 Discussion
The collection of ideas and techniques known as EDM can be extremely effective when the
data derive from deterministic dynamics in some state space. This analytical framework
allows to solve an inverse problem of considerable complexity: from data you can infer
properties of some hidden dynamical system. However, the assumption of determinism
makes these methods largely unsuitable for characterizing stochastic aspects of data.
All the methods considered here rely on reconstructing the unobserved state space thanks
to the powerful method of delay-coordinate embedding. Yet, this method has some practical
limitations. Firstly, estimation of the minimal sufficient embedding delay and dimension is
a non-trivial problem [17], as thoroughly described in section 8.2.2. Further, resolution of
such an attractor might be obscured when short and noisy time series are available. Data
pre-processing techniques have been proposed to extract the high-frequency components of
the signal, yet distinguishing noise from deterministic chaos can be a harder challenge as
both types of signals exhibit irregular temporal fluctuations, and there is a risk that these
algorithms might filter signal out along with the noise [202].
We applied SSA to extract signal from observed time series data of influenza and IPD
incidence in England, and used the resulting signal-processed time series to reconstruct the
underlying systems. Trend and seasonality components were isolated and from both time
series: these successfully explained over 90% of the variability for IPD, whereas 57% of
influenza variability was left unattributed. We might argue that, despite identifying trend
and seasonality, our algorithm excessively smoothed the observed time series: by looking
closely at the unattributed components we see how some important information in the data,
such as the different phase of seasonal spikes, has been filtered out. Moreover, embed-
ding of these extracted signals resulted in well-defined spiral-shaped manifolds for both
phenomena, as expected due to annual seasonal oscillations, however the limited length
of our time series prevented us from detecting a real convergence to an underlying attrac-
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tor, leading to inconclusive evidence about the deterministic nature of the considered systems.
Further, two complex systems that appear to be weakly coupled are difficult to analyze,
as there are multiple ways in which they could be causally linked: neither influences the
others’ temporal dynamics, and the variables are therefore causally unrelated; a forcing
process influences the temporal dynamics of a response process, but the response process
has no effect on the forcing process in return, i.e. there is unidirectional causality; or there is
bidirectional causality where each variable influences the others’ dynamics. Standing on the
theory of embedding, CCM has recently been introduced as a practical numerical approach
to identify causal relationships in weakly coupled nonlinear systems without requiring corre-
lation. However, its ability to distinguish among these three cases depends on the strength of
underlying relationship, beyond the general issues with state space reconstruction described
above [26].
We applied time-delay CCM both to the signal-processed and the original time series to
test for the presence of any causal relationship between influenza and IPD: each variable
contained information about the others’ dynamics, suggesting they could interact in the same
dynamical system, however lack of a clear temporal ordering did not allow us to conclude
towards any directionality. We replicated this analysis both on signal-processed and noisy
data as our aim was not to distinguish between chaos and noise, but rather attempting to
reduce the impact of noise when gaining insights on the underlying system complexity.
While we acknowledge that pathogens of interest might interact in a nonlinear way,
the complexity and multidimensionality of the setting, including environmental forces that
have not been inspected here, does not lead us to recommend an EDM analysis to make
statements about their causal interaction: as Cobey and Baskerville [28] highlighted in their
work, the little prior knowledge of a system’s complexity, with transient dynamics and noise,
prevents us from reaching statistically rigorous conclusions about who interacts with whom.
Further, this method does not allow the inclusion of covariates, making it impossible to
account for meteorological effects as we did in previous chapters. Finally, incidence for
the pathogens of interest could be effectively described by a nonlinear system to produce
satisfactory short-term forecasts, but identification of long-term properties remains an open
question. Finally, the challenge of separability and noise isolation also requires more work.
Chapter 9
Conclusions and future work
Over 100 years have elapsed since the 1918 influenza pandemic, yet the impact of respira-
tory pathogens on human health remains substantial despite increasing availability of novel
preventative and therapeutic strategies. Efforts to enhance pandemic preparedness should not
be forgotten as the COVID-19 pandemic is vivid in our minds: novel pathogens continue
to emerge in animals, subsequent spillovers into human populations are likely, and current
global conditions, characterised by international travel, migration, and urbanization, enable
pathogens to spread widely and quickly [126].
Even if a large portion of the LRTI deaths due to endemic pathogens could be avoided by
enhancing access to healthcare for people who currently don’t receive immunisation or timely
antibiotics [150], the increasing incidence of chronic illnesses in an aging population and
the rising number of drug-resistant pathogens place individuals at greater risk of infection
and complications from respiratory viruses [24]. Further, declining levels of protection from
vaccines due to anti-vaccination sentiments in some communities is enabling previously
declining respiratory viruses to cause significant outbreaks [WHO].
Surveillance data represent a fundamental component in the monitoring of epidemics,
both to inform detection of new outbreaks and retrospective reconstruction of past ones, and
statistical methods play a crucial role in quantifying the burden and estimating effectiveness
of interventions. The work of this thesis, placed at the interface of public health, epidemiol-
ogy and statistics, is an example of what role these quantitative methods can play in fostering
this understanding.
Regression-type approaches have been historically employed at Public Health England to
provide a picture of disease incidence from surveillance data. We consider these methods to
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be somehow too simplistic, and propose a portfolio of novel time-series-based approaches
which allow modelling surveillance data while accounting for temporal dependency, ap-
proximating the transmission dynamics. Special attention is also being paid to an accurate
quantification of uncertainty. Application of these new methods has the potential to improve
substantive evidence, to inform policy and the government decision-making.
9.1 Main thesis findings
9.1.1 Pneumococcal disease progression
Chapter 2 makes use of a longitudinal study jointly tracking asymptomatic carriage of
S.Pneumoniae and LRTI infections at the individual level. We reconstruct within-subject
disease dynamics and quantify the impact of seasonality, temperature and viral circulation on
the probability of disease progression and clearance. Importantly, our model estimates that
the risk of developing pneumonia is 67% higher during the influenza season, and 47% higher
during the RSV season, after taking into account meteorological variations.
The nature of this information, where the asymptomatic condition is ascertained at pre-
defined time instances while time of LRTI occurrence is exactly identified as people seek
healthcare in the presence of symptoms, posed some challenges to our inference. In particular,
we used standard methods to account for exact observation time for the pneumonias, however
we could not use the viral positivity measured in the cohort as a covariate, as it was only
recorded at the pneumonia onset, being an informative observation. Hence, we replaced this
with viral positivity from the national-level surveillance. A similar modelling strategy could
be applied to other cohort studies tracking disease evolution of pathogens characterised by
an asymptomatic phase.
9.1.2 Burden of endemic respiratory pathogens
Chapter 3 reviews currently used methods for the estimation of seasonal disease burden.
The focus of the chapter is on the limitations of these models, highlighting in particular the
need to account for time dependence and the challenge of disentangling the contribution of
different factors with overlapping seasonality. Methods that include virological circulation
are considered, as they represent a natural framework to estimate the counterfactual, i.e. the
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baseline burden not attributable to a specific pathogen.
In chapter 4 we apply one of these methods to English surveillance data to clarify the
contribution of the influenza virus on severe pneumococcal infections across age groups, in
both seasonal and pandemic settings. We find their association to be significant, particularly
in younger age groups, during the 2009 flu pandemic, whereas the seasonal contribution does
not appear to be relevant. These findings have implications for pandemic preparedness in
terms of advising on antibiotic stockpiles in England, for which currently there is no clear
evidence.
We believe our approach could be valuably applied to retrospectively investigate rela-
tionships of other notifiable diseases. For example, the contribution of viruses to secondary
bacterial infections due to Staphylococcus Aureus and Streptococcus Pyogenes requires
further investigation, to better inform antibiotic prescription policies. Despite limitations due
to the available data and modelling assumptions, the proposed model successfully improves
existing understanding of interaction between multiple pathogens. A similar modelling strat-
egy could be usefully employed by many countries that rely on infectious disease surveillance
for informing policy, and extended to tackle spatial dynamics if region-specific counts are
available.
9.1.3 Evaluation of pneumococcal vaccine and serotype replacement
Chapter 5 introduces the intervention evaluation framework. Estimation of the impact of
an intervention is a key problem in many public health institutions and international organi-
sations. We present two classes of methods, case-only and case-controlled, that have been
used to estimate intervention effects from time series data. We focus initially on the ITS
framework: this method relies on a pre-chosen function for the intervention effect, and suffers
from unobserved confounding, however it is the best choice when no controls are available.
We then present the CIM method, a DLM including a Bayesian variable selection strat-
egy, which allows including several control time series as covariates naturally dealing with
multicollinearity issues. In fact, the spike-and-slab prior selectively includes covariates
which maximise model fit to observed data, and the posterior distributions of the coefficients
naturally yield weights to combine controls into a weighted average. Further, the DLM
structure, describing the outcome dependency over time through an evolution equation, effec-
tively accounts for temporal dependence avoiding the common assumption of independence
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between observations.
We explore their application in chapter 6, investigating the impact of pneumococcal vac-
cine introduction in England. PHE have previously used counterfactual analysis somewhat
parsimoniously in evaluating policy impact, relying on simple impact indicators [113]. Our
work adds to such existing evidence: we successfully disentangle vaccine effectiveness from
serotype replacement across age groups by modelling serotype-specific IPD incidence over
an 18 year period, providing important evidence to inform future vaccination policies.
9.1.4 COVID-19 excess mortality
We cast the problem of estimating baseline mortality during an outbreak in terms of counter-
factual estimation, following the methods presented in chapter 5, and we apply this idea to
estimate excess mortality in England during the COVID-10 pandemic. Baseline mortality in
the absence of COVID-19 is forecast from a DLM model fitted to the daily mortality rates
observed for the 2019/20 epidemic year, before the pandemic started. Several predictors of
all-cause mortality are considered, including mortality in the corresponding period of past
seasons, as well as meteorological conditions and viral circulation. As described above, the
most suitable predictors are selected through a spike-and-slab prior.
We estimate a cumulative excess of 100.8 (95% CrI 95.8-106.4) deaths per 100,000
residents from the 2nd March until 29th May 2020, 147% (95% CrI 145%-150%) of the
mortality expected during a corresponding spring period. Important differences are identified
across regions, with the excess mortality above the baseline estimated to be 178% (95% CrI
175%-182%) in London, and much lower than average in the South West, East Midlands and
East of England.
Beyond quantifying excess mortality across regions and age groups, we identify differen-
tial starting dates for the outbreak across population subgroups making use of the Bayesian
credible intervals for the estimated cumulative excess. Important differences can be seen
across age groups in terms of when the excess deaths started: as early as 14th March in the
age group 25-44, and as late as the 27th March in the 75-84 years old.
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9.1.5 Empirical dynamical modelling
Finally, in chapter 8, we explore empirical dynamical modelling, which aims to investigate if
one or multiple observed time series that have complex, highly variable appearance have been
generated by an unobserved dynamical system, and to test whether two variables belong to
the same dynamic system. This relates to chaos theory, which tries to reconstruct long-term
dynamic behaviour of a system, exploring its potential nonlinear shape and whether it will
settle to a steady state.
We applied time-delay CCM, a phase-space reconstruction method, to test for the pres-
ence of any causal relationship between influenza and IPD. We concluded that each variable
contained information about the others’ dynamics, suggesting they could interact in the
same dynamical system, however lack of a clear temporal ordering did not allow us to make
definitive conclusions about the direction of their relationship.
9.2 Future work
This thesis, while providing some answers to the questions posed at the beginning of the PhD,
opens new research directions. Some of the future work should be aimed at extending and
improving the models proposed in this thesis, as well as focussing on new methodological
avenues.
9.2.1 Extensions to the hhh modelling framework
Nonlinearity of effects
In the hhh modelling work we assume effects of covariates to be linear, including possi-
ble lags. We then go as far as exploring nonlinear dynamics through empirical dynamical
modelling and state-space reconstruction. Alternative solutions to investigate nonlinearity
of effects could be considered among stochastic models. In particular, Gasparrini [61] pro-
posed distributed lag non-linear models (DLNM), which allow nonlinear exposure–response
dependencies and delayed effects, assuming the outcome to follow a Poisson distribution
with independence among observations. If instead an autoregressive component should
be included, the (G)ARCH-family of models, popular in the financial literature, could be
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considered [52].
Time varying parameters
In the hhh model for IPD counts, we estimated the autoregressive coefficients to be constant
over time. Such an assumption has kept our model easy to interpret and avoided overfitting,
however this implies that both pneumococcal transmission and its interaction with influenza
have no seasonal behaviour. This might not be true, as S.Pneumoniae transmission is likely
to change over time following known and unknown factors, including climatic influence and
host susceptibility. An extension of this work could account for difference in transmission
across seasons, during school opening etc, making the proposed model more realistic, and
providing a better approximation of pneumococcal transmission.
9.2.2 Incorporating a transmission model
Microbiologically confirmed cases of S.Pneumoniae, recorded in the surveillance system, do
not fully capture the burden of pneumococcal disease, as only invasive disease confirmed
by culture from sterile sites is identified. We use this information, assuming pneumococcal
infection to follow from transmission, yet we are aware that pneumococcus can be carried
asymptomatically, and that those individuals also contribute to the transmission.
Here we limited our work to phenomenological models, however an extension could
involve mechanistic models, that allow modelling transmission and severity, along the lines
of Opatowski et al. [162], Trotter et al. [207], van Hoek et al. [217]. Any information about
carriage would prove useful in estimating transmission parameters. Further, if serotype-
specific information was available both at the carriage and at the invasive disease stages, this
would allow disentangling differential transmission and invasiveness of each serotype.
9.2.3 Multiple baseline design
Addressing the vaccine effects on the population overall ignores the difference between
the direct effects on vaccinated children and indirect effects due to herd immunity. We
estimated the age-specific effect of PCV introduction, however our model assumed the effect
of the intervention to be common to all age groups. A multiple baseline design [80], an
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extension of the CITS design, could be applied to measure the lag of PCV effect across
groups, or to jointly assess the effect of PCV7 and PCV13. This kind of design assumes that
the intervention is introduced in different groups at different times, with a different subset
acting either as intervention or control groups at each time. This is similar to a stepped wedge
cluster randomized trial, but typically does not involve randomization [123].
9.2.4 Indirect effect of reduced S.Pneumoniae circulation
We included counts of other respiratory bacterial infections, assuming no interference. How-
ever, future work might be needed to investigate whether, in reducing carriage of vaccine-type
pneumococci, PCVs are creating an ecological niche favoring colonization by alternative res-
piratory pathogens such as Staphylococcus aureus, Haemophilus influenzae, and Moraxella
catarrhalis.
9.3 Concluding remarks
This thesis focussed on identifying, extending and applying statistical models that had been
previously employed in the analysis of routinely collected infectious disease data, to address
their limitations.
Multiple modelling approaches can be explored when aiming to estimate disease burden
or to evaluate effectiveness of interventions based on public health surveillance data. The
standard approach in this field is to employ regression-based methods, while novel extensions
of methods from the much-richer field of time-series are proposed here. Such time-series
methods had only partially been exploited to date.
We have demonstrated here their usefulness and improved flexibility over the standard
regression-based approaches in a novel setting: they allow modelling time dependence; and
reduce the number of assumptions regarding seasonality and relationships between multiple
time series.
Lastly, in applying these novel methods we have provided relevant estimates of influenza
contribution to LRTI, pneumococcal vaccine impact and COVID-19 excess mortality, and
clarified the contributing role of risk factors and heterogeneity across age groups in terms of
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LRTI burden.
References
[1] Abadie, A., Diamond, A., and Hainmueller, J. (2010). Synthetic control methods for
comparative case studies: Estimating the effect of california’s tobacco control program.
Journal of the American statistical Association, 105(490):493–505.
[2] Abdullahi, O., Karani, A., Tigoi, C. C., Mugo, D., Kungu, S., Wanjiru, E., Jomo, J.,
Musyimi, R., Lipsitch, M., and Scott, J. A. G. (2012). The prevalence and risk factors for
pneumococcal colonization of the nasopharynx among children in kilifi district, kenya.
PloS one, 7(2):e30787.
[3] Aberth, J. (2016). The Black Death: the great mortality of 1348-1350: a brief history
with documents. Springer.
[4] Andersen, P. K. and Keiding, N. (2002). Multi-state models for event history analysis.
Statistical methods in medical research, 11(2):91–115.
[5] Auranen, K., Mehtälä, J., Tanskanen, A., and S Kaltoft, M. (2010). Between-strain
competition in acquisition and clearance of pneumococcal carriage—epidemiologic evi-
dence from a longitudinal study of day-care children. American journal of epidemiology,
171(2):169–176.
[6] Baker, P. J. (1992). T cell regulation of the antibody response to bacterial polysaccharide
antigens: an examination of some general characteristics and their implications. Journal
of Infectious Diseases, 165(Supplement_1):S44–S48.
[7] Balsells, E., Guillot, L., Nair, H., and Kyaw, M. H. (2017). Serotype distribution of
streptococcus pneumoniae causing invasive disease in children in the post-pcv era: A
systematic review and meta-analysis. PloS one, 12(5):e0177113.
[8] Baltrusaitis, K., Noddin, K., Nguyen, C., Crawley, A., Brownstein, J. S., and White,
L. F. (2018). Evaluation of approaches that adjust for biases in participatory surveillance
systems. Online Journal of Public Health Informatics, 10(1).
[9] Bergmeir, C., Hyndman, R. J., and Koo, B. (2018). A note on the validity of cross-
validation for evaluating autoregressive time series prediction. Computational Statistics &
Data Analysis, 120:70–83.
[10] Black, S., Shinefield, H., Fireman, B., Lewis, E., Ray, P., Hansen, J. R., Elvin, L.,
Ensor, K. M., Hackell, J., Siber, G., et al. (2000). Efficacy, safety and immunogenicity of
heptavalent pneumococcal conjugate vaccine in children. The Pediatric infectious disease
journal, 19(3):187–195.
164 References
[11] Bonell, C. P., Hargreaves, J., Cousens, S., Ross, D., Hayes, R., Petticrew, M., and
Kirkwood, B. (2011). Alternatives to randomisation in the evaluation of public health
interventions: design challenges and solutions. Journal of Epidemiology & Community
Health, 65(7):582–587.
[12] Box, G. E., Jenkins, G. M., Reinsel, G. C., and Ljung, G. M. (1976). Time series
analysis: forecasting and control. John Wiley & Sons.
[13] Bracher, J. and Held, L. (2017). Periodically stationary multivariate non-gaussian
autoregressive models. arXiv preprint arXiv:1707.04635.
[14] Bradley, E. and Kantz, H. (2015). Nonlinear time-series analysis revisited. Chaos: An
Interdisciplinary Journal of Nonlinear Science, 25(9):097610.
[15] Brodersen, K. H., Gallusser, F., Koehler, J., Remy, N., Scott, S. L., et al. (2015).
Inferring causal impact using bayesian structural time-series models. The Annals of
Applied Statistics, 9(1):247–274.
[16] Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N.,
and Rubin, G. J. (2020). The psychological impact of quarantine and how to reduce it:
rapid review of the evidence. The Lancet.
[17] Casdagli, M., Eubank, S., Farmer, J. D., and Gibson, J. (1991). State space reconstruc-
tion in the presence of noise. Physica D: Nonlinear Phenomena, 51(1-3):52–98.
[18] Cawkwell, G. (2006). Thucydides and the Peloponnesian war. Routledge.
[19] CDC (2008). Public health surveillance- the best weapon to avert epidemics. Available
from http://docshare.tips/dcpp-surveillance588be5 f cb6d87 f 06598b46dc.html.
[20] Chatfield, C. (2016). The analysis of time series: an introduction. CRC press.
[21] Cherazard, R., Epstein, M., Doan, T.-L., Salim, T., Bharti, S., and Smith, M. A. (2017).
Antimicrobial resistant streptococcus pneumoniae: prevalence, mechanisms, and clinical
implications. American journal of therapeutics, 24(3):e361–e369.
[22] Chertow, D. S. and Memoli, M. J. (2013). Bacterial coinfection in influenza: a grand
rounds review. Jama, 309(3):275–282.
[23] Chittaganpitch, M., Waicharoen, S., Yingyong, T., Praphasiri, P., Sangkitporn, S., Olsen,
S. J., and Lindblade, K. A. (2018). Viral etiologies of influenza-like illness and severe acute
respiratory infections in thailand. Influenza and other respiratory viruses, 12(4):482–489.
[24] Choi, B. C., Morrison, H., Wong, T., Wu, J., and Yan, Y.-P. (2007). Bringing chronic
disease epidemiology and infectious disease epidemiology back together. Journal of Epi-
demiology & Community Health, 61(9):802–802.
[25] Choi, K. and Thacker, S. B. (1981). An evaluation of influenza mortality surveillance,
1962–1979 i. time series forecasts of expected pneumonia and influenza deaths. American
journal of epidemiology, 113(3):215–226.
References 165
[26] Clark, A. T., Ye, H., Isbell, F., Deyle, E. R., Cowles, J., Tilman, G. D., and Sugihara,
G. (2015). Spatial convergent cross mapping to detect causal relationships from short time
series. Ecology, 96(5):1174–1181.
[27] Clifford, R. E., Smith, J., Tillett, H. E., and Wherry, P. J. (1977). Excess mortality
associated with influenza in england and wales. International journal of epidemiology,
6(2):115–128.
[28] Cobey, S. and Baskerville, E. B. (2016). Limits to causal inference with state-space
reconstruction for infectious disease. PloS one, 11(12).
[29] Cohen, R. (2006). Approaches to reduce antibiotic resistance in the community. The
Pediatric infectious disease journal, 25(10):977–980.
[30] Collaborators, G. . L. R. I. et al. (2018). Estimates of the global, regional, and national
morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–
2016: a systematic analysis for the global burden of disease study 2016. The Lancet.
Infectious diseases, 18(11):1191.
[Columbia University] Columbia University. Difference-in-difference estimation.
[32] Commenges, D. (2002). Inference for multi-state models from interval-censored data.
Statistical methods in medical research, 11(2):167–182.
[33] Cooper, B. S., Kotirum, S., Kulpeng, W., Praditsitthikorn, N., Chittaganpitch, M., Lim-
mathurotsakul, D., Day, N. P., Coker, R., Teerawattananon, Y., and Meeyai, A. (2015).
Mortality attributable to seasonal influenza a and b infections in thailand, 2005–2009: a
longitudinal study. American journal of epidemiology, 181(11):898–907.
[34] Correa, A., Hinton, W., McGovern, A., van Vlymen, J., Yonova, I., Jones, S., and de Lusig-
nan, S. (2016). Royal college of general practitioners research and surveillance centre (rcgp
rsc) sentinel network: a cohort profile. BMJ open, 6(4):e011092.
[35] Cox, D. R., Gudmundsson, G., Lindgren, G., Bondesson, L., Harsaae, E., Laake, P.,
Juselius, K., and Lauritzen, S. L. (1981). Statistical analysis of time series: Some recent
developments [with discussion and reply]. Scandinavian Journal of Statistics, pages 93–115.
[36] Cox, D. R. and Miller, H. D. (1977). The theory of stochastic processes, volume 134. CRC
Press.
[37] Craig, P., Cooper, C., Gunnell, D., Haw, S., Lawson, K., Macintyre, S., Ogilvie, D.,
Petticrew, M., Reeves, B., Sutton, M., et al. (2012). Using natural experiments to evaluate
population health interventions: new medical research council guidance. J Epidemiol
Community Health, 66(12):1182–1186.
[38] Crawford, D. H. (2007). Deadly companions: How microbes shaped our history. OUP
Oxford.
[39] Cromer, D., van Hoek, A. J., Jit, M., Edmunds, W. J., Fleming, D., and Miller, E. (2014).
The burden of influenza in england by age and clinical risk group: a statistical analysis to
inform vaccine policy. Journal of Infection, 68(4):363–371.
166 References
[40] Czado, C., Gneiting, T., and Held, L. (2009). Predictive model assessment for count data.
Biometrics, 65(4):1254–1261.
[41] Dagan, R., Fraser, D., Givon, N., and Yagupsky, P. (1999). Carriage of resistant pneumo-
cocci by children in southern israel and impact of conjugate vaccines on carriage. Clinical
microbiology and infection, 5:4S29–4S37.
[42] Danino, D., Givon-Lavi, N., Ben-Shimol, S., Greenberg, D., and Dagan, R. (2018).
Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal
colonization following pneumococcal conjugate vaccine implementation in young children.
Clinical Infectious Diseases.
[43] Davis, B. M., Aiello, A. E., Dawid, S., Rohani, P., Shrestha, S., and Foxman, B. (2012).
Influenza and community-acquired pneumonia interactions: the impact of order and time of
infection on population patterns. American journal of epidemiology, page kwr402.
[44] De Angelis, D., Presanis, A. M., Birrell, P. J., Tomba, G. S., and House, T. (2015). Four
key challenges in infectious disease modelling using data from multiple sources. Epidemics,
10:83–87.
[45] De Rosa, S., Spaccarotella, C., Basso, C., Calabrò, M. P., Curcio, A., Filardi, P. P., Man-
cone, M., Mercuro, G., Muscoli, S., Nodari, S., et al. (2020). Reduction of hospitalizations
for myocardial infarction in italy in the covid-19 era. European Heart Journal.
[46] Deyle, E. R., Maher, M. C., Hernandez, R. D., Basu, S., and Sugihara, G. (2016). Global
environmental drivers of influenza. Proceedings of the National Academy of Sciences, page
201607747.
[47] Dochez, A. and Gillespie, L. (1913). A biologic classification of pneumococci by means
of immunity reactions. Journal of the American Medical Association, 61(10):727–732.
[48] Dowell, S. F. (2001). Seasonal variation in host susceptibility and cycles of certain
infectious diseases. Emerging infectious diseases, 7(3):369.
[49] Durbin, J. and Koopman, S. J. (2012). Time series analysis by state space methods. Oxford
university press.
[ECDC] ECDC. Graphs and maps.
[51] England, P. H. (2014). Standards for microbiology investigations (smi). Available
from https://www.gov.uk/government/collections/standards-for-microbiology-investigations-
smi.
[52] Engle, R. (2001). Garch 101: The use of arch/garch models in applied econometrics.
Journal of economic perspectives, 15(4):157–168.
[53] Farré, L., Fasani, F., and Mueller, H. (2018). Feeling useless: the effect of unemployment
on mental health in the great recession. IZA Journal of Labor Economics, 7(1):8.
[54] Farrington, C., Andrews, N. J., Beale, A., and Catchpole, M. (1996). A statistical algorithm
for the early detection of outbreaks of infectious disease. Journal of the Royal Statistical
Society: Series A (Statistics in Society), 159(3):547–563.
References 167
[55] Farrington, C., Kanaan, M., and Gay, N. (2003). Branching process models for surveillance
of infectious diseases controlled by mass vaccination. Biostatistics, 4(2):279–295.
[56] Fears, J. R. (2004). The plague under marcus aurelius and the decline and fall of the roman
empire.
[57] Feikin, D. R., Kagucia, E. W., Loo, J. D., Link-Gelles, R., Puhan, M. A., Cherian, T.,
Levine, O. S., Whitney, C. G., O’Brien, K. L., Moore, M. R., et al. (2013). Serotype-specific
changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction:
a pooled analysis of multiple surveillance sites. PLoS medicine, 10(9):e1001517.
[58] Feldman, C. and Anderson, R. (2014). Current and new generation pneumococcal vaccines.
Journal of Infection, 69(4):309–325.
[59] for Disease Control, C., (CDC, P., et al. (2010). Licensure of a 13-valent pneumococcal
conjugate vaccine (pcv13) and recommendations for use among children-advisory committee
on immunization practices (acip), 2010. MMWR. Morbidity and mortality weekly report,
59(9):258.
[60] Fu, W. J. (1998). Penalized regressions: the bridge versus the lasso. Journal of computa-
tional and graphical statistics, 7(3):397–416.
[61] Gasparrini, A. (2014). Modeling exposure–lag–response associations with distributed lag
non-linear models. Statistics in medicine, 33(5):881–899.
[62] Gay, N., Andrews, N., Trotter, C., and Edmunds, W. (2003). Estimating deaths due to
influenza and respiratory syncytial virus—reply. JAMA, 289(19):2499–2502.
[63] Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Vehtari, A., and Rubin, D. B. (2013).
Bayesian data analysis. CRC press.
[64] Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C.,
Konradsen, H. B., and Nahm, M. H. (2015). Pneumococcal capsules and their types: past,
present, and future. Clinical microbiology reviews, 28(3):871–899.
[65] George, E. I. and McCulloch, R. E. (1993). Variable selection via gibbs sampling. Journal
of the American Statistical Association, 88(423):881–889.
[66] George, E. I. and McCulloch, R. E. (1997). Approaches for bayesian variable selection.
Statistica sinica, pages 339–373.
[67] Ghislandi, S., Muttarak, R., Sauerberg, M., and Scotti, B. (2020). News from the front:
Estimation of excess mortality and life expectancy in the major epicenters of the covid-19
pandemic in italy. medRxiv.
[68] Gilca, R., De Serres, G., Skowronski, D., Boivin, G., and Buckeridge, D. L. (2009).
The need for validation of statistical methods for estimating respiratory virus–attributable
hospitalization. American journal of epidemiology, 170(7):925–936.
[69] Goettler, D., Streng, A., Kemmling, D., Schoen, C., von Kries, R., Rose, M., van der
Linden, M., and Liese, J. (2020). Increase in streptococcus pneumoniae serotype 3 associ-
ated parapneumonic pleural effusion/empyema after the introduction of pcv13 in germany.
Vaccine, 38(3):570–577.
168 References
[70] Goldstein, E., Viboud, C., Charu, V., and Lipsitch, M. (2012). Improving the estimation
of influenza-related mortality over a seasonal baseline. Epidemiology (Cambridge, Mass.),
23(6):829.
[71] Golyandina, N. and Korobeynikov, A. (2014). Basic singular spectrum analysis and
forecasting with r. Computational Statistics & Data Analysis, 71:934–954.
[72] Golyandina, N., Nekrutkin, V., and Zhigljavsky, A. A. (2001). Analysis of time series
structure: SSA and related techniques. CRC press.
[73] Graham, A. L., Allen, J. E., and Read, A. F. (2005). Evolutionary causes and consequences
of immunopathology. Annu. Rev. Ecol. Evol. Syst., 36:373–397.
[74] Granat, S. M., Mia, Z., Ollgren, J., Herva, E., Das, M., Piirainen, L., Auranen, K., and
Mäkelä, P. H. (2007). Longitudinal study on pneumococcal carriage during the first year of
life in bangladesh. The Pediatric infectious disease journal, 26(4):319–324.
[75] Granger, C. W. (1969). Testing for causality and feedback. Econometrica, 37(3):424–438.
[76] Gruger, J., Kay, R., and Schumacher, M. (1991). The validity of inferences based on
incomplete observations in disease state models. Biometrics, pages 595–605.
[77] Hanquet, G., Krizova, P., Valentiner-Branth, P., Ladhani, S. N., Nuorti, J. P., Lepoutre,
A., Mereckiene, J., Knol, M., Winje, B. A., Ciruela, P., et al. (2019). Effect of childhood
pneumococcal conjugate vaccination on invasive disease in older adults of 10 european
countries: implications for adult vaccination. Thorax, 74(5):473–482.
[78] Harris, T. E. (2002). The theory of branching processes. Courier Corporation.
[79] Hassani, H. (2007). Singular spectrum analysis: methodology and comparison.
[80] Hawkins, N. G., Sanson-Fisher, R. W., Shakeshaft, A., D’Este, C., and Green, L. W. (2007).
The multiple baseline design for evaluating population-based research. American journal of
preventive medicine, 33(2):162–168.
[81] Hays, J. N. (2005). Epidemics and pandemics: their impacts on human history. Abc-clio.
[82] He, M. M. (2016). Driving through the great recession: Why does motor vehicle fatality
decrease when the economy slows down? Social Science & Medicine, 155:1–11.
[83] Healy, M. (1983). A simple method for monitoring routine statistics. The Statistician,
pages 347–349.
[84] Hegger, R., Kantz, H., and Schreiber, T. (1999). Practical implementation of nonlinear
time series methods: The tisean package. Chaos: An Interdisciplinary Journal of Nonlinear
Science, 9(2):413–435.
[85] Held, L., Hofmann, M., Höhle, M., and Schmid, V. (2006). A two-component model for
counts of infectious diseases. Biostatistics, 7(3):422–437.
[86] Held, L., Höhle, M., and Hofmann, M. (2005). A statistical framework for the analysis of
multivariate infectious disease surveillance counts. Statistical modelling, 5(3):187–199.
References 169
[87] Held, L., Meyer, S., and Bracher, J. (2017). Probabilistic forecasting in infectious disease
epidemiology: the 13th armitage lecture. Statistics in medicine, 36(22):3443–3460.
[88] Hellard, E., Fouchet, D., Vavre, F., and Pontier, D. (2015). Parasite–parasite interactions
in the wild: How to detect them? Trends in parasitology, 31(12):640–652.
[89] Hendriks, W., Boshuizen, H., Dekkers, A., Knol, M., Donker, G. A., van der Ende, A., and
Korthals Altes, H. (2017). Temporal cross-correlation between influenza-like illnesses and
invasive pneumococcal disease in the netherlands. Influenza and Other Respiratory Viruses.
[90] Henrichsen, J. (1995). Six newly recognized types of streptococcus pneumoniae. Journal
of clinical microbiology, 33(10):2759.
[91] Hill, P. C., Cheung, Y. B., Akisanya, A., Sankareh, K., Lahai, G., Greenwood, B. M., and
Adegbola, R. A. (2008). Nasopharyngeal carriage of streptococcus pneumoniae in gambian
infants: a longitudinal study. Clinical infectious diseases, 46(6):807–814.
[92] Holland, P. W. (1986). Statistics and causal inference. Journal of the American statistical
Association, 81(396):945–960.
[93] Holt, C. C. (2004). Forecasting seasonals and trends by exponentially weighted moving
averages. International journal of forecasting, 20(1):5–10.
[94] Hopkins, D. R. (1980). Ramses v: earliest know victim?
[95] Hougaard, P. (1999). Multi-state models: a review. Lifetime data analysis, 5(3):239–264.
[96] Hubert, B., Watier, L., Garnerin, P., and Richardson, S. (1992). Meningococcal disease and
influenza-like syndrome: a new approach to an old question. Journal of Infectious Diseases,
166(3):542–545.
[97] Huffaker, R., Bittelli, M., and Rosa, R. (2017). Nonlinear time series analysis with R.
Oxford University Press.
[98] Hulten, K. G. (2018). The changing epidemiology of pneumococcal diseases. The Lancet
Infectious Diseases, 18(9):929–930.
[99] Ihekweazu, C. A., Dance, D., Pebody, R., George, R., Smith, M., Waight, P., Christensen,
H., Cartwright, K., and Stuart, J. (2008). Trends in incidence of pneumococcal disease
before introduction of conjugate vaccine: South west england, 1996–2005. Epidemiology &
Infection, 136(8):1096–1102.
[100] Imai, C. and Hashizume, M. (2015). A systematic review of methodology: time series
regression analysis for environmental factors and infectious diseases. Tropical medicine and
health, 43(1):1–9.
[101] Imbens, G. W. and Wooldridge, J. M. (2009). Recent developments in the econometrics
of program evaluation. Journal of economic literature, 47(1):5–86.
[Ipsos Mori] Ipsos Mori. The health foundation covid-19 survey.
170 References
[103] Izurieta, H. S., Thompson, W. W., Kramarz, P., Shay, D. K., Davis, R. L., DeStefano, F.,
Black, S., Shinefield, H., and Fukuda, K. (2000). Influenza and the rates of hospitalization
for respiratory disease among infants and young children. New England Journal of Medicine,
342(4):232–239.
[104] Jackson, M., Peterson, D., Nelson, J., Greene, S., Jacobsen, S., Belongia, E., Baxter,
R., and Jackson, L. A. (2015). Using winter 2009–2010 to assess the accuracy of methods
which estimate influenza-related morbidity and mortality. Epidemiology and infection,
143(11):2399–2407.
[105] Jackson, M. L. (2009). Confounding by season in ecologic studies of seasonal expo-
sures and outcomes: examples from estimates of mortality due to influenza. Annals of
Epidemiology, 19(10):681–691.
[106] Janeway, C. A., Travers, P., Walport, M., Shlomchik, M., et al. (1996). Immunobiology:
the immune system in health and disease, volume 7. Current Biology London.
[107] Kalbfleisch, J. and Lawless, J. F. (1985). The analysis of panel data under a markov
assumption. Journal of the American Statistical Association, 80(392):863–871.
[108] Kantz, H. and Schreiber, T. (2004). Nonlinear time series analysis, volume 7. Cambridge
university press.
[109] Karppinen, S., Teräsjärvi, J., Auranen, K., Schuez-Havupalo, L., Siira, L., He, Q., Waris,
M., and Peltola, V. (2017). Acquisition and transmission of streptococcus pneumoniae
are facilitated during rhinovirus infection in families with children. American journal of
respiratory and critical care medicine, 196(9):1172–1180.
[110] Kennel, M. B., Brown, R., and Abarbanel, H. D. (1992). Determining embedding
dimension for phase-space reconstruction using a geometrical construction. Physical review
A, 45(6):3403.
[111] Klugman, K. P. (2001). Efficacy of pneumococcal conjugate vaccines and their effect on
carriage and antimicrobial resistance. The Lancet infectious diseases, 1(2):85–91.
[112] Kuster, S. P., Tuite, A. R., Kwong, J. C., McGeer, A., Fisman, D. N., Network, T. I. B. D.,
et al. (2011). Evaluation of coseasonality of influenza and invasive pneumococcal disease:
results from prospective surveillance. PLoS Med, 8(6):e1001042.
[113] Ladhani, S. N., Collins, S., Djennad, A., Sheppard, C. L., Borrow, R., Fry, N. K., Andrews,
N. J., Miller, E., and Ramsay, M. E. (2018). Rapid increase in non-vaccine serotypes causing
invasive pneumococcal disease in england and wales, 2000–17: a prospective national
observational cohort study. The Lancet Infectious Diseases, 18(4):441–451.
[114] Launes, C., de Sevilla, M.-F., Selva, L., Garcia-Garcia, J.-J., Pallares, R., and Muñoz-
Almagro, C. (2012). Viral coinfection in children less than five years old with invasive
pneumococcal disease. The Pediatric infectious disease journal, 31(6):650–653.
[115] Lawless, J. and Fredette, M. (2005). Frequentist prediction intervals and predictive
distributions. Biometrika, 92(3):529–542.
References 171
[116] Lewis, D. (1973). Counterfactuals and comparative possibility. In Ifs, pages 57–85.
Springer.
[117] Lewnard, J. A. and Hanage, W. P. (2019). Making sense of differences in pneumococcal
serotype replacement. The Lancet Infectious Diseases.
[118] Linden, A. and Yarnold, P. R. (2016). Using machine learning to identify structural
breaks in single-group interrupted time series designs. Journal of Evaluation in Clinical
Practice, 22(6):855–859.
[119] Linley, E., Bell, A., Gritzfeld, J., and Borrow, R. (2019). Should pneumococcal serotype
3 be included in serotype-specific immunoassays? Vaccines, 7(1):4.
[120] Lipsitch, M., Abdullahi, O., D’Amour, A., Xie, W., Weinberger, D. M., Tchetgen, E. T.,
and Scott, J. A. G. (2012). Estimating rates of carriage acquisition and clearance and
competitive ability for pneumococcal serotypes in kenya with a markov transition model.
Epidemiology (Cambridge, Mass.), 23(4):510.
[121] Littman, R. J. (2009). The plague of athens: epidemiology and paleopathology. Mount
Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine: A Journal
of Translational and Personalized Medicine, 76(5):456–467.
[122] Loi, M. and Rodrigues, M. (2012). A note on the impact evaluation of public policies:
the counterfactual analysis.
[123] Lopez Bernal, J., Cummins, S., and Gasparrini, A. (2018). The use of controls in
interrupted time series studies of public health interventions. International journal of
epidemiology, 47(6):2082–2093.
[124] Lorenz, E. N. (1963). Deterministic nonperiodic flow. Journal of the atmospheric
sciences, 20(2):130–141.
[125] Lui, K.-J. and Kendal, A. P. (1987). Impact of influenza epidemics on mortality in the
united states from october 1972 to may 1985. American journal of public health, 77(6):712–
716.
[126] Madhav, N., Oppenheim, B., Gallivan, M., Mulembakani, P., Rubin, E., and Wolfe, N.
(2017). Pandemics: risks, impacts, and mitigation. In Disease Control Priorities: Improving
Health and Reducing Poverty. 3rd edition. The International Bank for Reconstruction and
Development/The World Bank.
[127] Makela, P. (2008). Bj. history of pneumococcal immunization siber gr kk, makela ph.
[128] Marks, G. and Beatty, W. K. (1976). Epidemics. Scribner.
[129] Matias, G., Taylor, R. J., Haguinet, F., Schuck-Paim, C., Lustig, R. L., and Fleming, D. M.
(2016). Modelling estimates of age-specific influenza-related hospitalisation and mortality in
the united kingdom. BMC public health, 16(1):481.
[130] Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., and Klugman, K. P.
(1999). Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococ-
cal conjugate vaccine. The Journal of infectious diseases, 180(4):1171–1176.
172 References
[131] McCullers, J. A. (2006). Insights into the interaction between influenza virus and
pneumococcus. Clinical microbiology reviews, 19(3):571–582.
[132] McCullers, J. A. (2014). The co-pathogenesis of influenza viruses with bacteria in the
lung. Nature Reviews Microbiology, 12(4):252–262.
[133] McIsaac, D. I., Abdulla, K., Yang, H., Sundaresan, S., Doering, P., Vaswani, S. G.,
Thavorn, K., and Forster, A. J. (2017). Association of delay of urgent or emergency surgery
with mortality and use of health care resources: a propensity score–matched observational
cohort study. Cmaj, 189(27):E905–E912.
[134] McLaughlin, J. M., Jiang, Q., Gessner, B. D., Swerdlow, D. L., Sings, H. L., Isturiz, R. E.,
and Jodar, L. (2019). Pneumococcal conjugate vaccine against serotype 3 pneumococcal
pneumonia in adults: A systematic review and pooled analysis. Vaccine.
[135] McNeill, W. H. (1993). Patterns of disease emergence in history. Emerging viruses,
pages 29–36.
[136] Mehr, S. and Wood, N. (2012). Streptococcus pneumoniae–a review of carriage, infection,
serotype replacement and vaccination. Paediatric respiratory reviews, 13(4):258–264.
[137] Mehtälä, J., Antonio, M., Kaltoft, M. S., O’Brien, K. L., and Auranen, K. (2013).
Competition between streptococcus pneumoniae strains: implications for vaccine-induced
replacement in colonization and disease. Epidemiology, pages 522–529.
[138] Melegaro, A., Choi, Y., Pebody, R., and Gay, N. (2007). Pneumococcal carriage in united
kingdom families: estimating serotype-specific transmission parameters from longitudinal
data. American journal of epidemiology, 166(2):228–235.
[139] Meyer, S., Held, L., et al. (2014). Power-law models for infectious disease spread. The
Annals of Applied Statistics, 8(3):1612–1639.
[140] Meyer, S., Held, L., and Höhle, M. (2016). hhh4: Endemic-epidemic modeling of areal
count time series. Journal of Statistical Software.
[141] Millar, E. V., O’Brien, K. L., Zell, E. R., Bronsdon, M. A., Reid, R., and Santosham, M.
(2009). Nasopharyngeal carriage of streptococcus pneumoniae in navajo and white mountain
apache children before the introduction of pneumococcal conjugate vaccine. The Pediatric
infectious disease journal, 28(8):711–716.
[142] Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P., and George, R. C. (2011). Herd
immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate
vaccination in england and wales: an observational cohort study. The Lancet infectious
diseases, 11(10):760–768.
[143] Mills, T. C. (1991). Time series techniques for economists. Cambridge University Press.
[144] Mina, M. J. and Klugman, K. P. (2014). The role of influenza in the severity and
transmission of respiratory bacterial disease. The Lancet Respiratory Medicine, 2(9):750–
763.
References 173
[145] Mitchell, T. J. and Beauchamp, J. J. (1988). Bayesian variable selection in linear
regression. Journal of the american statistical association, 83(404):1023–1032.
[146] Mølbak, K. and Mazick, A. (2013). European monitoring of excess mortality for public
health action (euromomo) kåre mølbak. European Journal of Public Health, 23(suppl_1).
[147] Montemurro, N. (2020). The emotional impact of covid-19: From medical staff to
common people. Brain, behavior, and immunity.
[148] Morens, D. M., Taubenberger, J. K., and Fauci, A. S. (2008). Predominant role of
bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic
influenza preparedness. Journal of Infectious Diseases, 198(7):962–970.
[149] Mossong, J., Hens, N., Jit, M., Beutels, P., Auranen, K., Mikolajczyk, R., Massari, M.,
Salmaso, S., Tomba, G. S., Wallinga, J., et al. (2008). Social contacts and mixing patterns
relevant to the spread of infectious diseases. PLoS medicine, 5(3):e74.
[150] Murdoch, D. R. and Howie, S. R. (2018). The global burden of lower respiratory
infections: making progress, but we need to do better. The Lancet Infectious Diseases,
18(11):1162–1163.
[151] Murdoch, D. R. and Jennings, L. C. (2009). Association of respiratory virus activity
and environmental factors with the incidence of invasive pneumococcal disease. Journal of
Infection, 58(1):37–46.
[152] NHS England. Ae attendances and emergency admissions may 2020 statistical commen-
tary.
[153] NHS England. Cancer waiting times data.
[154] NHS England. Nhs inpatient admission and outpatient referrals and attendances.
[155] NHS England. Nhs referral to treatment (rtt) waiting times data.
[156] Nicoli, E. J., Trotter, C. L., Turner, K. M., Colijn, C., Waight, P., and Miller, E. (2013).
Influenza and rsv make a modest contribution to invasive pneumococcal disease incidence in
the uk. Journal of Infection, 66(6):512–520.
[157] Obaro, S. K., Adegbola, R., Banya, W., and Greenwood, B. (1996). Carriage of pneumo-
cocci after pneumococcal vaccination. The Lancet, 348(9022):271–272.
[158] O’Brien, K. L., Moulton, L. H., Reid, R., Weatherholtz, R., Oski, J., Brown, L., Kumar,
G., Parkinson, A., Hu, D., Hackell, J., et al. (2003). Efficacy and safety of seven-valent
conjugate pneumococcal vaccine in american indian children: group randomised trial. The
Lancet, 362(9381):355–361.
[159] O’Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N.,
Lee, E., Mulholland, K., Levine, O. S., Cherian, T., et al. (2009). Burden of disease caused
by streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet,
374(9693):893–902.
[160] Olsen, L. F. and Schaffer, W. M. (1990). Chaos versus noisy periodicity: alternative
hypotheses for childhood epidemics. Science, 249(4968):499–504.
174 References
[161] ONS (2017). England population mid-year esti-
mate, office for national statistics. Available from:
https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop.
[162] Opatowski, L., Varon, E., Dupont, C., Temime, L., van der Werf, S., Gutmann, L.,
Boëlle, P.-Y., Watier, L., and Guillemot, D. (2013). Assessing pneumococcal meningitis
association with viral respiratory infections and antibiotics: insights from statistical and
mathematical models. Proceedings of the Royal Society of London B: Biological Sciences,
280(1764):20130519.
[163] Ouldali, N., Levy, C., Minodier, P., Morin, L., Biscardi, S., Aurel, M., Dubos, F.,
Dommergues, M. A., Mezgueldi, E., Levieux, K., et al. (2019). Long-term association of
13-valent pneumococcal conjugate vaccine implementation with rates of community-acquired
pneumonia in children. JAMA pediatrics, 173(4):362–370.
[164] Park, R. E. and Mitchell, B. M. (1980). Estimating the autocorrelated error model with
trended data. Journal of Econometrics, 13(2):185–201.
[165] Parker, D. E., Legg, T. P., and Folland, C. K. (1992). A new daily central england
temperature series, 1772–1991. International Journal of Climatology, 12(4):317–342.
[166] Paul, M., Held, L., and Toschke, A. M. (2008). Multivariate modelling of infectious
disease surveillance data. Statistics in medicine, 27(29):6250.
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Fig. A.1 Fitted IPD values all ages
Age α γ δ log(ψ) log(τ) log(θ) log(ζ ) log(λ ) log(φ)
<5 -2.369 -0.319 -0.062 2.524 - -2.307 -4.000 2.178 1.225
5-14 -4.395 -0.367 -0.062 1.598 -3.245 - - 2.282 1.308
15-44 -4.034 -0.477 -0.062 3.027 -1.627 - - 3.725 4.094
45-64 -2.912 -0.315 -0.062 3.304 -2.156 2.215 2.754 3.158 3.646
65+ -2.046 -0.458 -0.062 3.341 - 2.504 2.571 3.097 4.337
Table A.1 Model K: Coefficient estimates for the age-specific model of IPD including Flu,
rhinovirus and RSV

































































































































































































































































Fig. A.2 RSV and rhinovirus incidence rates
Age α γ δ log(ψ) log(τ) log(θ) log(ζ ) log(λ ) log(φ)
< 5 0.016 0.017 0.003 0.039 - 0.311 1.140 0.011 0.016
5−14 0.014 0.009 0.003 0.072 0.100 - - 0.052 0.025
15−44 0.006 0.006 0.003 0.022 0.066 - - 0.007 0.001
45−64 0.014 0.012 0.003 0.018 0.671 0.040 0.051 0.006 0.001
65+ 0.004 0.003 0.003 0.011 - 0.028 0.047 0.003 0.001
Table A.2 Model K: Coefficient standard errors for the age-specific model of IPD including



































































































































































































































































Fig. A.3 Observed counts: 15-44 years old





































































































































































































































































































































































































































































































































Fig. A.5 Observed counts: 65+ years old













































































































































































































































































































































































































































































































Fig. A.7 Model H: Predictive distribution for 45-64 and 65+

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. A.11 Model K: Fitted IPD values for the 45-64 age group






















































































































































































































































































































































































































































































































Fig. A.12 Model K: Fitted IPD values for the elderly
Appendix B
Supplementary information to chapter 6
B.1 Observed IPD incidence by age and PCV group










































































































































Fig. B.1 PCV7 serotypes, incidence rate per million residents (scales differ across panels)
.










































































































































Fig. B.2 PCV13 serotypes, incidence rate per million residents (scales differ across panels)
.










































































































































Fig. B.3 NV serotypes, incidence rate per million residents (scales differ across panels)
.
B.2 Sensitivity analysis for change of lag in ITS 195



































































































































































































































































































































































Fig. B.4 Control time series, incidence rate per million residents (scales differ across panels)
.
B.2 Sensitivity analysis for change of lag in ITS
The results presented in the main text assume that impact of intervention kicks in at one
year lag from the policy implementation. Here we explore how using a two-years lag affects
our conclusions. We can say that change of lag does not produce a significant change when
modelling the impact of PCV overall, as shown in figure B.5. Similarly, when modelling
PCV7-IPD and non-PCV7-IPD, we can see that the two-year lag slightly amplifies the
intervention effect, as for B.6, but effects have the same direction and magnitude. Finally,
results don’t change considerably also when modelling PCV13-IPD and nonPCV13-IPD, as
shown in B.7. Hence, we are overall confident that our results are robust with respect to the
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Poisson regression with PCV
Counterfactual without PCV
Fig. B.5 Fitted IPD counts based on three ITS models
.
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Jul 2000 Jul 2001 Jul 2002 Jul 2003 Jul 2004 Jul 2005 Jul 2006 Jul 2007 Jul 2008 Jul 2009 Jul 2010
Observed Counts
Poisson regression with PCV
Counterfactual without PCV
Fig. B.6 Fitted PCV7- and nonPCV7-IPD counts based on three ITS models
.
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Observed Counts
Poisson regression with PCV
Counterfactual without PCV
Fig. B.7 Fitted PCV13- and NVT-IPD counts based on three ITS models
B.3 BSTS for IPD by age 199
B.3 BSTS for IPD by age
B.3.1 Models B and C: impact of PCV7















































































































































































Fig. B.8 Fitted PCV7- and nonPCV7-IPD incidence rates in children younger than 5
.
B.3.2 Models D and E: impact of PCV13


















































































































































































Fig. B.9 Fitted PCV7- and nonPCV7-IPD incidence rates in children of age 5-14


















































































































































































Fig. B.10 Fitted PCV7- and nonPCV7-IPD incidence rates in adults aged 15-44














































































































































































Fig. B.11 Fitted PCV7- and nonPCV7-IPD incidence rates in adults aged 45-64














































































































































































Fig. B.12 Fitted PCV7- and nonPCV7-IPD incidence rates in adults aged 65+

















































































































































































































Fig. B.13 Fitted PCV13- and NVT-IPD incidence rates in children younger than 5
.


















































































































































































































Fig. B.14 Fitted PCV13- and NVT-IPD incidence rates in children of age 5-14
.














































































































































































































Fig. B.15 Fitted PCV13- and NVT-IPD incidence rates in adults aged 15-44
.


















































































































































































































Fig. B.16 Fitted PCV13- and NVT-IPD incidence rates in adults aged 45-64
.

















































































































































































































Supplementary information to chapter 7
C.1 Singular value decomposition (SVD)
Spectral decomposition, or eigendecomposition, is the expansion of the original data in a
coordinate system where the covariate matrix is diagonal. Given a square matrix A, this
process leads to its factorization in a simpler form, in terms of its eigenvalues and eigenvectors.
Its eigenvalues λ (A) and its eigenvectors x(A) are the set of values for which




x(A) = 0 (C.2)
Since x(A) must be non-zero, the matrix A−λ (A)I must have zero determinant. Thus, the
eigenvalues λ (A) are determined first by solving the characteristic equation |A−λ (A)I|= 0,
i.e. by finding a unique set of values λ (A) such that the determinant of A−λ (A)I is equal to
zero. The resulting set of eigenvalues is also called spectrum of A.
The set of equations in C.2 is then solved for each eigenvalue: for each value λ (A)i one
set of eigenvectors x(A)i , of dimension n, is obtained. Given n distinct eigenvalues, n sets of
linearly independent eigenvectors x(A)i are obtained.
This process is also called diagonalisation of A, as finding eigenvalues and eigenvectors
allows writing A = PΛP−1, where P is an orthogonal matrix whose columns vector are the
set of orthonormal eigenvectors of A, while the diagonal entries of Λ are the corresponding
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eigenvalues of A. It results that:
A = λ1 p1 pT1 + · · ·+λn pn pTn (C.3)
Given a matrix B, of dimension nxp, a generalisation of spectral decomposition is
necessary: singular value decomposition consists of a two-bases diagonalisation. Eigenvalues
and eigenvectors for BBT and BTB are computed, and this leads to the factorisation
B = UΣV−1 (C.4)
where U is a nxn matrix whose columns are the orthonormal eigenvectors of BBT, also called
left singular vectors; Σ is a diagonal matrix nxp whose diagonal elements are square roots
of the eigenvalues of BBT, also called singular values; finally, V is a pxp matrix whose
columns are the orthonormal eigenvectors of BTB, also called right singular vectors. Hence
U and V are orthogonal bases.
Singular values σi =
√
λi are identified in descending order. Generally, r<p of them are




λ1u1vT1 + · · ·+
√
λrurvTr (C.5)
Hence, the rank r matrix B is separated into r rank 1 matrices, called elementary matrices, or-
dered from the largest to the smallest. The triple
√
(λi),ui,vi is also known as ith eigentriple.
C.2 Supplementary results
C.2.1 SSA IPD
When aiming to extract a seasonality component from observed time series, SSA helps
to identify eigenvectors that bear correspondence with a harmonic wave. This is easily
identifiable from pairs of components which have the form of sine/cosine sequences with
the same frequency from the eigenvector plot. In our case, as shown in the top panel of
Figure C.1, components 2 and 3 feature four oscillations over 208 weeks, i.e. one oscillation
every 52 weeks. Each panel also indicates a percentage representing the portion of total
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variance in the observed time series explained by the particular eigenvector: in the case of
IPD, seasonality explains a total of 10.5% of the variability.
Visual analysis of the pairwise scatterplots of the singular vectors also allows to visually
identify those eigentriples that corresponds to the harmonic components of the series: a pair
of sine/cosine waves with equal frequencies, amplitudes, and phases create a scatterplot with
points lying on a circle. The purer the information on these harmonic waves, the easier it
is to identify their frequency based on the number of vertices of a regular polygon. In our
example, eigenvectors 2-3 picture a well-defined circle as they describe yearly periodicity, as
shown in the bottom panel of Figure C.1.
C.2.2 SSA flu
In the top panel of Figure C.3, eigenvectors 2 and 3 hint at seasonal harmonics, with four
oscillations over 208 weeks as for IPD, jointly explaining 22.7% of the variability. This is
confirmed by the plot for the corresponding eigenvector pair, in the bottom panel of Figure
C.3, which pictures a circle even though not as well defined as in the case of IPD.
C.2.3 Embedding and CCM on original rates
We show here for comparison the choice of embedding parameters if we had computed AMI
and FNN for the original rates instead of the extracted signals: in both cases, we would have
required higher embedding dimensions, specifically 4 for IPD and 5 for influenza.
The resulting CCM predictive skills are summarised in Figure C.7
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Eigenvectors
1 (79.76%) 2 (5.3%) 3 (5.23%)
4 (0.65%) 5 (0.53%) 6 (0.53%)
7 (0.51%) 8 (0.5%) 9 (0.49%)
Pairs of eigenvectors
1 (79.76%) vs 2 (5.3%) 2 (5.3%) vs 3 (5.23%) 3 (5.23%) vs 4 (0.65%)
4 (0.65%) vs 5 (0.53%) 5 (0.53%) vs 6 (0.53%) 6 (0.53%) vs 7 (0.51%)
7 (0.51%) vs 8 (0.5%) 8 (0.5%) vs 9 (0.49%) 9 (0.49%) vs 10 (0.49%)
Fig. C.1 Eigenvectors for SSA of IPD time series, individually and in pairs
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Fig. C.2 W-correlation matrix on the IPD residuals shows no separability for other compo-
nents
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Eigenvectors
1 (20.96%) 2 (11.29%) 3 (10.39%)
4 (3.79%) 5 (3.57%) 6 (3.13%)
7 (2.69%) 8 (2.63%) 9 (2.41%)
Pairs of eigenvectors
1 (20.96%) vs 2 (11.29%) 2 (11.29%) vs 3 (10.39%) 3 (10.39%) vs 4 (3.79%)
4 (3.79%) vs 5 (3.57%) 5 (3.57%) vs 6 (3.13%) 6 (3.13%) vs 7 (2.69%)
7 (2.69%) vs 8 (2.63%) 8 (2.63%) vs 9 (2.41%) 9 (2.41%) vs 10 (2.09%)
Fig. C.3 Eigenvectors for SSA of Flu time series, individually and in pairs
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Fig. C.4 W-correlation matrix on the IPD residuals shows no separability for other compo-
nents















































Fig. C.5 Selection of time delay τ and embedding dimension E for the original IPD rates
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Fig. C.6 Selection of time delay τ and embedding dimension E for the original flu rates











Flu xmap to IPD
IPD xmap to Flu
Fig. C.7 CCM predictive skills when applied on the original time series

